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Abstract 
 
A number of oxygenated heterocycles have been described in nature as having a myriad of 
biological activities. Owing to these biological activities and their complex structure, these 
compounds are of interest to us and the preparation of selected oxygenated heterocycles is 
described in this thesis. Three main sections form this thesis, with each representing a class of 
oxygenated heterocycle. 
 
The first part of the thesis deals with pyranonaphthoquinone analogues where a model study was 
performed to construct the skeleton of the isochromane kalafungin. The synthesis of 
isochromane 6,9-dimethoxy-3,3a,5,9b-tetrahydro-2H-furo[3,2-c]isochromen-2-one was 
successfully achieved from commercially available 2,5-dihydroxybenzoic acid in an overall yield 
of 9.5%. The key steps employed in the synthesis of the isochromane were a cross metathesis 
reaction between (2-allyl-3,6-dimethoxyphenyl)methanol and ethyl acrylate to afford the α,β-
unsaturated ester (E)-ethyl-4-(2-(hydroxymethyl)-3,6-dimethoxyphenyl)but-2-enoate which, 
after several synthetic steps, was converted to the isochromane via a radical induced 
lactonization using a hypervalent iodine reagent. The success of this route led us to the 
preparation of iscochromane (3aR, 5R, 9bR)-6,9-dimethoxy-5-methyl-3,3a,5,9b-tetrahydro-2H-
furo[3,2-c]isochromen-2-one. Our initial aim was to enzymatically resolve intermediate racemic 
alcohol 1-(2-allyl-3,6-dimethoxyphenyl)ethanol, however, the use of Candida antarctica lipase 
B (CALB) to facilitate the kinetic resolution was not as successful as we hoped. Therefore, using 
racemic alcohol 1-(2-allyl-3,6-dimethoxyphenyl)ethanol and the key reaction conditions 
developed in the model study of 6,9-dimethoxy-3,3a,5,9b-tetrahydro-2H-furo[3,2-c]isochromen-
2-one, we successfully prepared isochromane (3aR, 5R, 9bR)-6,9-dimethoxy-5-methyl-3,3a,5,9b-
tetrahydro-2H-furo[3,2-c]isochromen-2-one in an overall yield of 0.4%, albeit racemically. 
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The second part of this thesis involved the use of nitroalkanes as precursors to spiroketals. In this 
section, we managed to successfully elucidate the mechanism of a novel Nef reaction previously 
described in our laboratories using three different substrates. The key steps involved during the 
elucidation of the mechanism were a Henry condensation reaction and a key modified Nef 
reaction. The preparation of the spiroketal skeleton of the griseusins was also attempted. 
 
The last part of this PhD thesis focused on the formation of angucycline analogues, specifically 
analogues related to the landomycins. We have successfully managed to prepare landomycin 
analogues tetraphene-7,12-dione, 3-methoxytetraphene-7,12-dione and 3,8-dimethoxytetraphene-
7,12-dione. A Suzuki reaction followed by a Wittig reaction, isomerisation and final ring closing 
metathesis allowed for the smooth preparation of these analogues. The preparation of related 
analogues bearing seven-membered rings has also been achieved and is described.
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Chapter 1: Pyranonaphthoquinones - An Introduction 
 
1.1. Biological importance of pyranonaphthoquinones 
 
A large number of isochromane containing compounds exist in nature. The main class of 
isochromanes relating to this thesis are the pyranonaphthoquinones, which have been isolated 
from various strains of bacteria and fungi. The basic structure of these compounds (Figure 1.1) 
is the naphtho[2,3-c]pyran-5,10-dione ring system shown in structure 1. Another feature found in 
some members of this class of compounds is the γ-lactone ring as shown in structure 2, which is 
fused to the pyran moiety. Some members possess a carboxylic acid side chain at C3 3.1,2 
 
 
 
Figure 1.1 
 
These compounds are of interest as they exhibit a wide variety of pharmacological properties. 
Derivatives of such compounds are also found to exhibit plant-growth and herbicidal activities, 
while others have been found in fragrances, e.g. galaxolide 4, shown in Figure 1.2.3 As a result, 
there is a growing interest in developing improved methods for the synthesis of these 
isochromane containing compounds. It is for this reason that scientific research directed towards 
the synthesis of compounds of this class is necessary.  
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Figure 1.2 
 
1.2. Naturally occurring pyran fused quinones 
 
The literature contains many examples of naturally occurring quinones isolated from various 
fungal and bacterial strains. These can be classified into three types of pyranonaphthoquinones, 
namely monomeric, dimeric and carbohydrate derived pyranonaphthoquinones. Each of these 
classes of quinones will be briefly discussed in the following sections. 
 
1.2.1. Monomeric pyranonaphthoquinones 
 
1.2.1.1. Simple and Fusarium based quinones 
 
One of the simplest compounds which contains the naphthopyrandione system is psychorubin, 5 
(Figure 1.3), which was isolated from Psychotria rubra. This compound bears a hydroxyl 
substituent at the C3 position of the pyran ring making it a hemiacetal. It has been found to 
exhibit significant cytotoxicity against KB cancer cells.4 Anhydrofusarubin 6, shown in 
Figure 1.3, has recently been isolated from the sea-fan-derived fungus Fusarium spp. and is of 
interest due to its excellent biological activity. It has been shown to exhibit better cytotoxicity 
against both oral and breast cancer cell lines than the current drugs of choice: ellipticine and 
doxorubicin respectively.5 As will be discussed later, this quinone has been synthesised in our 
laboratories.4 
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Figure 1.3 
 
1.2.1.2. Monomeric pyranonaphthoquinones 
 
An example of a monomeric pyran fused quinone is thysanone, 7 shown in Figure 1.4, which 
was isolated from cultures of Thysanophora penicilloides. Thysanone has been shown to exhibit 
potent activity against HRV 3C-protease, which is a human rhinovirus (HRV) from the family of 
picornaviruses which are responsible for human diseases such as hepatitis A and polio. 
Thysanone is therefore one of the lead compounds in the development of a cure for the common 
cold.6,7 Another type of monomeric quinone containing a pyran ring is 5-hydroxy-6-methoxy-α-
lapachome, 8, which has been isolated from the stem bark of Melloa quadivalvis. This compound 
has been found to exhibit cytotoxic activity against the lung carcinoma cell line, NC1H292.2 An 
important monomeric quinone which contains an additional γ-lactone ring fused to the basic 
naphtho[2,3-c]pyran-5,10-dione ring system that is important to this thesis is kalafungin, 9 
(Figure 1.4).1 This antifungal pigment was isolated from Streptomyces tanashiensis as well as 
Nocardia dassonvillie.  
 
 
 
Figure 1.4 
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Kalafungin, 9 (Figure 1.4), has been found to be inhibitory in vitro against a variety of 
pathogenic fungi, protozoa, yeasts as well as gram-positive bacteria. Recent studies have shown 
that kalafungin displays inhibitory activity against L5178Y mouse leukemic cells in vitro. 8 The 
stereochemistry present in kalafungin has also made it an attractive substrate to pursue 
synthetically. 
 
1.2.2. Dimeric pyranonaphthoquinones 
 
Research conducted at the University of the Witwatersrand on dimeric quinones includes the 
synthesis of pyranonaphthoquinone-type pigments, known as the cardinalins. This group of 
compounds is the first class of pyranonaphthoquinones to be discovered in higher order fungi. 
Cardinalins 1 to 6 have been isolated from the New Zealand toadstool Dermocybe cardinalis 
which is known to produce distinctive purple and orange fruit bodies. All six cardinalins display 
good anticancer activities. Studies conducted at the University of the Witwatersrand focused on 
the synthesis of cardinalin 3, 10, a dimer of ventiloquinone L, 11 (Figure 1.5), which has been 
isolated from Ventolago goughii. This study used a bidirectional synthetic approach to assemble 
cardinalin 3, 10.9 
 
10 11
O
O
O
O OH
OMe
OH
MeO
O
O
O
OH
MeO
O
O
 
 
Figure 1.5 
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Other research which has occurred in the Wits laboratories includes the synthesis of chiral 
isochromanquinones using Corey-Bakshi-Shibata reductions.10 In addition, the synthesis of 
isochroman-4-ols and isochroman-3-ols has been accomplished in our laboratories using the key 
steps of an oxidative mercury-mediated ring closure and ozonolysis reaction respectively.10 The 
synthesis of the oxygen analogue of the michellamines, which has been isolated for 
Ancistrocladus korupensis has also been accomplished in the Wits laboratories. Interest in 
michellamines has risen as a result of their reported anti-HIV activity. 11 
 
1.2.3. Carbohydrate derived pyranonaphthoquinones 
 
Medermycin, 12 (Figure 1.6) is a compound that has been isolated from Streptomyces 
tanashiensis as a monohydrochloride salt. It was found to have a similar structure to kalafungin 
due to the fused lactone ring. This compound is known to exhibit biological activity against 
gram-positive bacteria. It has also shown toxicity against cell lines of K562 human myeloid 
leukemia as well as P-388 murine leukemia.1,12 A related quinone named after the red garnet-like 
crystals isolated from Streptomyces olivaceus, granaticin A, 13, has been shown to exhibit 
antibiotic activity against gram-positive bacteria. It has also been shown to possess antitumour 
activity against lymphatic leukemia in mice, as well as being cytotoxic against KB cells which 
are cells associated with mouth epidermal carcinoma.  
 
 
Figure 1.6 
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1.2.4. Other interesting isochromane compounds 
 
The isolation of an isochromane fungal metabolite, pseudodeflectitusin, 14 (Figure 1.7), from a 
culture broth of Aspergillus pseudodeflectus has been reported. This compound was identified as 
an isochromane derivative using spectrometric and physicochemical techniques. Ogawa et al. 
reported that one enantiomer of these compounds showed an inhibitory effect on the cell growth 
of the NUGC-3 human stomach cancer cell line. Similar results were observed for the HeLa 
human cervix cancer line and the HL-60 human peripheral blood cancer line. 13 
 
 
 
Figure 1.7 
 
The synthesis of BCH-2051 15, an interesting isochromane containing compound, by Wang et 
al., and its subsequent biological screening showed that BCH-2051 is a very potent analogue of 
anthracycline compounds.14 Furthermore, it has been shown to exhibit even better activity than 
adriamycin 16, shown in Figure 1.8, which stabilises the topoisomerase-DNA cleavage complex 
which leads to DNA damage.  
 
 
 
Figure 1.8 
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1.3. Proposed mechanisms of biological activity of pyranonaphthoquinone antibiotics 
 
In Section 1.2 we highlighted a few examples of the different classes of the 
pyranonaphthoquinones and briefly discussed the biological activities of the classes mentioned. 
In this section we will outline the proposed mechanisms of action of these quinones. The 
pyranonapthoquinone antibiotics have been postulated to act as bioreductive alkylating agents by 
Moore and coworkers.15 Compounds which are considered to be bioreductive alkylating agents 
become potent alkylating agents after they undergo a reduction in vivo. These types of 
compounds have also been shown to possess a high level of antineoplastic activity.15 
Furthermore, there have been various studies conducted which have described topoisomerase II 
inhibition by pyranonaphthoquinones, thus revealing new possibilities in the design of anti-
cancer drugs.16,17  
 
1.3.1. Simple quinone methides 
 
A generalised model for their activity is shown in Scheme 1.1. The first step in this process is the 
in vivo bioreduction of quinone, A, resulting in the formation of hydroquinone B. Cleavage of a 
benzylic substituent from B results in the formation of a quinone methide C. Structure C now 
has the potential to act as an alkylating agent, by reacting with a nucleophile in a Michael 
addition step. An example is the formation of a covalent adduct with DNA, which will lead to 
cell death. In particular, the nucleophile is expected to be the nitrogenous base of a DNA 
molecule, in a cancer cell. 
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Scheme 1.1 
 
The ability of these quinones to act as bioreductive alkylating agents has been demonstrated by 
Lin et al. who synthesised benzoquinone derivatives with one or two side chains. These 
derivatives form highly reactive Michael acceptors as shown in Scheme 1.2.18 Lin and co-
workers performed a reduction on 2,3-dimethyl-5,6-bis(acetoxymethyl)-1,4-benzoquinone, 17, to 
afford hydroquinone 18. This hydroquinone then decomposed to form the quinone methide 19 
which acts as the alkylating agent (Scheme 1.2).19 Quinone methide 19 was reacted with aniline 
and morpholine to demostrate its potential to alkylate biological materials in vivo.19 
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Scheme 1.2 
 
A known example of a bioreductive alkylating agent is mitomycin C, 20, which has been isolated 
from strains of Streptomyces species. Mitomycin C is an antineoplastic antibiotic and has been 
used to inhibit the synthesis of nucleic acids, such as DNA and RNA. It is believed that 
mitomycin C performs its function by joining together the two polynucleotide strands of DNA, 
forming a covalent cross-link. This cross-link results in the interference of DNA functions and 
ultimately the inhibition of DNA synthesis.19 It is believed that the function of the drug arises 
from the enzymatic reduction of mitomycin C 20, as shown in Scheme 1.3, followed by the loss 
of methanol and subsequent aziridine ring opening affording intermediate 21. Displacement of 
the carbamate group in 21 allows for the attack of intermediate 22 by nucleophilic sites on DNA 
resulting in the formation of the cross-linked DNA product 23.20 
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Scheme 1.3 
 
1.3.2. Inhibition of the DNA topoisomerase II enzyme 
 
The topoisomerase enzyme II (TopoII) has become a desirable target for potential anti-cancer 
drugs due to its important catalytic function. This enzyme has various functions which can be 
simplified to the maintenance of the topological state of DNA during processes such as 
replication, transcription and recombination.21,22 The function of the topoisomerase enzyme can 
be interrupted in two ways. These include the stabilization of the covalent intermediate of the 
enzyme with DNA by compounds known as topoisomerase II poisons, or by compounds, known 
as catalytic inhibitors, which target any step in the catalytic cycle.23 Topoisomerase II was 
identified as a possible target for anticancer drugs such as doxorubicin, 24, and mitoxantrone, 25, 
which are potent TopoII poisons (Figure 1.9).16 The quinone moiety is known to possess anti-
proliferative activity against a wide range of organisms and cancer cells. It has also been stated 
that the quinone moieties combine features of poisons and catalytic inhibitors which allow them 
to possess enhanced activity. Eleutherin, 26, isolated from the bulb of Eleutherine Americana, 
has been shown to exhibit catalytic inhibition of TopoII.17 
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Figure 1.9 
 
The biological activities discussed in the previous sections have therefore made the 
pyranonaphthoquinones synthetically attractive compounds. This has led to numerous synthetic 
strategies being developed towards the assembly of these compounds. A few selected synthetic 
strategies will be discussed in the sections that follow. However, before we discuss the synthetic 
literature, it is important to highlight how the construction of the isochromane core is 
accomplished through biosynthesis.  
 
1.4. Biosynthesis of pyranonaphthoquinone antibiotics 
 
It has been proposed that the biosynthesis of pyranonaphthoquinone antibiotics involves a 
polyketide synthase (PKS) pathway. A comprehensive report into the biosynthesis of polyketide 
metabolites has been published by O’Hagan where polyketides have been shown to originate 
from various sources, ranging from mammals to bacteria and fungi.24 Actinomycetes, in 
particular have been shown to produce polyketides which are important antibiotics or 
chemotherapeutic agents, as compared to the polyketides originating from other bacteria, fungi 
and higher plants which have been shown to act as toxins, flavours and pigments.25 The same 
biosynthetic mechanism is followed regardless of the vastness of the polyketide structural 
classes, in which single, simple carboxylic acid subunits are used. An oligoketide intermediate 
results in the formation of six-membered rings, characteristic of pyranonaphthoquinones, due to 
several intramolecular Aldol or Dieckmann cyclisation reactions.25 
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This biosynthetic process is exemplified by the biosynthesis of actinorhodin 27, as shown in 
Scheme 1.4. The monomeric unit of actinorhodin, 27, can essentially be derived from a reaction 
of an acetylCoA unit and seven malonylCoA units to afford linear polyketide 28. A regiospecific 
intramolecular Aldol condensation of C7 with C12 results in the formation of intermediate 29. A 
second condensation reaction between C5 and C14 will result in the formation of 30. The 
condensation reactions involved during the biosynthesis of actinorhodin are controlled by an 
aldolase enzyme, and gene clusters allow for the correct bond formation to occur.25 
 
 
 
Scheme 1.4 
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1.5. Synthetic strategies for the assembly of Isochromanes 
 
There are a number of synthetic strategies which have been employed to access the isochromane 
core. The following sections will highlight only a few selected routes with some emphasis placed 
on the research conducted in our laboratories over the past few years.  
 
1.5.1. Diels-Alder cycloadditions 
 
One of the most common strategies for pyranonaphthoquinone preparation employs Diels-Alder 
methodology. An example is the total synthesis of thysanone 7 in which a Diels-Alder 
cycloaddition was used as the key step.7 The synthesis commenced with the bromination of (S)-
mellein 31 followed by O-methylation to yield the methyl ether 32. The lactone ring was then 
reduced to the benzopyran ring, 33, followed by oxidation to the (S)-pyranobenzoquinone 34, 
which was the dienophile component for the Diels-Alder cycloadditon step. A Diels-Alder 
reaction between (S)-pyranobenzoquinone 34 and diene 35 afforded pyranonaphthoquinone 36 
which underwent a final stereospecific hydroxylation to afford thysanone 7 (Scheme 1.5).  
 
 
Scheme 1.5 Reagents and conditions: (i) NBS, DMF, RT, dark, 16 h, 91%; (ii) Me2SO4, K2CO3, acetone, 
∆, 1 h, 98%; (iii) DIBAL-H, toluene, -70°C; (iv) NaBH4, THF, 30°C, 1 h 90% over 2 steps; (v) 
(PhCH2Se)2, NaBH4, DMF, ∆, 1 h, 86%; (vi) CAN, MeCN-H2O, RT, 30 min, 82%, (vii) diene 35, 
toluene, ∆, 3 h, 73%; (viii) Br2, CCl4, hv, 30 min; (ix) THF-H2O, RT, 1 h, 85% over 2 steps.  
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The synthesis of frenolicin B, 37, has been achieved by Kraus and co-workers, also using Diels-
Alder methodology as a key step.26 The synthesis commenced with the synthesis of alcohol 38 
via an enantioselective reduction of ketone 39. The dianion formed through metalation of alcohol 
38, was reacted with acrolein 40 to afford 41 as a mixture of diastereomers in a 1:1.5 ratio. 
Lactone 42 was then formed by a palladium catalysed carbonylation and cyclisation of diol 41, 
followed by oxidation to the corresponding quinone 43. Reaction of 43 with diene 44 to furnish 
the Diels-Alder adduct followed by treatment with Jones reagent afforded frenolicin B, 37 
(Scheme 1.6). 
 
 
 
Scheme 1.6 Reagents and conditions: (i) THF, –25°C, (+)-Ipc2BCl, 100%; (ii) Et2O, BunLi, 0°C to RT, 
then –78°C, 36, 44%; (iii) Pd(OAc)2, CO (g), THF, 65%; (iv) AgO, THF, 6N HNO3, RT, 95%; (v) 
CH2Cl2, – 78°C; (vi) Me2CO, Jones reagent 0°C, 81% over 2 steps.  
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1.5.2. Phthalide annulation strategy 
 
The use of the phthalide annulation to access pyranonaphthoquinones was first described by 
Kraus and Sugimoto and has subsequently been used in the preparation of many 
pyranonaphthoquinones.27 In the total synthesis of (–)-hongconin 45 described by Baker and co-
workers,28 a phthalide annulation reaction between methoxy cyanophthalide 46 and heterocyclic 
compound 47 furnished hongconin 45, as shown in Scheme 1.7. The synthesis commenced with 
the Lewis acid-catalysed C-1 alkylation of glycal 48 followed by the formation of enone 47. The 
reaction between enone 47 phthalide 46 resulted in the formation of hongconin 45. 
 
  
 
Scheme 1.7 Reagents and conditions: (i) AlCl3, TiCl4, 85%; (ii) NH3, MeOH; (iii) pyridinium 
dichromate, Ac2O, 60% over 2 steps; (iv) THF, –78°C, LiCl (cat.), ~65%. 
 
In the preparation of pentalongin 49, De Kimpe et al. employed a phthalide annulation reaction 
between cyanophthalide 50 and the heterocyclic compound 51.{Claessens, 2006 #230} This 
annulation reaction resulted in the formation of a hongconin analogue 52. Protection of the 
hydroquinone followed by reduction of the ketone afforded alcohol 53. Oxidation of alcohol 53 
to quinone 54 and subsequent dehydration gave pentalongin 49 (Scheme 1.8). 
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Scheme 1.8 Reagents and conditions: (i) BunLi, ButOH, LiCl, THF, –78°C to RT, 88%; (ii) K2CO3, 
Me2SO4, acetone, ∆, 50%; (iii) NaBH4, MeOH–CH2Cl2, RT, 52%; (iv) CAN, CH3CN–H2O, 0°C then RT, 
95%; (v) p-TsOH, benzene, ∆, 37%. 
 
1.5.3. Reductive mercury(II) acetate-mediated cyclisations 
 
In our laboratories, de Koning and co-workers have shown that the oxidative ring closure of 
benzylic alcohol 55 with mercury(II) acetate, followed by two functional group interconversions 
affords the cis-isochromanol 56 (Scheme 1.9). Their synthesis involved the treatment of benzyl 
alcohol 55 with mercury(II) acetate followed by exposure to oxygen, and then sodium 
borohydride, to yield a 1:1 mixture of the cis:trans alcohols 57. These alcohols were then 
oxidised to the ketone 58 using PCC followed by a reduction using lithium aluminium hydride to 
afford exclusively the cis-isochroman-4-ol 56 as a mixture of enantiomers. The only requirement 
for the oxidative ring closure was the presence of a vinyl group ortho to the benzyl alcohol. 10 
 
 
 
Scheme 1.9 Reagents and conditions: (i) Hg(OAc)2, THF, 15 min; (ii) NABH4, DMF, O2, 86%; (iii) PCC, 
CH2Cl2, 74%; (iv) LiAlH4, Et2O, 80%. 
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1.5.4. Ring-closing metathesis (RCM) 
 
Another strategy used to prepare pyranonaphthoquinones is ring-closing metathesis, which has 
been demonstrated by de Kimpe and co-workers in the total synthesis of pentalongin 49 and its 
precursor psychorubin 5. 30 
 
 
Figure 1.10 
 
In their synthesis, compound 59 was subjected to based-induced isomerisation of the allyl group. 
The intermediate was then treated with vinyl acetate in the presence of chloro(1,5-
cyclooctadiene)iridium(I) to afford E-vinyl ether 60. Ring-closing metathesis was then 
accomplished upon treatment of E-vinyl ether 60 with Grubbs’ first-generation catalyst 
furnishing cyclic ether 61, which was converted to hemiacetal 62 when subjected to reflux in 
aqueous acetonitrile in the presence of tosic acid. Psychorubin 5 was then formed by the 
oxidative demethylation of 62 using ceric ammonium nitrate, followed by heating with tosic acid 
in benzene to furnish pentalongin 49 (Scheme 1.10).  
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Scheme 1.10 Reagents and conditions: (i) ButOK, THF, RT, 3 h, 95%; (ii) vinyl acetate, Na2CO3, 
[IrCl(cod)]2, 100°C, 12 h, 96%; (iii) Grubbs’ I catalyst, PhMe, RT, 12 h, then 100°C, 12 h, 86%; (iv) p-
TsOH, MeCN-H2O, 100°C, 3 h, 75%; (v) CAN, MeCN-H2O, RT, 30 min, 91%; (vi) p-TsOH, benzene, 
80°C, 20 min, 72%. 
 
1.6. Project objectives 
 
Over the past few years, research conducted in our laboratories has focused on the synthesis of 
pyranonaphthoquinones. To date, we have managed to successfully prepare ventiloquinone L 11 
(Figure 1.11) which is the monomer of cardinalin 3 10.9,31 The bidirectional racemic synthesis of 
cardinalin 3 10 has also been achieved in our laboratories. More recently, the synthesis of 
dehydroherbarin 63 and anhydrofusarubin 6 has also been achieved, using Wacker oxidation 
methodology as the key step.4 This section of the PhD thesis will describe the approach to be 
used in this work leading to the synthesis of the isochromane core of the pyranonaphthoquinones 
containing a γ-fused lactone ring as found in frenolicin B 37 and medermycin 12, as shown in 
Figure 1.12. 
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Figure 1.11 
 
 
 
Figure 1.12 
 
As has been demonstrated by de Koning and Pelly,32 and shown in Scheme 1.11, 2,5-
dihydroxybenzoic acid 64 has been converted into the aromatic alcohol 65. We envisaged that 
this alcohol 65 could be converted into the Michael acceptor 66 utilising cross metathesis as the 
key step. Subsequent Michael addition would then result in the formation of the 3 substituted 
isochromane 67. 
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Scheme 1.11 
 
Once the methodology for construction of the C3 substituted pyran ring is in place, we will then 
turn our focus to the formation of 1,3-disubstituted pyran rings. We envisaged that we could 
access this substitution pattern using a Grignard reaction on the oxidised aldehyde formed from 
65 which would yield the secondary alcohol ±68. A cross metathesis reaction would then furnish 
the 1,3-disubstituted pyran ring, ±69 which subsequent to an intramolecular oxa-Michael 
addition would afford ±70 (Scheme 1.12).  
 
 
 
Scheme 1.12 
 
Once the pyran ring has been constructed, we will turn our efforts to the preparation of the 
lactone ring shown in Scheme 1.13, which would provide us with the desired tricyclic system. 
This would initially be conducted on the model system 67 lacking the C1 methyl substituent. The 
ester chain positioned at C3 would be used to construct the lactone ring. To achieve this, ester 67 
could be hydrolysed to the carboxylic acid 71. The acid 71 would then pave the way, using a 
radical mediated lactone formation discussed in Section 2.4.1, to give the desired tricyclic ring 
system 72, as found in various pyranonaphthoquinone natural products. 
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Scheme 1.13 
 
We would like to prepare the 1,3-disubstitued pyranonaphthoquinone core stereoselectively, as 
this would more closely resemble the core found in natural products like kalafungin 9 
(Figure 1.13). An ever increasingly popular route is the use of enzymatic kinetic resolution or 
dynamic kinetic resolution, which we hope will afford a single enriched enantiomer of an 
advanced precursor, as will be discussed below, from which we hoped to prepare the desired 1,3-
disubstituted isochromane core 73. 
 
 
 
Figure 1.13 
 
Hence, in practice we envisage that if our racemic benzylic alcohol ±68 could be selectively 
acetylated to afford ±74, we would be able to separate the enantiomers using enzymatic 
resolution, as shown in Scheme 1.14. This would provide us with an enantiomerically enriched 
benzylic alcohol which we could employ in the construction of the 1,3-disubstituted pyran ring. 
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Scheme 1.14 
 
Thus, the central theme of this part of the project is the preparation of the isochromane core 
found in a number of natural products. We aim to achieve this by using cross metathesis 
methodology to provide us with the C3 substituted pyran. A novel radical type transformation 
will be then employed to furnish the desired tricyclic isochromane core. Finally, we will attempt 
the resolution of racemic alcohol ±68, providing us with an enriched alcohol from which we can 
construct the isochromane core. 
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Chapter 2: Approaches toward the isochromane core  
 
2.1. Introduction 
 
Kalafungin 9 (Figure 2.1) was initially isolated from Streptomyces tanashiensis in 1968. 33 Its 
interesting biological activity as well as its stereochemical features, has made it the subject of a 
number of total syntheses. The key steps, some of which were outlined in the previous chapter, 
include asymmetric dihydroxylation, Oxa-Pictet-Spengler cyclization and acid mediated 
isomerisations;34 tandem Michael-Dieckmann approaches;35 and approaches using Diels-Alder 
reactions.36  
 
The results discussed in this section of the PhD thesis will focus on our attempts to construct the 
isochromane core, starting with a model study to construct the γ-lactone isochromane nucleus 72, 
shown in Figure 2.1. The success of the model study will allow us to expand the methodology to 
the preparation of 1,3-disubstituted isochromanes, e.g. 75, however, lacking the naphthalene 
nucleus which occurs in natural products like kalafungin 9. 
 
 
 
Figure 2.1 
 
In her PhD thesis, a fellow student, Pelly described her approach to the construction of the pyran 
ring systems.32 Related work has been published by Hume and coworkers describing the 
construction of pyranonaphthoquinones using cross metathesis as one of their key steps.37 Using 
methodology developed at the University of the Witwatersrand, we will firstly prepare 
isochromane 72 (discussed in Section 2.2 and 2.4), which will serve as the model study. We will 
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then conduct the racemic/diastereomeric synthesis of 75 (discussed in Section 2.5). Finally our 
attempts to synthesise 75 enantioselectively will be discussed. Our results will therefore 
contribute to the research on the construction of this tricyclic quinone scaffold of isochromanes. 
Improvements to existing methodology will also be highlighted.  
 
2.2. Preparation of ((2-allyl-3,6-dimethosybenzyl)oxy)(tert-butyl)dimethylsilane 79 
 
 
 
Scheme 2.1 Reagents and conditions: (i) K2CO3, allyl bromide, acetone, ∆, 18 h, 82%; (ii) 170°C, 18 h, 
78%; (iii) K2CO3, dimethylsulfate, acetone, ∆, 18 h, 95%; (iv) LiAlH4, THF, 40°C, 2 h, 77%; (v) NaH, 
TBDMSCl, THF, RT, 18 h, 90%. 
 
The preparation of [(2-allyl-3,6-dimethoxybenzyl)oxy](tert-butyl)dimethylsilane 79 was 
achieved starting from the commercially available 2,5-dihydroxbenzoic acid 64 over 5 steps 
using methods previously developed in our laboratories. The synthesis commenced with the 
selective diallylation of both the carboxylic acid and the 5-OH positions of 64 to give the 
diallylated product 76 in an 82% yield. The dilute reaction conditions and hydrogen bonding of 
the 2-OH to the carbonyl group of the benzoic acid ensured selectivity. This was confirmed by 
the presence of a broad singlet at δ 10.36 in the 1H NMR spectrum, which is characteristic of a 
hydrogen bonded phenol. Thermal Claisen rearrangement of the diallylated compound 76 
afforded the desired product 77 in 78% yield. The 1H NMR spectrum confirmed that the product 
was obtained owing to the simplification of the aromatic region, which shows two doublets at 
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δ 6.99 ppm and δ 6.81 ppm with ortho coupling contants of 8.9 Hz each. The hydroquinone 77 
was then methylated using dimethyl sulfate in the presence of potassium carbonate to afford the 
product 78 as an oil in 95% yield. This proved to be an improved yield, (95% vs 82%) compared 
to that obtained by Pelly.32 The most distinctive features of the 13C NMR spectrum are the 
presence of two upfield signals at δ 56.38 ppm and δ 56.26 ppm which are due to the newly 
introduced methoxy substituents. Reduction of ester 78 was achieved using lithium aluminium 
hydride to afford the primary alcohol 65 in 77% yield. The absence of a signal above δ 160 ppm 
in the 13C NMR spectrum confirmed the loss of the carbonyl group which was present in the 
starting material. Primary alcohol 65 was then protected using tert-butyldimethyl silyl chloride, 
in the presence of sodium hydride. The product 79 was obtained in 90% yield. Spectroscopic 
data compared well with that of Pelly with the dimethyl and t-butyl groups of the silyl protecting 
group appearing as signals at δ 0.93 ppm and δ 0.10 ppm respectively in the 1H NMR spectrum. 
 
With both our free alcohol 65 and silicon-protected alcohol 79 in hand, we could turn our focus 
towards the cross metathesis reaction which would ultimately provide us with a C3 carboxylic 
acid substituted isochromane. 
 
2.3. Background and mechanism of the olefin metathesis reaction 
 
In the early 1950’s, Karl Ziegler first noted that certain heterogeneous catalysts not only 
promoted the polymerization of olefins under mild conditions but that they also facilitated the 
cleavage and formation of double bonds. This is generally referred to as alkene metathesis.38 The 
term metathesis is derived from the Greek words meta meaning change and thesis meaning 
position and therefore it is the exchange of parts of two substances as shown in Scheme 2.2. 
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Scheme 2.2 
 
First generation heterogeneous metathesis catalysts were unattractive to synthetic chemists due 
to their limited scope in advanced organic synthesis. This was mainly due to their poor 
compatibility, especially with polar functional groups, even though they exhibited high activity. 
This then importantly led to the development of second and third generation homogeneous 
catalysts that were considered to perform better, more importantly, with higher tolerance towards 
functional groups. These catalysts also showed an increased thermal stability and were more 
stable to air and moisture.39 The two most popular and versatile  homogeneous catalysts (shown 
in Figure 2.2) are the tungsten or molybdenum catalyst, 80, developed by Schrock and co-
workers and the ruthenium carbene, 81 developed by Grubbs and co-workers.  
 
 
 
Figure 2.2 
 
The generally accepted mechanism, also known as the Chauvin mechanism, consists of formal 
[2+2] cycloadditions involving alkenes and metal carbenes. The catalytic cycle shown in 
Scheme 2.3 shows the metal carbene acting as a catalyst. The metal alkylidene 82 reacts with 
one olefin of the diene 83 forming the metallocyclobutane intermediate 84. Cleavage of this 
intermediate results in the loss of ethylene 85 and the formation of a new metal alkylidene 86. 
This newly formed metal alkylidene reacts intramolecularly with the second olefin to form a 
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metallocyclobutane intermediate 87. This undergoes a second [2+2] cycloreversion to yield 
alkene 88 while the metal carbene catalyst reenters the catalytic cycle. These developments led 
to Grubbs, Schrock and Chauvin being awarded the Nobel prize for chemistry in 2005.  
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Scheme 2.3 
 
All the individual steps of the catalytic cycle are reversible and therefore results in an 
equilibrium mixture of olefins. It is therefore necessary to shift this equilibrium forward. In the 
ring closing metathesis catalytic scheme shown above, the process is both entropically driven, as 
the process cleaves one substrate molecule into two products liberating ethene 85, and 
equilibrium driven since the ethene liberated is volatile and therefore leaves the cycle.38 
 
The metathesis of interest to us is cross metathesis as we hope to use this reaction to introduce 
the C3 substituent to the pyran ring system. The catalytic mechanism for the cross-metathesis of 
two alkenes is shown in Scheme 2.4 and is similar to the Chauvin mechanism shown in 
Scheme 2.3. The catalytic cycle commences with a [2+2] cycloaddition reaction between alkene 
89 and metal carbene 90 forming the metallacyclobutane intermediate 91. This is followed by 
cleavage to afford a new metal alkylidene 92 and the newly formed alkene product 93. The new 
metal alkylidene 92 then reenters the catalytic cycle to react with another alkene.  
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Scheme 2.3 
 
2.4. Preparation of isochromane 72 
 
 
 
Scheme 2.4 Reagents and conditions: (i) Ethyl acrylate, Grubbs II catalyst, toluene, 90°C, 18 h, 78%. 
 
With the protected alkene 79 in hand, we were now in a position to 
build the pyran ring of compound 72. We anticipated that cross 
metathesis of alkene 79 with ethyl acrylate would afford ester 94 as 
a result of one alkene being electron rich and the other electron 
poor as this favours cross-metathesis. Indeed this was found to be the case, with the desired 
product 77 isolated in a yield of 78% in the presence of Grubbs II (Scheme 2.5). The formation 
of the trans product was evident by 1H NMR analysis showing a doublet of triplets at δ 5.68 ppm 
assigned as H6 with a coupling constant of 15.6 Hz to a signal at δ 7.13 ppm due to H5. The 
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presence of a quartet at δ 4.15 ppm and a triplet at δ 1.26 ppm in the 1H NMR spectrum owing to 
the ethyl group and a signal at δ 166.9 ppm due to the carbonyl carbon further confirmed the 
formation of the desired product. 
 
 
 
Scheme 2.6 Reagents and conditions: (i) Ethyl acrylate, Grubbs II catalyst, CH2Cl2, 40°C, 4 h, 86%. 
 
We also attempted cross metathesis on the free benzylic alcohol 65, even though we suspected 
that the free alcohol may interfere with the catalyst’s activity. To this end, in the presence of 
Grubbs second generation catalyst, the free alcohol and ethyl acrylate were dissolved in 
dichloromethane and refluxed for 4 hours. Much to our delight, the α,β-unsaturated ester 66 was 
obtained as a clear oil in 86% yield (Scheme 2.6). The use of dichloromethane instead of toluene 
as solvent allowed for a cleaner reaction and for shorter reaction times than that of the silylated 
alcohol 79. This allowed us to avoid both the protection and deprotection steps thus shortening 
the synthesis. In the analysis of the 1H NMR spectrum we found a quartet and triplet at δ 4.14 
and δ 1.26 ppm due to the newly added ester functional group. The 13C NMR spectrum showed 
the presence of a carbonyl group at δ 171.2 ppm and a strong absorption at 1714 cm–1 was noted 
in the IR spectrum due to the carbonyl group, further confirming that the reaction had been 
successful.  
 
Having successfully formed both metathesis products 94 and 66, we attempted the internal oxa-
Michael addition ring closure to form the pyran ring. Ester 94 was deprotected using 
tetrabutylammonium fluoride, which in turn led to the formation of the pyran ring system 67 in 
88% yield with the ester substituent present on the C3 position of the isochromane nucleus. 
Alternatively, stirring ester 66 in the presence of sodium hydride afforded the same pyran ring 
system 67 in 86% yield (Scheme 2.7).  
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Scheme 2.7 Reagents and conditions: (i) TBAF, AcOH, THF, 0°C–RT, 18 h, 88%; (ii) NaH, THF, RT, 
30 min, 86%. 
 
Analysis of the 1H NMR spectrum of ester 67 showed a clear absence of the t-butyl and dimethyl 
groups of the silyl protecting group of the starting material which were present at δ 0.90 and 
δ 0.07 ppm respectively. The C1 position of the pyran ring contained hydrogens that were now 
non-equivalent and gave rise to signals at δ 4.91 and δ 4.62 ppm as compared to the starting 
materials which showed equivalent hydrogens at the benzylic position producing a singlet at 
δ 4.74 and δ 4.66 ppm for 94 and 66 respectively. The alkene protons in the starting materials 
observed as signals at δ 5.68 and δ 5.63 ppm were also noticeably absent which further provided 
evidence for the formation of the pyran ring. Interestingly, the downfield region of the 1H NMR 
spectrum was only occupied by two ortho coupled aromatic protons. Lastly the most notable 
feature in the 13C NMR spectrum was the clear absence of the signals previously associated with 
the alkene carbons at δ 70.7 and δ 41.1 ppm. 
 
With the pyran ring in place, we could now focus on the formation of the γ-lactone ring. This 
would give us the tricyclic product we required. In order to achieve this we envisaged that the 
ester group of 67 needed to be converted into the free carboxylic acid to afford 71, followed by 
the formation of the lactone ring. Pyran ester 67 was therefore subjected to a KOH–methanol 
saponification which afforded the desired acid product 71 as a white powder in 95% yield, as 
shown in Scheme 2.8.40 
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Scheme 2.8 Reagents and conditions: (i) KOH, MeOH, RT, 3 h, 88%. 
 
Interpretation of the 1H NMR spectrum unequivocally confirmed the presence of the product 
through the appearance of a broad singlet at δ 11.00 ppm, which is characteristic of a carboxylic 
acid. The quartet and triplet at δ 4.19 and δ 1.28 ppm observed in ethyl 2-(5,8-
dimethoxyisochroman-3-yl)acetate 67 were also noticeably absent. Similarly, a broad stretch at 
3015 cm–1 in the IR spectrum further attested to the formation of the carboxylic acid 71. 
 
2.4.1. Lactone formation using hypervalent iodine reagents 
 
Having formed acid 71, the final step remaining in the synthesis of our model compound was 
formation of the lactone ring of 72. Kita and coworkers recently reported on methodology to 
achieve lactone ring closure from similar precursors to our substrate.41 In their study they 
developed a method using hypervalent iodine(III) reagents with potassium bromide to form aryl 
lactones from carboxylic and benzoic acids. In particular, they were able to prepare a range of 
lactones using p-anisiodine diacetate. The proposed reaction mechanism is shown in 
Scheme 2.9. Initially, selective benzylic hydrogen abstraction occurs due to action of the 
iodine(III) oxidants with KBr. The resulting benzylic radical 95 then paves the way for the 
successive oxidative lactone formation step. 
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Scheme 2.9: Possible reaction mechanism for the formation of lactones from carboxylic acids 
 
Using the reaction conditions proposed by Kita and co-workers, we attempted the novel lactone 
forming reaction from our substrate, acid 71. To this end, potassium bromide and p-anisiodine 
diacetate were added to the acid 71 dissolved in dry dichloromethane and the reaction stirred at 
room temperature. Disappointingly, TLC analysis of the reaction was inconclusive and only 
showed that starting material was being consumed, with no new product of different Rf visible by 
UV. We then turned to TLC stains in an attempt to visualize the forming lactone. After testing a 
range of TLC stains, ceric ammonium sulfate proved to be the best stain to visualize the forming 
lactone. Purification of the reaction mixture proved quite difficult and a low yield of 29% of the 
desired lactone was obtained. We suspect that there are two possible reasons for this outcome. 
The first reason is that the reaction is low yielding and possible side products may be forming 
under the radical reaction conditions, such as the possible formation of the carbonyloxy 
radical  96, mentioned by Kita, shown in Scheme 2.10.  
 
 
 
Scheme 2.10 
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However, TLC analysis did not show the formation of any other products and no other products 
were isolated by column chromatography. The second reason may be due to the fact that the 
lactone could not be visualized readily by TLC. Although this result was disappointing, we were 
pleased that we had synthesised lactone 72, albeit in a low yield. 
 
 
 
Scheme 2.11 Reagents and conditions: (i) p-Anisiodine diacetate, KBr, CH2Cl2, RT, 18 h, 29%. 
 
The most notable feature of the 1H NMR spectrum of lactone 72 was the absence of the OH 
signal previously observed at δ 11.00 ppm. Simplification of the upfield region of δ 2.50–3.00 
ppm was also observed, with the protons in the position α to the carbonyl giving rise to a doublet 
at δ 2.71 ppm and a doublet of doublets at δ 2.91 ppm. H4 was now observed slightly downfield 
as a doublet at δ 5.33 ppm indicating that these protons were now more deshielded owing to the 
adjacent oxygen atom. The signal at δ 2.71 ppm only showed geminal coupling of 17.5 Hz, while 
the signal at δ 2.91 showed 3J coupling to the proton at the C3 position of 4.9 Hz in addition to 
the geminal coupling of 17.5 Hz. The 13C NMR spectrum also clearly showed the downfield 
shifting of the carbon at C4 from δ 28.15 to δ 71.84 ppm which indicates that this carbon is now 
bonded to a more electronegative atom. The spectroscopic data compares well with literature,42 
however, the melting point obtained (173–175°C) was higher than the literature value of 162–
165°C.  
 
Having had success with the preparation of 72, we decided to continue with our synthesis of the 
C1 methyl containing analogue 75. Using the methodology developed for both the pyran and 
lactone ring closures, we envisaged that we could begin with racemic alcohol ±68 (Scheme 
2.12). The racemic synthesis of 75 will be discussed in the next section. 
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Scheme 2.12: Proposed retrosynthesis of isochromane 75. 
 
2.5. Preparation of isochromane 75 
 
In order to prepare racemic secondary alcohol ±68, we would begin the synthesis using our 
previously prepared alcohol 65. This would then be oxidised to aldehyde 97. We would then use 
a Grignard reaction to introduce the methyl group at C1, thus preparing the desired racemic 
alcohol ±68, shown in Scheme 2.13.  
 
 
 
Scheme 2.13: Proposed synthesis of racemic alcohol ±65. 
 
To achieve this, alcohol 65 was oxidised using pyridinium chlorochromate adsorbed onto neutral 
alumina in dry dichloromethane to afford the aldehyde 97 as a clear yellow oil in 90% yield. The 
downfield singlet at δ 10.57 ppm in the 1H NMR spectrum, which is characteristic of an 
aldehyde, proved unequivocally that the product had formed. Additional evidence was the 
presence of a carbonyl signal at δ 192.5 ppm in the 13C NMR spectrum. With the aldehyde 97 in 
hand, we turned to the preparation of our Grignard reagent. This was achieved by stirring 
magnesium turnings with methyl iodide in dry diethyl ether. Once the Grignard reagent had 
formed, the aldehyde was dissolved in dry THF and added dropwise to the newly formed 
Grignard reagent. After work-up and purification, the racemic alcohol was isolated as a clear oil 
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in 84% yield. The IR spectrum showed a broad stretch at 3549 cm–1 due to an OH group 
suggesting the formation of the racemic alcohol ±68. In the 13C NMR spectrum, the loss of the 
aldehyde peak previously observed at δ 192.5 ppm further confirmed that the Grignard reaction 
was successful. Finally, a signal integrating for three protons at δ 1.53 ppm confirmed the 
addition of the methyl substituent. 
 
With the racemic alcohol in hand, we could now continue our synthesis of isochromane 75, the 
retrosynthesis of which is outlined in Scheme 2.12. In order to achieve this, we subjected alcohol 
±68 to a cross metathesis reaction with ethyl acrylate in dry dichloromethane while stirring under 
reflux. After 18 hours, the crude material was purified to yield the α,β-unsaturated ester 69 as a 
brown oil in an excellent yield of 94% (Scheme 2.14). This reaction proved even better yielding 
than the previous model study. 
 
 
 
Scheme 2.14 Reagents and conditions: (i) ethyl acrylate, Grubbs II catalyst, CH2Cl2, 40°C, 4 h, 94%. 
 
The presence of additional signals due to the ethyl acrylate moiety 
in the 1H NMR spectrum was an immediate indication of the 
success of the reaction. Interestingly, a doublet of triplets due to the 
β alkene proton H6, was significantly deshielded and was found 
slightly downfield of the aromatic protons at δ 7.05 ppm. This signal showed coupling to the 
benzylic CH2, H5 and the α-alkene proton, H7 found at δ 3.60 and δ 5.66 ppm respectively. The 
coupling constant between the α and β alkene protons of J = 15.6 Hz clearly indicates that the 
trans product was obtained. The two upfield signals, a doublet at δ 1.51 and a triplet at δ 1.24 
ppm could easily be assigned as H4 and H9 respectively based on their multiplicity. Analysis of 
the 13C NMR and IR spectra showed a downfield signal at δ 166.66 ppm and a stretch at 
1712 cm–1 respectively which are clear indications of a carbonyl group. High resolution mass 
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spectroscopic analysis of this compound was in good agreement with the expected value 
(303.1198 amu, the calculated value for C15H20O5 is 303.1211 amu). 
 
Once again we were ready to attempt the formation of the pyran ring. To effect this, the α,β-
unsaturated alkene ±69 in THF was treated with sodium hydride as shown in Scheme 2.15. The 
reaction proceeded smoothly with a colour change from light brown to clear indicating that the 
Michael addition pyran ring closure was occurring. The product 70 was isolated after purification 
by column chromatography in 85% yield as a clear oil. 
 
 
 
Scheme 2.15 Reagents and conditions: (i) NaH, THF, RT, 16 h, 85%. 
 
Subsequent analysis of the 1H NMR spectrum of the product showed the presence of a 50:50 
mixture of diastereomers, owing to the additional methyl group at the C1 position of the pyran 
ring. The most apparent feature of the spectrum was the doubling up of signals, in particular 
those associated with the two stereogenic centres. This was evident for the quartets at δ 5.08 and 
δ 4.99 ppm which each integrate for one proton and are due to the benzylic proton at the C1 
position of each diastereomer. Similarly, the multiplets at δ 4.44–4.34 and δ 4.00–3.88 ppm were 
each due to the proton at the second stereogenic centre at the C3 position. Although complex, the 
multiplet at δ 2.90–2.31 ppm was characteristic of the benzylic CH2 at C4 as well as the CH2 
alpha to the carbonyl group. The presence of this multiplet confirms that the Michael addition 
reaction was successful as it was not observed in the starting α,β-unsaturated ester, but was 
previously observed for the ring closed product 67. The additional signals in the 13C NMR 
spectrum also confirmed that diastereomers were present. This was evident by the two carbonyl 
signals at δ 171.27 and δ 171.23 ppm. Noticeably, we no longer observed signals due to alkene 
carbons, with signals only visible in the aliphatic and aromatic regions of the spectrum. 
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As before, with the pyran ring in place we moved our attention to the formation of the lactone 
ring. Therefore, using the saponification conditions used in the model system we stirred the ester 
70 in a KOH–methanol mixture for 2 hours. After this time, the product was extracted from the 
acidified aqueous phase to afford carboxylic acid 98 as a mixture of diastereomers in 73% yield 
(Scheme 2.16). 
 
 
 
Scheme 2.16 Reagents and conditions: (i) KOH, MeOH, rt, 2 h, 73%. 
 
An analysis of the 1H NMR spectrum showed that the 50:50 mixture of 
diastereomers was still evident. The most distinctive feature in the 1H 
NMR and IR spectra respectively, was the broad singlet at δ 10.42 ppm 
and the broad stretch at 2974 cm–1 due to the OH group. The 1H NMR 
spectrum also showed the absence of the quartet and triplet at δ 4.25 and δ 1.29 ppm which were 
due to the CH2 and CH3 groups of the ethyl group. Accordingly, the carbon signals associated 
with these two groups were also not present in the 13C NMR spectrum. Mass determination of 
m/z 267.1279 amu by high resolution mass spectrometry was in good agreement with the 
expected value, m/z 267.1223 amu. We can therefore confidently say that the desired carboxylic 
acid was formed. 
 
All that remained now was to induce lactone formation to furnish the tricyclic system 75. To this 
end, we dissolved the acid 98 in dry dichloromethane. Potassium bromide and p-anisiodine 
diacetate were then added and the reaction was allowed to stir for 18 hours. Having determined 
the optimal conditions to visualize the lactone, we once again used CAS as the TLC stain. After 
work up and purification, we obtained the lactone as a white solid in 26% yield. As before, the 
yield was disappointingly low and numerous attempts at optimizing this were unsuccessful. 
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However, we now appeared to have only formed a single diastereomer, presumably the 
thermodynamic trans product, shown in Scheme 2.17. 
 
 
 
Scheme 2.17 Reagents and conditions: (i) p-Anisiodine diacetate, KBr, CH2Cl2, RT, 18 h, 26%. 
 
In the 1H NMR spectrum, the most distinctive change was that there was no 
longer doubling up of the signals, as depicted in structure 98, in the δ 2.50–3.00 
ppm region, where previously we observed the mutiplet due to the benzylic 
CH2 and the CH2 alpha to the carbonyl. The benzylic proton at C4 shifted 
downfield due to bonding to the more electronegative oxygen atom, and was 
observed as a doublet at δ 5.34 ppm with a coupling constant of 2.8 Hz showing coupling to the 
proton at C3. The non-equivalent CH2 alpha to the carbonyl occurs as a doublet and a doublet of 
doublets at δ 2.65 and δ 2.92 ppm respectively, where the latter shows coupling of 5.2 Hz to the 
proton at C3. The COSY spectrum unambiguously confirmed the assignment of H3 as the 
doublet of doublets at δ 4.69 ppm with coupling constants of 4.9 and 2.9 Hz. The 13C NMR 
spectrum clearly showed the downfield shifting of the carbon at C4 from two signals at δ 29.10 
and δ 28.19 ppm to a single peak at δ 71.52 ppm, indicating that the lactone had formed as a 
single diastereomer. HPLC analysis of 75 further proved the formation of one diastereomer, with 
the presence of a single peak at a retention time of 8.60 min as shown is Figure 2.3. The 
spectroscopic data compared well with literature and confirmed that we had isolated the trans 
product as depicted in structure 75.  
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Figure 2.3: HPLC chromatogram of lactone 75 
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2.6. Enantiomeric discrimination 
 
The next section will focus on our attempts to prepare isochromane 75 enantioselectively. There 
are various ways in which to introduce chirality into molecules, including chiral reduction of 
ketones, the use of chromium complexes to selectively make one enantiomer and more recently, 
enzymatic routes for the preparation of chiral molecules. During the synthesis of 75, a racemate 
of compound ±68 was obtained which led to the formation of diastereomers along the synthetic 
route we successfully followed. We were therefore interested in producing the individual 
enantiomers of 68 which would then potentially allow for the enantioselective synthesis of the 
desired isochromane 75.  
 
2.6.1. Background  
 
In recent years, we have investigated the use of enzymes to kinetically resolve racemic mixtures 
of alcohols. This was first attempted in our laboratories by Govender in her MSc research,43 
where she attempted to kinetically resolve a range of secondary alcohols including  ±99 and 
±100, and found that the most suitable enzyme for this transformation was Novozyme 525 (also 
known as CALB). The two transformations that Govender successfully accomplished are 
highlighted in Scheme 2.1843, which gave rise to both the enantiomerically pure ester and 
alcohol through kinetic resolution. 
 
 
 
Scheme 2.18 Reagents and conditions: Toluene, buffer sol (pH 7.5), lipase enzyme, RT, 2h. 
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In our studies we aim to build on this foundation and develop this synthetic tool within our 
research group. In the section below, we will briefly introduce the family of lipase enzymes as 
well as outline the mechanism by which these enzymes operate.  
 
2.6.2. Introduction to Biocatalysis 
 
In recent years, biocatalysis has become a valuable tool used by organic chemists, especially in 
homochiral molecule production. This is because enzymes are remarkable catalysts that display 
high chemo-, regio- and enantio-selectivity, but are also capable of accepting a wide range of 
substrates. The availability and price of most classes of enzymes have significantly decreased 
and thus enzymes have become economically attractive as catalysts in recent years.44 
 
Enzymes are macromolecules which belong to the protein biochemical family. Their unique 
three-dimensional structure arises from the folding of a linear polypeptide chain. This 
polypeptide chain in turn consists of a linear sequence of α–amino acids joined by amide bonds. 
Enzymes possess catalytic activity, where a part of their tertiary structure is responsible for this 
catalytic activity. This is called the active site of the enzyme and is where enzyme chemistry 
occurs. The active site is a cavity in which the amino acid side chains are responsible for binding 
the substrate. Due to the chiral nature of the active site, it is often able to naturally bind one 
enantiomer of the substrate over the other. This high substrate selectivity is one of the hallmarks 
of enzyme catalysis. Our aim was to employ a lipase enzyme to kinetically resolve a racemic 
mixture of alcohols in order to isolate the individual optically active enantiomers.44 
 
2.6.3. Transesterification reactions using lipase enzymes 
 
Hydrolysis reactions remain vital to cellular metabolism. Lipase enzymes are known to 
hydrolyse the ester functional groups of fats, lipids and oils, which is an important aspect of food 
digestion. Not only is the lipase enzyme able to hydrolyse ester groups, but it can also facilitate 
the reverse acylation reaction when employed with an acyl donor and an alcohol acceptor. This is 
possible due to the formation of a covalent acyl enzyme intermediate. In synthetic organic 
chemistry, the use of vinyl acetate as a solvent in acylation reactions has resulted in these 
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reactions being high-yielding.44 As mentioned earlier, the chiral nature of the active site will 
allow one enantiomer of a stereogenic alcohol to be acetylated while the other remains unreacted 
resulting in regio- and more importantly, enantio-specificity. This ultimately allows for the 
separation of the enantiomers using standard chromatographic methods.  
 
2.6.4. Lipase reaction mechanism 
 
The CALB lipase enzyme belongs to the α/β-hydrolase-fold superfamily, an esterase class of 
hydrolases.45 The reaction mechanism by which CALB operates is believed to be that of the 
serine hydrolases. The active site contains a catalytic triad consisting of serine, histidine and 
glutamate or aspartate, often referred to as Ser105-His224-Asp187, common to all serine 
hydrolases. The amino acid serine 101, shown in Figure 2.4, contains a hydroxyl side chain 
which assists with hydrogen bonding during the substrate and enzyme interaction.46 
 
 
 
Figure 2.4 
 
There have been numerous molecular modelling studies which have been performed to 
rationalize and predict the enantioselectivity of CALB towards different substrates.47 The active 
site of CALB contains an oxyanion hole which is believed to stabilize the transition state as well 
as the oxyanion reaction intermediate. Also present within the active site is a small cavity called 
the stereospecificity pocket. This pocket is the site in which secondary alcohols orient one of the 
substituent during catalysis. The steric requirements of this pocket is what gives CALB its 
enantioselectivity towards secondary alcohols. As we can see in Scheme 2.19, the serine amino 
acid forms a tetrahedral intermediate with the substrate. Transesterification follows by the 
formation of a covalent bond with the substrate to form a covalent acyl enzyme and with the 
release of the secondary alcohol. In the presence of water as the solvent the alcohol will not be 
re-acetylated and the reaction will not be reversed. The acylated enzyme then forms a tetrahedral 
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intermediate with water bound in the active site. Subsequent release of the acid results in 
regeneration of the active site and the enzyme is ready to undergo another catalytic cycle.47 
 
  
 
Scheme 2.19 
 
In this project, we aimed to employ the natural hydrolysis reaction in an attempt to resolve a 
racemic mixture of benzylic secondary alcohols. It was therefore necessary to prepare the 
acetylated alcohol ±102, which we could subject to the lipase enzyme hydrolysis reaction. 
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2.6.5. Preparation of 1-(2-allyl-3,6-dimethoxyphenyl)ethyl acetate 102 
 
 
 
Scheme 2.20 Reagents and conditions: Acetic anhydride, DMAP, TEA, THF, RT, 18 h, 75%. 
 
Racemic benzylic alcohol ±68 was converted into the racemic acetate ±102 in a yield of 75%. 
This transformation was achieved by dissolving the racemic alcohol ±68 in dry THF and reacting 
it with acetic anhydride and triethylamine in the presence of a catalytic amount of 4-
dimethylaminopyridine. The success of the reaction was evident due to the large change in the Rf 
value of the product as compared to the staring material. The 1H NMR spectrum showed the 
clear absence of the doublet at δ 4.07 ppm previously due to the secondary hydroxyl group. An 
additional upfield singlet integrating for three protons was observed at δ 2.02 ppm which is due 
to the methyl of the newly introduced acetate group. The clear downfield shift of H4 from δ 
5.12–4.88 to δ 6.39 ppm shows that this proton is experiencing additional deshielding due to the 
acetate group attached. The 13C NMR spectrum further confirmed the formation of the product 
by the downfield signal at δ 170.57 ppm due to the carbonyl group of the newly formed ester 
 
As mentioned before, in her screening process, Govender determined that CALB lipase was 
suitable for the transformations shown in Scheme2.18.43 With our racemic acetate ±102 in hand 
we were now in a position to attempt the kinetic resolution of racemic acetate ±102. Before we 
could commence with our enzyme-catalysed reaction, we needed to determine the enantiomeric 
ratio of our racemate which should be 1:1. We tested the separation of the two enantiomers using 
two chiral high pressure liquid chromatography chiral columns, namely the Chiralcel OJ and the 
Chiralcel OD columns, and found that the latter showed better separation with a mixture of 
hexane and isopropyl alcohol as the mobile phase. The separation of the enantiomers of the 
substrate ±102 and hydrolysis product ±68 proved quite difficult and we decided that a 7.5:92.5 
isopropyl alcohol to hexane mixture was the best to use as the mobile phase, as this again 
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provided us with the best separation. The HPLC chromatograms for ±68 and ±102, in Figure 2.5 
and Figure 2.6 respectively show that we have a 1:1 racemic mixture of the two enantiomers of 
each compound, although for compound 65 the HPLC chromatogram was not ideal.  
 
 
 
Figure 2.5: HPLC chromatogram of the hydrolysis product ±68. 
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Figure 2.6: HPLC chromatogram of the acetylated product ±102. 
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2.6.6. Resolution of ±102 and ±68 
 
Having determined the optimal conditions for the separation of our enantiomers in the racemic 
mixture, we were in a position to attempt our enzymatic kinetic resolution of acetate 102. We 
decided initially to use CALB as the enzyme cacalyst as it previously showed promising results 
in our laboratories in a similar transformation. At this point, we decided to test the enzymatic 
hydrolysis reaction on a simple substrate to determine whether the enzyme we were using was in 
fact active. To this end, we subjected the test substrate benzyl acetate to our enzyme mediated 
reaction and, as expected, we observed the formation of the hydrolysed product. This was clearly 
shown by the change in Rf value by TLC, therefore confirming that the enzyme was active. 
 
We subjected our racemic acetate ±102 to an enzymatic hydrolysis reaction in the hope of 
yielding a single enriched enantiomer of the corresponding alcohol. The hydrolysis reaction is 
regarded as the simpler reaction as no acyl donor is required and more importantly, the ester 
hydrolysis is the natural reaction of the CALB lipase. The reaction conditions required a buffered 
reaction mixture for the optimal functioning of the enzyme. We therefore employed a 
tris(hydroxymethyl)amino methane (Tris HCl) buffer set to pH 7.5, which maintained our 
reaction suspension at pH 7.5. The racemic acetate ±102 was dissolved in a minimum of organic 
solvent, toluene, and added to the buffer solution. The reaction was vigorously stirred while 
being maintained at 30°C. Aliquots were taken at intervals and analysed by TLC and HPLC to 
determine reaction progress. To our disappointment, after several days of stirring, the reaction 
was not successful as no hydrolysis was observed. We then injected the recovered material on 
the HPLC Chiralcel OD column which showed our unreacted starting racemic acetate ±102 was 
untouched in a 1:1 mixture of enantiomers.  
 
We suspected that the steric crowding around the racemic stereocentre of our molecule, 
especially the ortho methoxy and allyl groups, could be hindering the kinetic resolution. We then 
decided to isomerise the terminal alkene in the hope of changing the sterics around the racemic 
stereocentre. To achieve this we subjected racemic alcohol ±68 to an isomerization reaction 
using potassium t-butoxide in dry THF at room temperature followed by acetylation to yield 
racemic acetate ±103, as shown in Scheme 2.21. 
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Scheme 2.21 Reagents and conditions: (i) KOtBu, THF, RT, 2 h, 75%; (ii) acetic anhydride, pyridine, 
RT, 18 h, 68%. 
 
 The isomerized alkene ±104 was isolated in 75% yield as a clear oil after 
purifying the crude material using flash silica gel column chromatography. The 
presence of an additional upfield signal integrating for three protons at 
δ 1.91 ppm in the 1H NMR spectrum, indicates that the isomerization was 
successful. This doublet of doublets at δ 1.91 ppm due to H3, showed coupling to H1 and H2 with 
coupling constants of 6.5 and 1.7 Hz. The 1H NMR spectrum also showed the change in the 
nature of the benzylic protons which were previously observed as a multiplet at δ 3.46 ppm 
integrating for two protons. The benzylic proton, H1, now integrated for only one proton and was 
found downfield at δ 6.35 ppm and showed trans coupling to H2 with a coupling constant of 
16.1 Hz. This therefore confirmed the exclusive formation of only the trans alkene, ±104. 
Finally, a doublet of quartets was observed at δ 5.74 ppm and was due to H2. This alkene proton 
showed trans coupling to H1 with a coupling constant of 16.0 Hz and coupling to H3 with a 
coupling constant of 6.5 Hz. We could therefore confidently confirm that the isomerized racemic 
alcohol ±104 had formed.  
 
With the isomerized alcohol successfully prepared, all that remained was to acetylate ±104 to 
form the racemic acetate ±103 which we planned to resolve using our enzymatic hydrolysis 
reaction. To achieve this, we reacted racemic alcohol ±104 with acetic anhydride in pyridine. 
The reaction was stirred overnight and after standard work up and purification the racemic 
acetate ±104 was afforded in a 68% yield. In the 13C NMR spectrum, a downfield signal at δ 
170.40 ppm, due to the newly introduced carbonyl group was observed. The carbonyl group was 
also evident in the IR spectrum which showed a peak at 1727 cm–1. The 1H NMR spectrum 
further confirmed that the acetate had formed due to the absence of the alcohol which was 
O
O OH
2
1 3
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previously observed as a doublet at δ 3.96 ppm. Before we could attempt our enzyme resolution 
reaction, we subjected ±103 to HPLC chromatography. The results, shown in Figure 2.7, 
indicated a 1:1 racemic mixture of enantiomers of ±103.  
 
 
 
Figure 2.7: HPLC chromatogram of the acetylated product ±103. 
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With the isomerized racemic acetate ±103 in hand, we again attempted our enzymatic kinetic 
resolution reaction. Employing the same reaction conditions as that for the resolution of ±102, 
we dissolved acetate ±103 in a minimum of solvent. The dissolved acetate was then added to the 
buffer solution and the reaction stirred at 30°C. TLC analysis of the reaction did not show any 
apparent evidence that the product had formed. Nevertheless we continued with HPLC analysis 
of the reaction mixture. This, however, proved that the unreacted racemic acetate ±103 was still 
present and thus that the desired hydrolysis reaction was not taking place. 
 
Unfortunately, our suspicions regarding the steric crowding of our substrate appeared to be 
confirmed. This result clearly proves that the CALB lipase is not as versatile as previously 
thought and that our compounds which contain an allyl group ortho to the benzylic alcohol, 
cannot be hydrolysed using CALB lipase. To test this theory, we aimed to try the hydrolysis of a 
similar substrate without the allyl group ortho to the benzylic stereogenic centre.  
 
2.6.7. Preparation of 1-(2,5-dimethoxyphenyl)ethyl acetate 
 
We decided to test the kinetic resolution using a simpler adduct, namely 1–(2,5-
dimethoxyphenyl)ethyl acetate ±99, shown in Scheme 2.22.  
 
 
 
Scheme 2.22 Reagents and conditions: (i) LiAlH4, THF, RT, 18 h, 99%; (ii) acetic anhydride, pyridine, 
RT, 2 h, 98%. 
 
Therefore, commercially available 2,5-dimethoxyacetophenone 105 was reduced to the 
secondary alcohol ±106 using lithium aluminium hydride in dry THF and the reaction stirred for 
2 hours at 40°C. Upon completion of the reaction as monitored by TLC, the mixture was cooled 
to 0°C and quenched with water. Purification of the crude material furnished the racemic alcohol 
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in quantitative yield. The 1H NMR spectrum unequivocally proved that we had formed the 
racemic alcohol ±106 with the presence of a broad singlet at δ 3.01 ppm due to the hydroxyl 
group. The IR spectrum also confirmed the presence of the hydroxyl group with a broad peak 
visible at 3410 cm–1. The racemic alcohol ±106 was readily acetylated by reacting it with acetic 
anhydride and triethylamine in the presence of a catalytic amount of DMAP affording the 
racemic acetate ±99 in 98% yield. The 1H NMR spectrum attested to the success of the reaction 
showing an additional upfield signal at δ 2.09 ppm integrating for three protons due to the methyl 
of the acetate group. The 13C NMR spectrum also clearly showed a downfield signal at δ 170.07 
ppm due to the carbonyl group which further confirmed the successful acetylation of our alcohol. 
 
All that remained was to determine whether the racemic acetate could be selectively hydrolysed 
enzymatically. We once again dissolved racemic acetate ±99 in a minimum of solvent and added 
this to the prepared buffer. The reaction was stirred at 30°C with vigorous stirring. After stirring 
for 18 hours, completion of the reaction was determined by HPLC analysis of an aliquot of the 
reaction mixture. We were pleased to see that as expected, we had a 50% conversion of the 
starting acetate to what we hoped was a single enantiomer of the corresponding alcohol. This can 
be seen in Figure 2.8, where the ratio of peaks are equal, but with a shift in retention time of one 
of the peaks to 6.07 min, while the acetate starting material had a retention time of 9.65 min. 
Pleased with this result, we then extracted the organic material into EtOAc, and separated the 
products using column chromatography to yield the expected alcohol ±106 in 43% yield and the 
acetate ±99 in 56% yield.  
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Figure 2.8: HPLC chromatogram confirming an equal ratio of acetylated product ±99 and hydrolysis 
product ±106. 
 
Satisfied with this result we could confidently say that the allyl or styrene substituent in racemic 
acetate ±102 was hindering the enantioselective hydrolysis of the acetate group of ±102.  
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2.7. Concluding remarks pertaining to the synthesis of isochromane 
 
In this section of the PhD thesis we aimed to develop a feasible method to access the 
isochromane core of the pyranonaphthoquinones and in particular, 1,3-disubstituted 
isochromanes containg a fused γ-lactone ring. Our keys steps in this study were the use of cross 
metathesis as well as a novel radical lactone cyclisation reaction to afford both 1,3-disubstituted 
isochromanes and the tricyclic isochromanes which are prevalent in many 
pyranonaphthoquinone compounds. We also hoped to use CALB lipase to kinetically resolve a 
racemic mixture of the isochromane precursors, as part of a stereoselective approach to the 
isochromanes. 
 
Our initial synthetic scheme successfully resulted in the formation of isochromane 72 in an 
overall yield of 9.5% over 8 steps. As mentioned, the first of our two key steps was a cross 
metathesis reaction. Our initial strategy was to protect alcohol 65 thus forming the silylated 
product 79. This was thought to be crucial as the Grubbs catalyst would be incompatible with the 
free alcohol. However, we attempted our metathesis reaction on the free alcohol 65 and were 
pleasantly surprised to find that the metathesis reaction worked better than on the silylated alkene 
79, thereby, shortening our synthetic route (Scheme 2.23). 
 
 
 
Scheme 2.23 
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We were then able to construct the required pyran ring readily by using an oxa-Michael addition 
reaction. All that then remained was the formation of our γ-fused lactone ring to furnish 72. The 
formation of the lactone ring was more challenging than originally thought and we encountered a 
few problems with this step, including with visualization of the lactone product 72 by TLC. We 
eventually managed to isolate our lactone 72, shown in Scheme 2.24, albeit in a disappointing 
yield.  
 
 
 
Scheme 2.24 
 
Employing the same reaction methodology used for the synthesis of isochromane 72 we formed 
the pyran ring 70 in 2.3% over 8 steps, as highlighted in Scheme 2.25. 
 
 
 
Scheme 2.25 
 
With the pyran ring constructed, we moved on to forming our lactone ring containing compound 
75 (Scheme 2.26). Once again, we obtained a poor yield for our lactone ring closure using the 
hypervalent iodine reagents. Upon closer inspection we were pleased to determine that we had 
formed only one diastereomer of the expected lactone 75. This was corroborated with literature 
spectroscopic data, and by HPLC analysis of our product. 
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Scheme 2.26 
 
We then turned our focus to the enantioselective preparation of isochromane 75. We initially 
envisaged that we could kinetically resolve our racemic alcohol using CALB lipase. 
Unfortunately, we were unable to resolve racemic acetate ±102 with this enzyme (Scheme 2.27). 
A major factor in the enzymatic hydrolysis reaction is the ability of the substrate to enter the 
active site and undergo hydrolysis. This was clearly evident as we suspected that the secondary 
alcohol of our substrate was too sterically crowded. A simple omission of the allyl group was all 
that was needed to effect kinetic resolution. There have been numerous research articles 
regarding kinetic resolution,48-50 and it is reported that CALA allows substrates containing larger 
groups attached to the stereogenic centre to be kinetically resolved. In recent months, the 
knowledge base regarding enzyme reactions has significantly increased and various enzymes, 
CALA among others, are being tested to resolve racemic acetate ±102. 
 
 
 
Scheme 2.27 
 
 
 
 
Chapter 2: Approaches toward the isochromane core 
 
 
56 
 
Although our enzymatic hydrolysis didn’t give us the desired outcome, the results obtained 
during this study bodes well for future research. Looking into the future, CALA lipase enzyme 
could be assessed in the kinetic resolution of alcohol ±68. If this transformation is successful, a 
single enantiomer of alcohol 68 could be used in the enantioselective synthesis of isochromane 
75, first by forming a single diastereomer of pyran ring 70 and finally the lactone ring of the 
desired product 75, as shown in Scheme 2.28.  
 
 
 
Scheme 2.28 
 
This completes our section on pyranonaphthoquinones. The work reported here serves as a 
foundation for the development of a stereoselective route to isochromanes.  
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Chapter 3: Spiroketals - An Introduction 
 
3.1. Introduction 
 
The spiroketal functionality is prevalent in a number of naturally occurring substances that have 
been isolated from various sources such as insects, microbes, plants, fungi and marine 
organisms. These sources have been reviewed in the literature and can be divided into two 
categories, namely the Pre-1970 metabolites and the Post-1970 metabolites. Compounds which 
contain the spiroketal functionality have been shown to possess a range of biological activities 
and as such have attracted synthetic attention.51 
 
3.1.1. Pre-1970 metabolites 
 
The first spiroketal containing structures observed in nature were the saponins and the 
sapogenins.52 These metabolites were isolated from plant sources and are generally named after 
their natural sources. They were found to possess a steroidal nucleus which contains a spiroketal 
assembly. There is very little variation in the structure of these spiroketal-containing compounds, 
with only a few variants known. Figure 3.1 shows two of the most common spiroketals of this 
class 107 and 108, where the difference between them occurs at C25. Tomatidine 109 is an 
interesting structural variant that is an aza analogue of 107.53 
 
 
 
Figure 3.1 
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Examples of other spiroketals found in nature are the spiroketal enol ethers that have been 
isolated from the Asteraceae plant family. These types of spiroketals contain one or more 
characteristic acetylene units in the side chain. They are also found as either the Z- or E-isomer 
of the enol ether alkene. Variation of the side chain has been shown with the presence of the 
common enediyne types 110 and 111 or the thioether 112 or thiophene 113 containing 
derivatives (Figure 3.2).54 
  
 
 
Figure 3.2 
 
Spiroketal containing compounds range from the simplest, such as oxetone 114, shown in 
Figure 3.3, and its derivative 115, isolated from Japanese hop oil;55 to the more complex 
spiroketal oligomycin 116 which has been demonstrated to act as a potent oxidative 
phosphorylation inhibitor.56 The identity of spiroketal 116 has been determined by X-ray 
crystallography.57 
 
 
 
Figure 3.3 
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3.1.2. Post-1970 metabolites 
 
3.1.2.1. Polyether ionophores 
 
Another class of these naturally occurring spiroketals have been derived from polyketides and as 
such have been named polyketide-derived polyether antibiotics. These antibiotics have been 
isolated from filamentous branching bacteria Actinomycetes and characterisation of these 
metabolites has shown that the spiroketal functionality forms only a very small part of more 
elaborate structures. Examples of some of these spiroketal ring systems, 117 and 118 are shown 
in Figure 3.4 where the 1,6–dioxaspiro[4.5]decanes predominate.51 
 
 
 
Figure 3.4 
 
Also members of this class are the trioxadispiroketal-containing compounds. These metabolites 
contain two spiroketal substructures, as shown in lenoremycin 11958 and dianemycin 12059 in 
Figure 3.5.  
 
Chapter 3: Spiroketals – An introduction 
 
 
60 
 
 
 
Figure 3.5 
 
3.1.2.2. Spiroketals from insect pheromones 
 
Simple spiroketals have been isolated from many species of flying insects. These species include 
bees, wasps, beetles and flies, and have been found to exhibit pheromonal activity.60-62 The 
majority of spiroketal compounds isolated contain an unbranched carbon skeleton and 
functionalisation does not readily occur. Spiroketals 121 and 122, (Figure 3.6) have been 
identified as odours of wasps of Paravespula vulgaris and possess an unbranched 
dihydroxynonanone skeleton.60 A second example of this class is the major sex pheromone of the 
olive fly, Dacus oleae, which has been identified as 1,7-dioxaspiro[5.5]undecane 123.62 The 
olive fly is generally found throughout the Mediterranean basin as well as parts of North Africa. 
It is one of the major pests of olives, hence its name. Compound 123 was the first spiroketal to 
be identified as a sex pheromone.  
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Figure 3.6 
 
3.1.2.3. Milbemycin and avermeticin antibiotics 
 
This class of antibiotics has generated the most interest in spiroketal synthesis due to the 
medicinal properties which they exhibit. These properties include insecticidal and acaricidal 
activity, however, the fact that they possess low mammalian toxicity has piqued interest in them 
as potential treatments for parasitic infections. One particular spiroketal, ivermectin 124, has 
been shown to inhibit the transmission of Onchocerca volvulus microfilariae by the black fly 
Simulium yahense (Figure 3.7).63 The transmission of Onchocerca volvulus microfilariae is 
responsible for the parasitic disease onchocerciasis (also known as river blindness) which 
sometimes results in permanent blindness. The current course of treatment for this disease 
involves the use of ivermectin and has been generously donated by Merck & Co for the control 
of this disease.64 
 
 
 
Figure 3.7 
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3.1.2.4. Spiroketals of marine origin 
 
Most spiroketals from the marine environment exhibit some form of toxicity and the first 
spiroketals of this class to be described were the polyether carboxylic acids, acanthafolicin 12565 
and okadaic acid 126, shown in Figure 3.8.66 These compounds were initially isolated from 
sponges, however, these compounds are believed to be produced by symbiotic microorganisms 
and cause diarrhetic shellfish poisoning. Other toxic metabolites such as 127 from blue-green 
algae have shown carcinogenic activity while other members of this class are responsible for 
contact dermatitis affecting swimmers of the Pacific Islands.  
 
 
 
Figure 3.8 
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3.1.3. Aromatic spiroketals of interest 
 
Spiroketal containing compounds more closely related to the compounds of interest to us are the 
aromatic spiroketals. These spiroketals include the griseusins and the rubromycins.67  
 
The griseusins, specifically griseusin A 128 and B 129, shown in Figure 3.9, are members of the 
class of pyranonaphthoquinones discussed in Chapter 1. Griseusin A and B have been isolated 
from a soil sample inoculated with Streptomyces griseusis.68 They are synthetically attractive as 
they contain a 1,7-dioxaspiro[5.5]undecane ring fused to a juglone moiety.  In addition, the same 
γ-lactone ring found in kalafungin 9 is evident. As discussed earlier, these compounds act as 
bioreductive alkylating agents, and are active against gram positive bacteria, pathogenic fungi 
and yeasts, thus making them attractive synthetic targets. 
 
 
 
Figure 3.9 
 
Other compounds of interest to us are the rubromycins.67 The rubromycins are typified by an 
aliphatic 5,6-spiroketal core 130 fused to an aromatic naphthoquinone and isocoumarin moieties 
as for 130. These compounds were initially isolated by Brockmann and co-workers as a red-
coloured dye produced by Streptomyces collinus.69,70 The rubromycins are considered potent 
antimicrobial agents and more importantly, as anticancer agents they suppress telomerase 
enzyme activity leading to cell death.71 
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Figure 3.10 
 
3.2. Selected synthetic strategies to spiroketals 
 
A number of synthetic strategies have been developed for the preparation of spiroketal-
containing compounds. A few selected strategies will be discussed below, with the emphasis on 
the preparation of the griseusin skeleton. 
 
3.2.1. Acid catalysed approaches 
 
The most widely used method for spiroketal formation is the acid-catalysed dehydration of 
dihydroxy ketones, shown in general Scheme 3.1.72 This method results in the formation of the 
lowest energy spiroketal stereoisomers. This method is highly effective for the preparation of 
anomeric spiroketals and therefore appropriate for most natural products possessing this 
structural feature. This method is not without serious drawbacks, including the intolerance of 
acid-labile functional groups. Furthermore, the synthesis of nonanomeric or 
contrathermodynamic spiroketals using this methodology is more challenging.73 
 
 
 
Scheme 3.1 
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The past 30 years has seen the development of transition-metal-catalysed methods as an 
alternative to the acidic conditions used previously. The use of these types of methods has 
allowed for different strategies to be employed which enable different modes of reactivity. These 
methods have also provided new classes of compounds which can serve as spiroketal synthons 
which have allowed for new advanced strategies to be adopted. A few selected strategies of this 
approach will be highlighted. For a more comprehensive view, review articles by Perron and 
Palmes should be consulted.51,73 
 
3.2.2. Hetero-Diels-Alder reaction methodology 
 
The use of the hetero-Diels-Alder (HDA) reaction methodology has proven to be an efficient 
strategy for accessing the spiroketal functionality. The HDA method is versatile as it allows for 
the modification of the prepared spiroketal system. A general outline is shown in Scheme 3.2, 
where the [4+2] cycloaddition reaction between enone/enal 131 and α-methylenefuran 132 or α-
pyran 133 will result in the construction of [6,5] and [6,6]-spiroketals 134 and 135, respectively. 
The only challenge that this method presents is the isomerisation of the exo-vinyl ether 132 to 
the thermodynamically more stable endo-vinyl ether 136 which readily occurs under mild acidic 
conditions (Scheme 3.3).74 
 
 
 
Scheme 3.2: The Hetreo-Diels-Alder (HDA) reaction for the synthesis of spiroketals. 
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Scheme 3.3: Undesired isomerisation of the methylene protons 
 
The preparation of optically active spiro-carbohydrates was achieved by Jorgensen and co-
workers using an enantioselective HDA approach (Scheme 3.4). In their approach, β,γ-
unstaturated α-ketone ester 137 was reacted with α-methylenefuran 132 in the presence of the 
transition metal catalyst 138. This transition-metal mediated approach afforded the endo-
spiroketal 139 as the major diastereomer in 74% ee. The carbohydrate derivative 140 was 
obtained by functionalisation of the alkene. The hydroxyl group was introduced in an anti-
Markovnikov sense.75 
 
 
 
Scheme 3.4: Reagents and conditions: (i) 20 mol% 138, THF, –78°C, 63% (for 139, 74% ee), 21% (for 
141, 84% ee); (ii) a. LiAlH4, b. BH3-SMe2, c. NaOH, H2O2, 40%, 100% de. 
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3.2.3. Oxycarbonylation of dienones 
 
The use of alkenes in spiroketal formation via π-bond activation has been extensively employed. 
During their construction of bifunctional spiroketals, Yadav and co-workers utilised a transition 
metal palladium-catalysed double cyclisation of dienones.76 Dienone 142 was converted to 
spiroketal 143, with the concomitant introduction of two side chains. This was achieved using 
catalytic palladium(II) chloride in the presence of copper(II) chloride, carbon monoxide and 
trimethylorthoformate. The reaction is presumed to proceed through a dimethyl ketal 
intermediate which was formed in situ. To substantiate this claim, a control experiment was 
conducted where ketal 144 was treated with the same reaction conditions to furnish 
spiroketal 145 (Scheme 3.5). 
 
145
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Scheme 3.5: Reagents and conditions: (i) cat. PdCl2, CuCl2, CO, MeOH, trimethylorthoformate, 
50% (for 143), 85% (for 145). 
 
3.2.4. Monoacetylated ketodiol cyclisation 
 
The diastereoselective construction of tetrahyropyrans from allylic acetates was reported by 
Cossy and co-workers, shown in Scheme 3.6. This type of cyclisation reaction was facilitated by 
an iron(III) catalyst which was used to cyclise hydroxy ketone 146 to afford spiroketal 147 
where a carbocation intermediate was proposed through which the cyclisation had occurred. 77 
Chapter 3: Spiroketals – An introduction 
 
 
68 
 
 
 
Scheme 3.6: Reagents and conditions: (i) 5 mol % FeCl3.6H2O, CH2Cl2, RT, 85 min, 76%. 
 
3.2.5. Synthesis of aromatic spiroketals: griseusin A and B 
 
Of direct interest to this section of the PhD thesis are the griseusin spiroketals that display 
interesting biological activity. Only one total synthesis of the griseusins has been reported. This 
synthesis by Yoshii and co-workers constructed the spiroketal ring system using the traditional 
intramolecular cyclisation reaction of a δ,δ'-dihydroxyketone. However, a number of other 
approaches to the core spiroketal system of the griseusins have been reported. In this section we 
will briefly look at a synthesis pertaining to the construction of the griseusin spiroketal core. 
 
In their study, Naysmith and Brimble reported the synthesis of the framework of griseusin from 
advanced precursors using a one-pot reaction (Scheme 3.7). The synthesis employed a Hauser-
Kraus annulation (discussed in Section 1.5.2.) between phthalide 50 and enone 148 to afford the 
hydroquinone dimethyl ether 149. The crude material was then subjected to a reductive 
methylation reaction to afford the spiroketal 150 as the sole product.78 
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Scheme 3.7: Reagents and conditions: ButOK, NaOH, Me2SO4, 49%. 
 
3.2.6. The nitroalkane approach to spiroketals 
 
The use of nitroalkanes as carbanionic precursors has become a widely used route for the 
preparation of spiroketals via the assembly of dihydroxy ketone frameworks. These nitroalkanes 
are usually accessed through Henry condensation or nitroaldol reactions and Michael additions. 
The Nef reaction then facilitates the conversion of the nitro group to a carbonyl group, thus 
introducing the keto functionality. The following sections will highlight the use of the Henry 
condensation reaction and Nef reaction to assemble the spiroketal framework.79 
 
3.2.6.1. Henry condensation reactions 
 
The introduction of a nitro group is quite a challenging obstacle to overcome. An easily 
recognizable manner in which to introduce the nitro group is using a Henry or nitroaldol 
reaction. This reaction is essentially a coupling of a carbonyl compound with an alkylnitro 
compound. This reaction process results in the formation of a new carbon-carbon bond and the 
concomitant introduction of a new functional group, namely the β-nitroalcohol.80 
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The nitroaldol reaction is often promoted by the use of protic or aprotic solvents, quaternary 
ammonium salts and organic bases. The reaction conditions are usually determined by other 
functional conditions present within the substrates as well as the solubility of the substrates.80 
 
The use of alumina to facilitate the nitroaldol reaction has been reported by Rosini and co-
workers.81 During their study, they described a simple and efficient method for the preparation of 
nitroalcohols using alumina as a catalyst in the absence of solvent. Using these conditions, the 
nitroalkane 151 and aldehyde 152 afforded nitroalkanol 153 in an excellent yield (Scheme 3.10). 
 
 
 
Scheme 3.10: Reagents and conditions: (i) Alumina, 0°C-RT, 80%. 
 
Microwave assisted nitroaldol reactions have been shown to afford high yields of the nitroalkene 
compounds without the isolation of the intermediate nitroalcohol. This procedure circumvents 
the dehydration of the nitroalcohol to the nitroalkene. Varma and co-workers demonstrated the 
use of this method in the synthesis of nitroalkenes, shown in Scheme 3.11,82 where 
benzaldehyde 154 was reacted with nitromethane in the presence of catalytic ammonium acetate 
to furnish nitroalkene 155 in a yield of 80%.  
 
 
 
Scheme 3.11: Reagents and conditions: (i) CH3NO2, NH4OAc, µν, 80%. 
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One of the early key reactions used in the synthesis of morphine alkaloid, (d,l)-thebainone A was 
a nitroaldol reaction. Tius and Kerr showed the formation of nitroalkene 156 from the acid-
catalysed condensation of o-vanillin 157 with nitromethane as shown in Scheme 3.12.83 The use 
of aromatic aldehydes allows for the formation of the nitroalkene directly as this affords a stable, 
conjugated alkene. 
 
 
 
Scheme 3.12: Reagents and conditions: (i) CH3NO2, NH4OAc, HOAc, 93%. 
 
3.2.6.2. The Nef reaction 
 
As outlined in Section 3.2.6, nitroalkanes have proven an efficient route to access the spiroketal 
skeleton. The nitro group has often been used as it can undergo a Nef reaction to the 
corresponding carbonyl group which undergoes nucleophilic addition with alcohols resulting in 
the spiroketal core. The nitro group is a very versatile functional group as it can undergo further 
nucleophilic addition or it can be transformed into other useful functional groups. Scheme 3.13 
outlines some of the different functional group transformations that the nitro group can undergo. 
Of interest to us, is the conversion of the nitro group into a carbonyl group, step D.84 This 
transformation is known as a Nef reaction. 
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Scheme 3.13 
 
The Nef reaction was originally described as a strong acidic hydrolysis of a nitronate salt 158 
which is produced from nitroalkane 159. The general mechanism is shown in Scheme 3.14, 
where nitronic acid 158 is protonated resulting in 160. Hydrolysis occurs on 160 producing 
intermediate 161 which undergoes a dehydration and loss of hyponitrous acid to afford carbonyl 
compound 162. 
 
 
 
Scheme 3.14 
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3.2.6.3. Nitroalkanes as precursors to spiroketals 
 
The preparation of chalcogran 163, the main component of the aggregation pheromone of the 
bark beetle was achieved using a double Michael addition of nitromethane to different α,β-
unsaturated carbonyl derivatives. As outlined in Scheme 3.8, nitromethane was added to 1-
penten-3-one 164 to afford the corresponding 4-nitro ketone 165. This newly formed ketone 165 
undergoes a 1,4-addition to acrolein 166 resulting in nitro diketone 167a. The carbonyl groups 
were reduced using sodium borohydride furnishing diol 167b. With the diol in place, a Nef 
reaction was conducted using titanium trichloride which facilitated the conversion of the nitro 
group to the carbonyl group followed by the spontaneous spiroketalisation to afford chalcogran 
163.85,86 
 
 
 
Scheme 3.8 Reagents and conditions: (i) Al2O3, 62%; (ii) acrolein, Al2O3, 53%; (iii) NaBH4, EtOH, 85%; 
(iv) TiCl3, H2O, 65%. 
 
Spiroketal (E)-7-methyl-1,6-dioxaspiro[4.5]decane 168, a component of odours of the wasp 
Paravespula vulgaris was efficiently prepared using nitroalkanes as spiroketal precursors. 
Starting from 1-bromo-5-hexene 169, Rosinidy and co-workers prepared ketone 170 using a 
Wacker-type oxidation with benzoquinone 171 (Scheme 3.9). A functional group 
interconversion by nucleophilic displacement of the bromine with sodium nitrite resulted in nitro 
ketone 172. A Michael addition of 172 with acrylaldehyde 166 then afforded nitro diketone 173. 
In order to form the spiroketal skeleton, nitro diketone 173 was reduced to the nitro diol 174 
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using sodium borohydride. The synthesis of 168 was completed with the Nef reaction of nitro 
diol 174, which exclusively resulted in the formation of the E stereoisomer.87 
 
 
 
Scheme 3.9 Reagents and conditions: (i) PdCl2, CuCl2, DMF, 87%; (ii) NaNO2, DMF, 75%; (iii) 
acrylaldehyde, amberlyst A21, 78%; (iv) NaBH4, MeOH, 85%, (v) NaOH, EtOH; (vi) H2SO4, n-C5H12, 
74%. 
 
3.3. Proposed project aims 
 
Synthesis of The spiroketal functionality presents both an interesting and challenging task to 
perform, and as such, one of the themes in our laboratory has been the synthesis and assembly of 
benzannelated spiroketals such as compound 175, a precursor of γ-rubromycin 130 (Figure 
3.11). Spiroketal 175 was successfully prepared in our laboratories by Cappechi, using the 
nitroalkane approach.  
 
 
 
Figure 3.11 
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In her PhD studies, Cappechi reported the use of Pearlman’s catalyst in the presence of a 
catalytic amount of concentrated hydrochloric acid and cyclohexene to facilitate the 
spiroketalisation.88 The synthesis commenced with the preparation of aldehyde 176 followed by 
a Henry condensation reaction of 176 with nitromethane to afford nitroalkene 177 and 
subsequent reduction of the alkene to give nitroalkane 178. A second Henry condensation of 178 
with aldehyde 179 afforded nitroalkene 180 which was subjected to a modified Nef reaction to 
furnish spiroketal 175, shown in Scheme 3.10. Ketone 181 was also isolated from the reaction. 
 
 
 
Scheme 3.10 Reagents and conditions: (i) (a) O3, –40°C, (b) Zn, AcOH, 84%; (ii) (a) MeNO2, 
cetyltrimethylammonium bromide (CTABr), 0.025 M NaOH, 100%; (b) MsCl, Pri2NEt, CH2Cl2, 96%; 
(iii) NaBH4, MeOH-THF, 70%; (iv) NH4OAc, AcOH, 57%; (v) cat. Pd(OH)2/C, EtOH, conc. HCl, 
cyclohexene, H2(g) (1atm), RT, 64% (for 175) and 18% (for 181). 
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Our central aim for this PhD thesis stems from the work earlier conducted by Capecchi as the 
mechanism of this modified Nef reaction is not known. Identification of the reaction 
intermediates of this Nef reaction may allow for the elucidation of the mechanism of this novel 
reaction. In order to conduct this investigation we envisaged that we required substrates which 
lacked a phenol that could be liberated under the reaction conditions as this would be required to 
facilitate the spiroketalisation reaction. A more detailed reasoning for the omission of the free 
phenols will be discussed in Section 4.1.  
 
We also plan to synthesise the spiroketal framework of griseusin A. We envisaged that we could 
achieve this by using methodology developed some time ago at Wits University, i.e., the 
nitroalkane approach. 
 
A proposed synthetic route is outlined in Scheme 3.11 which shows the formation of nitroalkane 
precursor 182 from readily prepared starting materials. This would allow the formation of 
nitroalkene 183 from the reaction of 182 and aldehyde 184. The synthesis of the aromatic core of 
griseusin A would then be accomplished through a Nef reaction of nitroalkene 183 to give 
spiroketal 185. 
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Scheme 3.11  
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Chapter 4: Mechanistic studies of the Nef reaction 
 
4.1. Introduction 
 
4.1.1. Background to project 
 
As discussed in the previous chapter, Capecchi, during her PhD studies observed what appeared 
to be a novel Nef-type reaction during the preparation of the bisbenzannelated spiroketal core 
175 of the γ-rubromycins 130, shown in Figure 4.1.88,89  
 
 
 
Figure 4.1 
 
In particular, Capecchi found that when nitroalkene 180 was exposed to Pearlman’s catalyst 
[Pd(OH)2/C] in ethanol with a catalytic amount of hydrochloric acid and cyclohexene under an 
atmosphere of hydrogen, spiroketal 175 and the “open” ketone 181 were formed and isolated in 
yields of 64% and 18%, respectively (Scheme 4.1). 
 
 
 
Scheme 4.1 Reagents and conditions: (i) cat. Pd(OH)2/C, EtOH, conc. HCl, cyclohexene, H2(g) (1atm), rt, 
64% (for 175) and 18% (for 181). 
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Two possible mechanisms for this transformation have been proposed and are shown in Scheme 
4.2. The first mechanism involves initial reduction of the nitro group 180 to the hydroxylamine 
186 followed by conversion to the enamine 187 which would hydrolyse to the carbonyl 181 
under aqueous acidic conditions. This would then pave the way for the cyclisation to the 
spiroketal product 175. An alternative mechanism involves the reduction of the nitro group 180 
to the hydroxylamine 186 which would then tautomerise to the oxime 188 and this would be 
followed by hydrolysis to the carbonyl 181 and once again as before converted to the 
spiroketal 175. Related literature precedence for the latter mechanism identified oximes as 
intermediates and they were indeed produced when nitro groups were reduced using palladium 
on carbon.90  
 
Chapter 4: Mechanistic studies of the Nef rection 
 
 
80 
 
 
 
Scheme 4.2: Proposed mechanism of the Nef reaction 
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Our research will therefore build on this as we hope to confidently elucidate the mechanism of 
this modified Nef reaction. Our main aim for this work is to try and identify stable and 
characterisable intermediates, if any, that are involved in our Nef reaction and thereby elucidate 
the mechanism of the reaction. As shown in Scheme 4.2, the formation of the carbonyl group of 
181 as well as the removal of the benzyl protecting groups is required for the formation of the 
spiroketal 175. In order to determine the intermediates involved in this transformation, we chose 
substrates that may afford stable, isolable intermediates that could not be converted further to the 
spiroketal functional group. We therefore decided to use three substrates lacking substituents that 
would furnish o-phenols, namely piperonal, anisaldehyde and vanillin, and convert them into 
aromatic conjugated nitro systems of the general structure shown in Figure 4.3. Compounds of 
this general structure, when subjected to Pearlman’s catalyst would then not be able to form 
spiroketals. 
 
 
 
Figure 4.2 
 
 
 
Figure 4.3 
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4.2. Preparation of nitroalkenes 
 
The following section describes the preparation of our initial nitroalkenes by a Henry 
condensation reaction. Methodology described by Merchant and Mountwala was employed to 
successfully prepare the desired nitroalkenes 189, 190 and 191. 91 
 
 
189: R1 = R2 = -OCH2O- 
190: R1 = OMe R2 = H 
191: R1 = OiPr R2 = OMe 
 
Scheme 4.3: General reaction scheme for the formation of nitroalkenes. 
 
Commercially available aldehydes piperonal 192, anisaldehyde 193, and O-isopropyl protected 
vanillin, (4-isopropoxy-3-methoxybenzaldehyde) 194, were added to freshly distilled 
nitromethane in the presence of ammonium acetate in glacial acetic acid. The reactions were then 
stirred under reflux for 6 hours resulting in deep red solutions. The reactions were cooled and 
after workup and purification by recrystallisation from a diethyl ether and hexane mixture, the 
corresponding nitroalkene products 189, 190 and 191 were furnished as yellow solids. The yields 
obtained for these reactions were determined after recrystallisation. The general reaction is 
shown in Scheme 4.3. 
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Table 4.1 shown below shows a summary of each the nitroalkenes prepared and their isolated 
yields after recrystallization.  
 
Table 4.1: Synthetic yields for the nitroalkenes prepared 
 
Substrate Product Yield (%) 
 
 
43 
 
 
51 
 
 
44 
 
It was evident from the 1H NMR spectrum of 189 that the aldehyde 
proton was absent. Also noted on the spectrum were two downfield 
doublets at δ 7.92 and δ 7.47 ppm due to H5 and H4, respectively. Each 
of these doublets showed coupling of 13.6 Hz confirming the formation 
of the trans isomer of the conjugated alkene 189. The aromatic region shows three distinct 
signals indicating three different environments. A doublet at δ 7.00 ppm due to H1 which shows 
meta coupling to the multiplet found at δ 7.08 ppm due to H2 with a coupling constant of 1.5 Hz, 
and doublet at δ 6.87 ppm due to H3 showing ortho coupling of 8.0 Hz to H2. The only remaining 
signal at δ 6.06 ppm, observed as a singlet integrating for two protons was therefore due to H6. 
The 13C NMR spectrum further attested to the success of the reaction as no signal above 
δ 160 ppm characteristic of a carbonyl group was observed. Instead, two new signals were 
present at δ 139.1 and δ 135.4 ppm due to the newly introduced alkene carbons C4 and C5 
respectively. The presence of the newly introduced nitro group was confirmed by IR 
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spectroscopy which showed absorption bands at 1500 and 1368 cm–1 which are characteristic of 
the nitro functional group. The trans geometry of the alkene was also confirmed by the presence 
of a CHEalkene stretch at 965 cm–1 in the IR spectrum. The experimental melting point was 
determined to be 161–162°C and correlated well with the expected melting point of 164–
165°C.92 
 
(E)-1-Methoxy-4-(2-nitrovinyl)benzene 190 was prepared using p-anisaldehyde as our starting 
material. The para substitution pattern observed on the aromatic ring results in a simplified 
NMR spectrum compared to the previously examined nitroalkene 189.93 
 
The most distinctive feature of the 13C NMR spectrum of 190 is the 
absence of a downfield signal above δ 160 ppm indicating that we no 
longer had our aldehyde functional group. Instead, we again observed 
signals in the alkene region at δ 139.03 and δ 135.07 ppm which are due to C3 and C4 
respectively. In the 1H NMR spectrum, the presence of the alkene was confirmed by the 
observation of a doublet at δ 7.97 ppm due to H3, showing trans coupling of 13.6 Hz to the 
multiplet at δ 7.51 ppm due to overlapping of the signals from  H4, H2 and H2’.  
 
(E)-1-Isopropoxy-2-methoxy-4-(2-nitrovinyl)benzene 191 was prepared from 4-isopropoxy-3-
methoxybenzaldehyde.94 This substrate was prepared by reacting vanillin dissolved in DMF with 
isopropyl bromide in the presence of sodium hydride. The most notable difference between 
nitroalkenes 189 and 191 was the presence of this isopropyloxy group as observed in the 1H and 
13C NMR spectra.  
 
The 1H NMR spectrum was characterized by the presence of an upfield 
doublet at δ 1.41 ppm integrating for six protons. This signal was due 
to H8 and showed coupling of 6.1 Hz to H7. The remaining differences 
between nitroalkene 189 and 191 were the presence of a singlet at 
δ 3.90 ppm integrating for three protons and a septet at δ 4.65 ppm integrating for one proton 
corresponding to H6 and H7 respectively. These features were also observed in the 13C NMR 
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spectrum with three upfield signals at δ 71.45, δ 56.12 and δ 21.93 ppm due to C7, C6 and C8 
respectively. 
4.3. Synthesis of nitroalkanes 
 
The reduction of the conjugated double bond present in each of the nitroalkenes was the next 
step in our synthesis. This was accomplished by the slow addition of sodium borohydride to a 
stirred slurry of the chosen nitroalkene and silica gel in a mixture of isopropanol and chloroform. 
The mixture of protic and aprotic solvents in the presence of an insoluble protic phase is believed 
to prevent the formation of dimeric products. These mild experimental conditions provide for a 
rapid reaction and more importantly, afford pure products in near quantitative yields.95 A visual 
indication that the reaction was progressing was the change in colour from bright yellow to 
colourless. Once completed, as indicated by TLC analysis, the reactions were filtered through 
celite and purified by column chromatography to yield the nitroalkane compounds 195, 196 and 
197 as pale yellow oils.  
 
5-(2-Nitroethyl)benzo[d][1,3]dioxole 195 was isolated in 71% yield and 
characterised by NMR spectroscopy. The 1H NMR spectrum confirmed 
the successful reduction of the double bond of nitroalkene 189, with the 
loss of signals previously associated with the alkene protons and the presence of two new triplets 
at δ 4.55 and δ 3.21 ppm for H5 and H4 respectively. The 13C NMR spectrum further attested to 
this with the upfield shift of the carbons associated with C4 and C5 from δ 139.08 and δ 135.44 
to δ 33.20 and δ 101.15 ppm respectively. A singlet integrating for two protons due to H6 was 
observed at δ 5.92 ppm in the 1H NMR spectrum. The remaining signals were due to the 
aromatic protons and were observed at δ 6.74 ppm due to H3, and at δ 6.68–6.62 ppm due to 
overlapping of the signals from protons H2 and H1. 
 
Analysis of the 1H NMR spectrum of 196 once again provided us with 
evidence that the reduction of the double bond of nitroalkene 190 was 
successful. We were pleased to observe the disappearance of signals 
arising from the alkene protons and the concomitant appearance of the expected triplets as 
Chapter 4: Mechanistic studies of the Nef rection 
 
 
86 
 
observed for nitroalkane 195. These triplets each integrated for two protons and were found at 
δ 4.55 and δ 3.24 ppm for H4 and H3 respectively. All other spectroscopic data, including 13C 
NMR and IR spectroscopic data, confirmed the formation of 196. 
 
The last reduction we attempted was performed on nitroalkene 191 
which resulted in the formation of nitroalkane 197. Pleasingly, when 
we examined the 13C NMR spectrum of 197, we noticed the 
unmistakable upfield shift of the carbon signals previously found at 
δ 139.41 and δ124.45 ppm due to the alkene protons, to δ 33.18 and δ 76.53 ppm, respectively. 
This therefore confirmed the change in the nature of these carbons from being sp2 hybridised to 
now being sp3 hybridised. 
 
4.4. Synthesis of nitroalkenes 199, 200 and 201 using Henry condensation reactions 
 
 
 
Scheme 4.4: General scheme for the preparation of nitroalkenes 
 
Having successfully prepared our nitroalkanes 195, 196 and 197, all that remained was to couple 
each of these nitroalkanes with a suitably substituted aldehyde. We chose 2,4-
dimethoxybenzaldehyde 198 as this would afford substrates that mimic the precursor 180 which 
contained two ortho-O-benzyl substituents as closely as possible. To this end, we attempted the 
Henry condensation reactions using the same method we employed in Section 4.2. However, 
following several attempts using TLC analysis to determine the progress of the reactions, we 
suspected that our product and starting nitroalkane had similar Rf values. This was confirmed by 
NMR spectroscopy. We therefore decided to adapt our method to drive the reactions to 
completion. The formation of nitroalkenes and not nitroalcohols as observed in some cases 
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indicates that spontaneous dehydration occurs forming the nitroalkene. We therefore employed a 
Dean-Stark set up for our subsequent Henry condensation reactions in order to facilitate 
dehydration of the intermediate nitroalcohol. Thus, nitroalkane 195, 196 or 197 was stirred in 
toluene under reflux with 2,4-dimethoxybenzaldehyde 198 in the presence of ammonium acetate. 
After six hours, the reactions were cooled and purification by recrystallization from a diethyl 
ether and hexane mixture afforded the desired conjugated nitroalkene compounds 199, 200 and 
201 as bright yellow solids (Scheme 4.4). 
 
Nitroalkane 195 was used as the precursor in the formation of (Z)-5-(3-(2,4-dimethoxyphenyl)-2-
nitroallyl)benzo[d][1,3]dioxole 199. TLC analysis of the reaction showed a bright yellow spot 
appearing which was visible to the naked eye and was a promising sign that we were forming a 
nitroalkene. The product was isolated and purified by silica gel column chromatography to yield 
what we expected to be our nitroalkene 199. However, the 1H NMR spectrum showed that our 
product was contaminated with the starting aldehyde. Recrystallization to remove the unreacted 
and unwanted starting material afforded pure (Z)-5-(3-(2,4-dimethoxyphenyl)-2-
nitroallyl)benzo[d][1,3]dioxole 199 in a good yield of 71%.  
 
Interpretation of the 1H NMR spectrum confirmed that the 
desired nitroalkene 199 had indeed formed. This was 
indicated by the presence of two singlets at δ 8.52 and 
δ 4.14 ppm corresponding to H1 and H2 respectively. 
Interestingly, the alkene proton H1 was significantly deshielded giving rise to a signal at 
δ 8.52 ppm, owing to the alkene being conjugated to both the nitro group and an aromatic ring. A 
singlet integrating for two protons was observed at δ 4.14 ppm, due to benzylic protons H2, 
slightly downfield compared to that of the starting nitroalkane 195. The 13C NMR spectrum 
showed the presence of an alkene carbon, C1, at δ 131.38 ppm and a CH correlation spectrum 
was used to unambiguously assign the remaining carbons of nitroalkene 199. The results of the 
mass spectral analysis afforded an accurate mass of 344.1129 which was in good agreement with 
the expected mass of 344.1129 for a compound of the formula C18H17NO6. 
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Table 4.2 shows a comparison of NMR spectroscopic data of nitroalkene products 200 and 201, 
and the recently discussed nitroalkene 199 (shown in Figure 4.3). It is evident from the table that 
the benzylic alkene proton occurs at a similar chemical shift and is significantly deshielded in 
each product. The benzylic methylene protons also occur at similar chemical shifts across all 
three products. The same trend is observed for the carbons associated with these protons as well 
as for the carbons attached to the nitro group. The yields obtained from these Henry 
condensation reactions were also considerably higher than those obtained for the nitroalkenes 
prepared in Section 4.2. The removal of water by use of a Dean-stark trap is clearly an 
advantage. All spectroscopic data including IR spectroscopy and mass spectrometry confirmed 
the identity of these aromatic nitroalkenes.  
 
 
 
Figure 4.3 
 
Table 4.2: Trends in the 1H and 13C NMR spectroscopic data of the nitroalkene products prepared 
and data comparison 
 
Signal 199(ppm) 200(ppm) 201(ppm) 
1H NMR spectrum    
H1 8.52 (s) 8.52 (s) 8.53 (s) 
H2 4.14 (s) 4.16 (s) 4.17 (s) 
13C NMR spectrum    
C1 131.38 131.11 131.27 
C2 32.98 32.43 32.82 
C-NO2 146.44 147.75 147.66 
Yield (%) 71 87 72 
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4.5. Application of our Novel Nef reaction conditions 
 
With nitroalkenes 199, 200 and 201 in hand, we turned our attention to the determination of the 
intermediates involved during what we considered to be a novel Nef reaction. To achieve this, 
we would subject each of our nitroalkenes 199–201 to Pearlman’s catalyst in ethanol in the 
presence of catalytic concentrated hydrochloric acid and cyclohexene under an atmosphere of 
hydrogen.96 
 
We first attempted these reaction conditions on nitroalkene 199, as shown in Scheme 4.4. Upon 
completion of the reaction as monitored by TLC, the reaction mixture was filtered to remove the 
Pearlman’s catalyst. The resulting filtrate, assumed to contain our reaction intermediates, was 
subjected to an aqueous work-up, and the crude reaction mixture was purified by column 
chromatography. This process yielded three products as yellow oils. Review and analysis of 
these three isolated products showed the formation of a reduced nitroalkane 202, an oxime 203 
and finally a carbonyl containing compound 204 (Scheme 4.4).  
 
 
 
Scheme 4.4 Reagents and conditions: cat. Pd(OH)2/C, EtOH, conc. HCl, cyclohexene, H2 (1atm), RT, 
29% (for 204), 37% (for 203) and 5% (for 202). 
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Compound 204 was isolated as a yellow oil in 29% yield with 
an Rf of 0.39 in a 30% ethyl acetate: hexane mixture. Analysis 
of the 1H NMR spectrum showed the loss of the alkene proton 
previously observed at δ 8.52 ppm, and the appearance of a 
singlet at δ 3.61 ppm. The only downfield signals we observed were due to the aromatic protons. 
The most downfield signal, observed as a doublet at δ 6.98 ppm showed ortho coupling of 
8.7 Hz and was assigned as H8 as confirmed by NOE experiments. This showed coupling to H7 
which was found within overlapping signals at δ 6.44 ppm. The doublet at δ 6.74 ppm was 
assigned as H5 as it only showed ortho coupling of 7.9 Hz. A slight upfield shift of proton H2 
was observed from δ 4.14 to δ 3.59 ppm, which is an indication that this proton is now less 
deshielded. The most notable feature in the 13C NMR spectrum was the presence of a downfield 
signal at δ 206.71 ppm, which unequivocally confirmed the presence of a carbonyl group. This 
result was corroborated by the IR spectrum which showed a stretch at 1715 cm–1 due to the 
carbonyl group. Furthermore, the signals associated with the alkene carbons at δ 146.44 and 
131.38 ppm were no longer present. 
 
The most polar product isolated, with an Rf of 0.25 in a 30% 
ethyl acetate: hexane mixture and in 37% yield, was 
determined to be an oxime containing compound. Analysis of 
both the 1H and 13C NMR spectra showed the doubling of 
signals and therefore led us to believe that an inseparable mixture of both the E and Z-isomers of 
oxime 203 were formed from nitroalkene 199. The 13C NMR spectrum showed the presence of  
signals at δ 158.42 and δ 158.31 ppm which were assigned to the E- and Z-isomers of  the carbon 
of the oxime functionality. A defining aspect of the 1H NMR spectrum was the presence of a 
broad singlet at δ 9.47 ppm which is due to the hydroxyl group of the oxime. This was also 
observed when analyzing the IR spectrum which showed a broad stretch at 3220 cm–1, 
characteristic of a hydroxyl group.  
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The final product isolated from the reaction mixture in 5% 
yield was nitroalkane 202 which was the least polar and was 
found at an Rf of 0.61 in a 30% ethyl acetate: hexane mixture. 
In the analysis of the 1H NMR spectrum, the most evident 
features were the loss of the alkene proton in the starting material found at δ 8.52 ppm, and the 
appearance of a multiplet integrating for one proton at δ 5.03–4.87 ppm. We therefore assigned 
this signal to H10. Using a COSY NMR spectrum, we confirmed that this signal coupled to the 
most upfield signal found at δ 3.24–2.86 ppm which integrated for four protons and was 
therefore due to protons H1 and H2. Under the reaction conditions used, it could be expected that 
the nitro group would also be reduced to the amine, however, no evidence of this was found. The 
1H NMR spectrum did not show the presence of a broad singlet integrating for two protons as 
would be expected. Furthermore, the IR spectrum showed stretches at 1591 and 1288 cm–1 which 
are characteristic of a nitro group. 
 
We then performed the reaction on nitroalkenes 200 and 201, and observed similar intermediates 
being formed to those isolated in our initial reaction with nitroalkene 199. Nitroalkene 200 
afforded carbonyl 205, oxime 206 and nitroalkane 207 when subjected to the novel Nef reaction. 
A similar trend was observed for the Nef reaction of nitroalkene 201 where we again isolated 
carbonyl 208, oxime 209 and nitroalkane 210. As shown in Table 4.3, the chemical shifts in the 
NMR spectra observed for 202, 203 and 204 were similar to those of 207 and 210, 206 and 209, 
and 205 and 208 (Figure 4.5). 
 
 
 
Figure 4.5 
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Table 4.3: A summary of the NMR spectroscopic data of products of our novel Nef reaction 
Compound 
1H NMR shift (ppm) 13C NMR shift (ppm) 
Yield (%) 
H1 H2 C=O C=N C–NO2 
204 3.61 3.59 206.71 – – 29 
203 3.60/3.55 3.41/3.32 – 158.42/158.31 – 37 
202 3.24-2.86 – – 89.73 5 
205 3.62 3.60 206.97 – – 24 
206 3.73/3.59 3.40/3.55 – 158.30/158.12 – 25 
207 3.26-2.95 – – 89.90 47 
208 3.62 3.61 206.97 – – 30 
209 3.62/3.59 3.43/3.35 – 158.43/158.35 – 17 
210 3.11 2.99 – – 89.64 7.4 
 
Having successfully isolated what we assumed to be the intermediates involved in the Nef 
reaction, we were in a position to propose a mechanism by which this particular Nef reaction 
operates. Based on the intermediates isolated, we propose that nitroalkene 180 is reduced to the 
hydroxylamine 186 and at the same time removal of the benzyl groups occurs (Scheme 4.5). 
This hydroxylamine 186 tautomerises to the more stable oxime 188 which in turn gets 
hydrolysed to the carbonyl 181. This carbonyl 181 is attacked by the free phenols which result in 
the formation of the spiroketal 175. This mechanism corroborates the earlier proposal by 
Capecchi.88,89 
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Scheme 4.5: Mechanism of the Nef reaction 
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4.6. Attempts towards the spiroketal core 
 
Having elucidated the mechanism of the novel Nef reaction, we could now turn our focus to the 
preparation of the spiroketal 185 (Scheme 4.6).  
 
 
 
Scheme 4.6 
 
The next section of this chapter of the PhD thesis will therefore focus on our attempts towards 
the assembly of the spiroketal 185. We aimed to use the methodology developed during our 
mechanistic studies where our key steps were a Henry condensation and our novel Nef reaction 
(Scheme 4.6). 
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We envisaged that spiroketal 185 could be prepared over several steps starting from 
commercially available 2-bromonaphthoquinone. The first step in the synthesis would employ a 
Hunsdiecker reaction to introduce the allyl group followed by protection of the quinone as the 
aromatic ether 212. The alkene could then be oxidised to the aldehyde followed by reduction and 
subsequent protection of the alcohol as the benzyl ether 215. Nitroalkane 182 could then be 
prepared using a palladium mediated cross coupling reaction with nitromethane which could be 
subjected to a Henry condensation reaction with 184 to afford nitroalkene 183. If successful, the 
more complex aromatic conjugated nitro containing compound could then be subjected to our 
novel Nef reaction conditions to give the desired spiroketal 185, as shown in Scheme 4.6.  
 
 
 
Scheme 4.7 Reagents and conditions: Vinyl acetic acid, AgNO3, ammonium persulfate, MeCN, 60–
70°C, 24 h, 79%. 
 
To this end, a modified Hunsdiecker reaction was employed where ammonium persulphate in 
water was added to a solution of vinyl acetic acid, silver nitrate and 2-bromonaphthoquinone in 
acetonitrile. The reaction was heated to 60–70°C for 24 hours before purification by column 
chromatography yielded 2-allyl-3-bromonaphthalene-1,4-dione 211 as a yellow solid in 79% 
yield (Scheme 4.7).29 This product proved unstable and decomposed on standing even at low 
temperatures (–20°C). As 211 is a known product, we decided to only obtain a 1H NMR 
spectrum to confirm the identity of the product, and to use the material in the subsequent step 
immediately to avoid decomposition. 
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In the analysis of the 1H NMR spectrum of 211 the presence of signals in 
the mid-region of the spectrum was a positive sign that the product had 
indeed been formed. The most upfield signal at δ 3.64 ppm integrating for 
two protons was observed as a doublet of triplets, and was assigned to the 
methylene protons at H1. This signal showed coupling to three other signals: 3J coupling of 
6.6 Hz to the protons at δ 5.87 ppm which we assigned to H2, and coupling of 1.4 Hz to the 
signals at δ 5.27 and δ 5.22–5.10 ppm which were due to alkene protons H3a and H3b. H2 also 
showed both trans and cis coupling to H3a and H3b of 16.6 and 10.0 Hz respectively. The only 
remaining signals were due to our aromatic protons and were found as multiplets at δ 8.21–8.11 
and δ 7.82–7.72 ppm each integrating for two protons. 
 
The next step was to protect our unstable quinone 211 as an aromatic ether. This was achieved 
by initially stirring quinone 211 with phase transfer catalyst tetrabutylammonium iodide in 
tetrahydrofuran with sodium dithionite in water to facilitate the reduction of the quinone to the 
hydroquinone. An aqueous solution of potassium hydroxide was then added to deprotonate the 
intermediate hydroquinone followed by the addition of dimethyl sulfate to furnish the dimethyl 
aromatic ether 211. Column chromatography yielded the product, 2-allyl-3-bromo-1,4-
dimethoxynaphthalene as a yellow solid in 75% yield over the two steps. 97 
 
 Evidence that the reaction was successful was obtained by examination of 
both the 1H and 13C NMR spectra. The most distinctive feature in the 1H 
NMR spectrum was the presence of two signals at δ 3.92 and δ 3.98 ppm 
each integrating for three protons. This confirmed that we had in fact 
introduced aromatic methoxy groups. This was validated by the 13C NMR spectrum with the 
presence of downfield signals at δ 150.17 and δ 150.95 ppm due to the two quaternary aromatic 
carbons attached to the methoxy groups. Similarly, the methoxy group carbons were found 
upfield in the expected region at δ 61.36 and δ 62.69 ppm. When the 1H NMR spectrum was 
examined we noticed a shifting of the methylene proton, H1 from δ 3.64 to δ 3.79 ppm indicating 
that these protons are more deshielded. A similar observation was made for the alkene protons 
where H2 was previously found at δ 5.87 ppm and was now observed at δ 6.07 ppm while H3a 
and H3b were now observed as one multiplet signal at δ 5.12–4.98 ppm. The IR spectrum agreed 
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with this finding as no carbonyl stretches of the quinone were observed. We could therefore 
confidently say that we had formed 212. 
 
Keeping our focus on the preparation of nitroalkane 182, as shown in Scheme 4.6, we now 
turned our attention to the conversion of the allyl substituent of 212 into the 2-carbon chain 
alcohol protected with a benzyl protecting group. In order to do this, bromoalkene 212 was first 
oxidised to aldehyde 213 using ozone as shown is Scheme 4.8. This was achieved by stirring 212 
in dicholoromethane in the presence of Sudan III as our indicator. The reaction was cooled to      
–78°C and ozone gas was passed through the reaction mixture. Upon completion of the reaction, 
as noted by the colour change from pink to colourless, dimethyl sulfide was added to quench the 
reaction and purification after work-up afforded aldehyde 213 in 63% yield as a pink solid.17 
 
 
 
Scheme 4.8: (i) Sudan III, O3, dimethyl sulfide, CH2Cl2, 63%. 
 
 The 1H NMR spectrum confirmed the formation of aldehyde 213 with the 
presence of a downfield signal at δ 9.86 ppm which is characteristic of an 
aldehyde functional group. Also noted was a downfield shift in the 
methylene proton signals from δ 3.79 to δ 4.13 ppm indicative of these 
protons being more deshielded due to the newly introduced aldehyde. These observations were 
verified by the 13C NMR spectrum, with the presence of a signal at δ 198.54 ppm indicating that 
the carbon of the aldehyde was present. Once again, the downfield shift observed for the 
methylene protons in the 1H NMR spectrum was supported by the 13C NMR spectroscopic data 
with the shift from δ 34.36 to δ 45.20 ppm. The IR spectrum further attested to the formation of 
the aldehyde showing a stretch at 1717 cm–1 due to the carbonyl functional group.  
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Reduction of aldehyde 213 was accomplished using sodium borohydride in methanol 
(Scheme 4.9). A change in the Rf value from 0.33 to 0.23 in a 20% ethyl acetate: hexane mixture 
suggested that the reduction of the aldehyde to the primary alcohol 214 had taken place. The 
product 214 was isolated as a white solid in 73% yield.  
 
 
 
Scheme 4.9: NaBH4, MeOH, RT, 73%. 
 
Examination of the IR spectrum of 214 provided the first piece of 
evidence of the success of the reaction, showing a broad stretch at 
3364 cm–1 due to the hydroxyl group. We also noticed the loss of the 
carbonyl stretch which was previously found at 1717 cm–1. The 1H NMR 
spectrum confirmed this as the only downfield signals we now observed were due to the 
aromatic protons. We observed a triplet at δ 1.91 ppm which showed coupling of 5.5 Hz to H2. 
H2 was observed at δ 3.92 ppm as a doublet of doublets with coupling of 12.5 and 6.7 Hz to the 
protons at H1, found as a signal at δ 3.31 ppm due to it being deshielded by the hydroxyl group. 
H1 coupled to the equivalent protons at H2 and was therefore observed as a triplet with a 
coupling constant 6.8 Hz. Formation of the alcohol was further confirmed by the 13C NMR 
spectrum. The most explicit indication was the loss of the carbonyl signal at δ 198.54 ppm. 
Instead, we now witnessed the presence of a signal at δ 61.36 ppm which was assigned as C2, as 
this was characteristic of a carbon attached to an oxygen atom. All other carbon signals were 
assigned using a CH correlation spectrum.  
 
All that remained to do before we attempted the formation of nitroalkane 182 was the protection 
of alcohol 214. We chose a benzyl protecting group as we knew that this would easily be 
removed if we subjected it to the Nef reaction conditions to form our desired spiroketal 185, 
shown in Scheme 4.6. Therefore, alcohol 214 was dissolved in dimethyl formamide. Sodium 
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hydride followed by benzyl bromide were added and the reaction mixture was stirred overnight. 
Column chromatography afforded our protected alcohol 215 as a white solid in 61% yield.  
 
As expected, we no longer observed the triplet at δ 1.91 ppm 
previously seen for the alcohol. A clear singlet at δ 4.58 ppm 
integrating for two protons had appeared which we expected to be 
due to the methylene protons, H3, of the newly introduced benzyl 
group. Additional signals were also observed for the aromatic protons of the benzyl group in the 
region δ 8.11–7.21 ppm. These protons overlapped with those of the naphthalene moiety and 
thus were not individually assigned. The 13C NMR spectrum also showed the appearance of 
more carbon signals, the most important being the methylene carbon of the benzyl group, C3 
which we observed at δ 72.90 ppm. The other signals which had appeared were found in the 
aromatic region as expected. Mass determination by HRMS of the product 215 showed the 
relevant increase in mass compared to the precursor 214.  
 
With 215 in hand we could move our efforts toward the formation of the aromatic nitroalkane 
182, realizing that this would be the most challenging step in our synthesis. However, a number 
of studies, in particular by Kozlowski, have been conducted describing the Pd-catalyzed coupling 
of aryl halides with nitromethane to furnish arylnitromethanes.98,99 In these studies, bromoaryl 
substrates were converted to the corresponding arylnitromethanes using nitromethane, an 
appropriate base and ligand as well as a palladium catalyst. A range of arylnitromethanes were 
prepared using these methods where the most appropriate base was determined to be caesium 
carbonate, the ligand chosen was XPhos, while the palladium catalyst used was Pd2dba3. We 
therefore decided to test the reaction on simple bromobenzene as was conducted in the reference 
articles (Scheme 4.10),98,99 and were pleased to observe the consumption of our starting material 
to afford the expected arylnitromethane 216 as confirmed by NMR spectroscopic analysis.  
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Scheme 4.10 
 
 
 
Scheme 4.11 
 
Therefore, using this methodology we dissolved bromonaphthalene 215 in nitromethane under an 
atmosphere of argon. 4Å Molecular sieves were added to ensure that the reaction was kept 
moisture free. Xphos ligand, caesium carbonate and Pd2dba3 were then added and the reaction 
mixture stirred at 50°C.99 The reaction progress was monitored by TLC and after stirring for 24 
hours no consumption of the starting aromatic halide 215 was observed. Work-up of the reaction 
resulted in the recovery of starting material (Scheme 4.11). At this stage, we proposed that a 
likely reason that the reaction may not be progressing could be owing to steric hindrance or the 
electron rich nature of the substrate not allowing the oxidative addition of the palladium(0) to 
take place on the aromatic bromide. 
 
We then decided that the reaction would be attempted on a substrate which lacked the alkyl side 
chain. To this end, we subjected 2-bromo-1,4-dimethoxynaphthalene 217 to the reaction 
conditions described above to determine whether the side chain was influencing the reaction 
(Scheme 4.12). To our disappointment we once again isolated only starting material.  
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Scheme 4.12 
 
We could therefore assume that our starting arylbromide 215 was overly electron rich due to the 
electron donating methoxy substituents and it was this electronic effect that was preventing our 
palladium-coupling reaction from proceeding. Reviewing the literature, we found another article 
by Kozlowski where she described a similar coupling reaction in which nitroacetates were used 
instead of nitromethane.100 The ethyl-2-nitroacetate was assumed to work more effectively due to 
the higher acidity (pKa 5.8) as compared to nitroalkanes (pKa 10). We therefore attempted the 
coupling reaction between our arylhalide 215 and ethyl-2-nitroacetate instead of nitromethane 
while keeping the palladium source and base the same as that of our earlier experiments (Section 
4.6). However, once again TLC analysis of the reaction mixture showed no consumption of our 
starting material and crude NMR spectroscopic analysis showed the presence of our starting 
arylhalide 215. 
 
4.7. Concluding remarks pertaining to Chapter 4. 
 
The central theme in this chapter was the elucidation of the intermediates, and thus the 
mechanism, of our novel Nef reaction. The key reactions involved in the preparation of these 
intermediates were a Henry condensation reaction as well as a modified Nef reaction. Our 
second aim was to develop methodology toward the preparation of the spiroketal core of 
Griseusin. 
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With respect to the elucidation of the mechanism of our modified Nef reaction, we envisaged 
that we would need to begin this investigation with substrates which did not contain any ortho-
phenolic groups (described in Section 4.1). To this end we used three different substrates, 
namely piperanal, anisaldehyde and vanillin in our synthesis of nitroalkene precursors. A Henry 
condensation reaction was performed on each of our initial substrates to yield nitroalkenes 189, 
190 and 191, as shown in Figure 4.5. 
 
 
 
Figure 4.5 
 
In order to obtain the bis-aromatic system, we envisaged that a second Henry condensation 
would be necessary. This was achieved by the reduction of the double bond in nitroalkenes 189, 
190 and 191 followed by a second Henry reaction with 2,4-dimethoxybenzaldehyde to form 
nitroalkenes 199, 200 and 201, shown in Figure 4.6. 
 
 
 
Figure 4.6 
 
Having successfully prepared the nitroalkenes illustrated in Figure 4.6, we performed our 
modified novel Nef reaction to determine which intermediates were involved. Isolation of the 
products from each reaction confirmed the presence of three different intermediates. These 
intermediates were classed as nitroalkanes, carbonyl-containing compounds and oximes. 
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Figure 4.7 shows these intermediates using the nitroalkenes 199, 200 and 201 as substrates in 
the Nef reaction.  
 
 
Figure 4.7 
 
Literature precedent by Varma and co-workers 90 confirms that oxime formation occurs from 
unsaturated nitroalkenes, while Monti and coworkers101 confirmed the rapid hydrogenolytic–
hydrolytic conversion of oximes to carbonyl containing compounds. Based on these results, we 
propose that the novel Nef reaction proceeds by the general mechanism shown in Scheme 4.13. 
Nitroalkene 218 is reduced to the hydroxylamine 219. This hydroxylamine tautomerises to the 
more stable oxime 220 which eventually undergoes a hydrolysis reaction to the carbonyl 
compound 221. Our substrates lack the ortho-phenolic groups and therefore cannot continue 
toward the formation of the spiroketal functionality. It was also pleasing that the intermediates 
themselves could be converted to the carbonyl intermediate which we postulate to be the 
precursor to the spiroketal moiety. 
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Scheme 4.13: Elucidated reaction mechanism of our Nef reaction 
Unfortunately, the preparation of the spiroketal core of griseusin proved less fruitful than the 
mechanistic studies. Although this was the case, we have made some progress towards the 
spiroketal core and we were able to propose synthetic routes which may prove less challenging. 
We initially envisaged that we could prepare the spiroketal core using the methodology 
developed in the mechanistic studies. We therefore aimed to prepare aromatic halide 182 from 
commercially available 2-bromo-naphthoquinone. This was successfully achieved in four steps, 
as shown in Scheme 4.14. 
 
Review of the literature provided evidence that we could couple arylbromides with nitroalkyl 
compounds using a palladium catalyst to provide arylnitromethane compounds. However, when 
we attempted this reaction on our substrate, we only isolated our starting bromide 215. We then 
tried the reaction on simpler systems such as bromobenzene and 2-bromo-1,4-
dimethoxynaphthalene 217 and found that the former reaction was successful while the latter 
yielded only starting bromide 217. As discussed earlier, the lack of success of this reaction may 
be due to the electron donating effect of the methoxy substituents inhibiting the oxidative 
addition of palladium(0) to arylbromides 215 and 217. 
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Scheme 4.14 
 
Even though our efforts to form the arylnitromethanes did not meet with much success, there are 
literature reports which provide alternative avenues to preparing these compounds. Looking into 
the future, we could employ the strategy used by Semmelhack for the preparation of 222.102 In 
their study they used chromium complexation to form allyl quinone type compounds. A 
conjugate addition of nitromethane to compound 223 was then performed followed by the 
reduction of the quinone system and subsequent protection to yield arylnitromethane 222, as 
shown in Scheme 4.15. 
 
 
 
Scheme 4.15 
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Once the arylnitromethane 222 is successfully formed, the alkene could be oxidised to the 
aldehyde 224 followed by reduction to yield alcohol 225 (Scheme 4.16). This alcohol 225 could 
then be protected using benzyl bromide to afford arylnitromethane 226. If these transformations 
were successful, a Henry condensation reaction between arylnitromethane 226 and 4-
(benzyloxy)butanal 184 would provide us with nitroalkene 227 on which we could perform our 
modified Nef reaction. This would hopefully result in the formation of our expected spiroketal 
core 228. 
 
 
 
Scheme 4.16 
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Chapter 5: The angucycline antibiotics 
 
5.1. Background and Introduction 
 
A large number of secondary metabolites of microbial origin, called the angucycline antibiotics, 
exist in nature. This group of metabolites receive their name from their characteristic four-ring 
frame (labelled A, B, C and D) of the aglycone moiety where an angular assembly is observed 
and is related to the aromatic tetracyclic benz[a]anthracene system 229 shown in 
Figure 5.1.103,104 
 
 
 
Figure 5.1 
 
The angucycline antibiotics have been shown to possess a range of biological activities which 
include antibacterial and antiviral activity and cytostatic and enzyme inhibitory effects. 
Tetrangomycin 230 and tetrangulol 231 were the first isolated members of the angucycline 
antibiotics and to date more than one hundred members have been described.103 The earliest 
antibiotics were considered simple sugarless angucyclines, such as tetrangulol 231 with 
relatively low molecular weights of slightly more than 300. However, recent examples of these 
compounds have molecular weights in excess of 1000, such as landomycin A 232 and urdamycin 
233, owing to their attached carbohydrate moieties (Figure 5.2). 
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Figure 5.2 
 
The anguclycline secondary metabolites have all been isolated from various soil samples or 
shallow sea mud.105 In the classification of these compounds, it was found that they all belong 
exclusively to the Actinomycetes group where the majority of the organisms were classified by 
various species of Streptomycetes.103 
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5.2. Classification of angucyclines 
 
The angucyclines are divided into two broad classes: classical and non-classical aglycone 
moieties (Scheme 5.1). The classical angucyclines are subdivided into two types, while the non-
classical angucyclines are subdivided into four types. This classification is based on structural 
features which arise from either the C-glycosylation or the 12b-mono-oxygenase reactions which 
are key biosynthetic reactions involved early in the synthesis of these antibiotics.106 Each of 
these classes and subclasses will briefly be discussed in the next few sections.  
 
 
 
Scheme 5.1 
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5.2.1. Classical angucyclines 
 
5.2.1.1. Angucyclines without C-glycoside moiety 
 
This type of angucycline system is most commonly found and considered the simplest based on 
the biosynthetic pathway. Most compounds of this class are angucyclinones, which are 
compounds lacking a sugar functionality, with the landomycins family being the exception. 
 
5.2.1.1.1. Metabolites with angular oxygen 
 
Metabolites of this class contain angular oxygen, which originates from acetate (4a–O) and from 
air (12b–O) early in their biosynthesis through introduction by a mono-oxygenase. The antibiotic 
SS-228Y 234105,107 and the sakyomicin family 235108 typify this class of metabolites (Figure 
5.3). The initial proposal for the structure of SS-228Y 234 was revised after biosynthetic studies 
on the vineomycins. Other antibiotics which fall into this class of metabolites are the sulfur-
containing antibiotics, an example of a sulfur-containing antibiotic is sakyomicin E 236 which 
contains a sulfide group believed to originate from methionine.103  
 
 
 
Figure 5.3 
 
Specifically related to this project are the landomycin antibiotics such as 232. This group of 
compounds was discovered in 1990 and is considered the best known family of the angucycline 
antibiotics. The landomycins were isolated from Streptomyces sp. and were found to comprise 
tri-, penta- or hexa-saccharidal chains. Feeding experiments have shown that the backbone of the 
landomycins arise from acetate and malonate where the biosynthesis involves a decaketide 
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intermediate 237 which undergoes cyclisation and aromatization to give landomycin 232 as 
shown in Scheme 5.2.109 
 
 
 
Scheme 5.2 
 
5.2.1.1.2. Metabolites without angular oxygen 
 
This subgroup of metabolites contains a variety of structurally related compounds that possess an 
anthraquinone chromophore and vary with respect to the number and positions of free or 
methylated hydroxyl groups present such as in X-14881 238 (Figure 5.4).110 A rarity of this 
group is the presence of O-glycosidically bonded sugar moieties. The angucyclinones possess a 
saturated angular ring and a keto-group at C1. Reduction of this keto-group to the secondary 
alcohol is observed in metabolites such as rubiginone A1 239. Other structural features observed 
in this class include the presence of the hydroxyl groups in unusual positions, such as in X-14881 
D 240 which arise as a result of the oxygenase activity of the producing organisms.111 
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Figure 5.4 
 
5.2.1.2. Angucyclines with a C-glycosidic moiety 
 
In this section, we will describe all angucyclines which possess a C-glycosidic moiety. A large 
number of angucycline antibiotics possess this characteristic and structural feature and therefore 
constitute the largest group of C-glycosidic antibiotics. The C-glycosidic containing 
angucyclines can also be divided into two classes: those containing metabolites with angular 
oxygen and those without angular oxygen. These two classes will be discussed below. 
 
5.2.1.1.1. Metabolites without angular oxygen 
 
These metabolites are the least common of the angucyclines. The first examples of these 
antibiotics include the benzanthrins A 241 and B 242 which exhibit a C-glycosidic moiety linked 
to ring A as well as an O-glycosidically bonded carbohydrate at C1 (Figure 5.5).112,113 A unique 
aspect of these carbohydrates is that they are amino sugars. 
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Figure 5.5 
 
5.2.1.1.2. Metabolites with angular oxygen 
 
The earliest example of this class of metabolites was aquayamycin 243.114-116 A number of 
structurally related angucyclines, such as urdamycinone E 244 and F 245, are often called the 
“aquayamycin-type” antibiotics and have also been described. Variation in this class of 
antibiotics occurs in the form of deoxy sugar units attached to C3, C4’, C5’ and C12b, as shown 
in Figure 5.6.103  
 
 
 
Figure 5.6 
 
Chapter 5: The angucycline antibiotics 
 
 
114 
 
5.2.2. Non-classical angucycline antibiotics 
 
The class of non-classical angucycline antibiotics is not as structurally diverse as the classical 
angucyclines and the inclusion of these compounds as angucyclines is based on the chemical and 
biosynthetic approaches. This class of compounds is subdivided into four categories two of 
which will briefly be discussed. 
 
Linearly annelated naphthacenequinone antibiotics have been described as containing 
galtamycinone 246 as their aglycone moiety (Figure 5.7).117 It is thought that these compounds 
are derived from classical angucyclines based on their oxygen atom substitution pattern, as well 
as the presence of the C-glycosidic moiety. Both enzymatic and non-enzymatic reactions are 
thought to allow this conversion to take place. An example of this class is galtamycin 246118,119 
which possess a linear fused ring system. 
 
 
 
Figure 5.7 
 
The chromophore enlarged angucycline antibiotics, named due to their conspicuous darker 
colour, were first found to occur within the urdamycin family. Studies on the biosynthesis of this 
class of compounds showed that the urdamycins are derived from the classical angucycline 
urdamycin A 248 and different amino acids.103 In Figure 5.8 we can see that the tetracyclic 
angular ring system is present in the chromophore enlarged angucycline antibiotics. 
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Figure 5.8 
 
5.3. Biological activity of landomycin 
 
The angucycline antibiotics, and in particular the landomycins, have been shown to possess a 
diverse range of biological activities such as anticancer, antibacterial and enzyme inhibitory 
activity. The biological activity of landomycin A has been extensively explored and it has been 
found to possess bioactivity against 60 cancer cell lines, including potent activity against prostate 
cancer cell lines.120 It has been shown to inhibit thymidine uptake in murine smooth muscle,121 
and also inhibits cell cycle progression. Its unusual activity is attributed to its long 
oligosaccharide chain, as landomycins which possess shorter oligosaccharide chains have 
expressed weaker activity.122 The angucycline antibiotic, landomycin E 249 (Figure 5.9), has 
exhibited anticancer activity in vitro and in vivo and has been suggested to act by inducing 
apoptosis.123 
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Figure 5.9 
 
5.4. Synthetic strategies towards the landomycin core 
 
A number of synthetic strategies have been developed for the synthesis of the angucycline 
antibiotics due to their diverse biological activities as well as the attractive structural features 
they possess. There are several reviews which describe the synthesis of these antibiotics where 
most of the earlier reported syntheses utilised classical reactions, such as the Diels-Alder reaction 
or nucleophilic or electrophilic addition, as the key step. In recent years, a number of additional 
reactions were used as key reactions in the synthesis of the angucyclines such as transition metal 
catalyzed cross coupling and intramolecular cyclization strategies. We will briefly discuss these 
classical and newer reaction methodologies for the synthesis of the landomycins. 
 
5.4.1. Diels-Alder reactions 
 
The tetracyclic core of the angucycline antibiotics has been widely accessed via a Diels-Alder 
reaction of a suitably substituted diene and dienophile. This method allows for the formation of a 
range of angucyclines due to the structural diversity of the dienes and dienophiles.  
 
The enantioselective synthesis of five closely related natural products has recently been achieved 
by Kaliappan and co-workers using this methodology, as shown in Scheme 5.3.124 A Diels-Alder 
reaction between 1,3-diene 250 and 5-acetoxy-2-bromo-1,4-naphthoquinone 251 in toluene at 
80°C afforded an intermediate Diels-Alder adduct. The debromination of this adduct followed by 
Chapter 5: The angucycline antibiotics 
 
 
117 
 
aromatisation yielded tetracycle 252. A photooxygenation reaction of 252 afforded natural 
product, (+)-ochromycinone 253. A methylation reaction of (+)-ochromycinone 253, afforded a 
second natural product, (+)-rubiginone 254. 
 
 
 
Scheme 5.3 Reagents and conditions: (i) Toluene, 80°C, 16 h; (ii) K2CO3, MeOH, 45% over two steps; 
(iii) hν, O2, benzene, 20 h, 82%; (iv) Ag2O, MeI, CH2Cl2, RT, 5 h, 82%. 
 
The aza anoalgues of the angucyclines have also been prepared using a key Diels-Alder reaction. 
Valderrama and co-workers illustrated this in the preparation of 5-aza-angucyclinone 
analogues.125 In their synthesis, 1,3-diene 256 was subjected to a Diels-Alder reaction with a 
substituted 7,10-phenanthrenedione 257, which furnished the nitrogen containing angucyclinone 
skeleton 258. Using a selective deprotection-oxidation technique, analogue 258 could be 
converted to either the corresponding 8-hydroxy angucyclinone analogue 260 or the 8-non-
hydroxy analogue 261 (Scheme 5.4). 
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Scheme 5.4: Reagents and conditions: (i) DCM, RT, 82%; (ii) HCl, THF-H2O; (iii) PCC, 63%; (iv) HCl, 
THF-H2O, 66%. 
 
5.4.2. Nucleophilic addition strategies 
 
Inter- and intra-molecular nucleophilic addition cyclisation reactions have been widely used 
since the first synthesis of tetrangulol 231. This reaction methodology has been used in the 
regioselective assembly of the tetracyclic core of angucycline antibiotics. The most widely used 
version of this type of reaction is the anionic [4+2] cycloaddition reaction. This is better known 
as the Hauser126 or the phthalide127 annulation. The nucleophilic reaction can be described as an 
intermolecular Michael addition which is followed by a cyclisation reaction between α,β-
unsturated carbonyls and an anion. This synthetic strategy, shown in Scheme 5.5, has been 
illustrated by Mal and Dey in the total synthesis of BE-23254 262.128 In their synthesis, lithium 
tert-butoxide was used to generate an anion of 263 which was used in the key reaction with 
quinone monoketal 264. This reaction afforded the preliminary angucyclone backbone 265. 
Aromatization using DDQ, followed by demethylation and subsequent ester hydrolysis furnished 
the natural product 262. 
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Scheme 5.5: Reagents and conditions: (i) ButOLi, THF, –60°C to RT, 71%; (ii) DDQ, 49%; (iii) AlCl3, 
78%; (iv) aq. NaOH, 92%. 
 
Another example in which a nucleophilic addition cyclisation reaction is used as a key step is in 
the total synthesis of landomycin 266. As shown in Scheme 5.6, Roush and Neitz constructed the 
tetracyclic angucyclinone skeleton 267, using a base mediated intramolecular nucleophilic 
addition cyclisation reaction of 268.129 The synthesis commenced with the construction of 
naphthoquinone 268 using a Dotz benzannulation reaction between alkyne 269 and chromium 
carbene 270. The key cyclization reaction of 268 was initiated by sodium ethoxide followed by 
the aerial oxidation of the unstable hydroquinone resulting in the formation of 267. Landomycin 
266 was afforded after the removal of the protecting groups. 
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Scheme 5.6: Reagents and conditions: (i) heptane, 55°C; (ii) CAN, CH3CN, 35-40%; (iii) NaOEt, EtOH, 
0°C, 87%; (iv) NaOEt, EtOH, air, 55°C, 45%; (v) 0.05 M HCl, MeOH, 0°C, 1.5 h; (vi) MgBr2, THF, 0°C, 
65% over two steps. 
 
5.4.3. Electrophilic addition strategies 
 
The synthesis of the angucyclinone skeleton using electrophilic addition or Friedel-Crafts type 
reactions has been widely reported. The first enantioselective total synthesis of kanamycin C 271 
has been achieved by Lei and Porco using this synthetic methodology, shown in Scheme 5.7.130 
The synthesis commenced with a Pd-catalysed Stille cross coupling between vinyl bromide 272 
and stannane 273 to afford biaryl compound 274. A diastereoselective reduction of the carbonyl 
group of 274, using Super-hydride, followed by the ring opening of the epoxide, acetyl 
protection and TBS deprotection afforded alcohol 275. The secondary alcohol 275 was oxidised 
to the carboxylic acid 276 before being subjected to a Friedel-Crafts cyclisation with 
trifluoroacetic anhydride to provide the tetracyclic core 277. The synthesis was completed to 
yield 271 after the oxidation of the hydroquinone and introduction of the diazo functionality.  
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Scheme 5.7: Reagents and conditions: (i) Pd2(dba)3, AsPH3, CuCl, DIEA, CH3CN, 70°C, 4 h, 70%; (ii) 
Super-Hydride, THF, –78°C, 1 h, 80% (dr> 10:1); (iii) Ti(OiPr)4, Bu4nNOAc, CH2Cl2, RT, 10 h, 60%; (iv) 
Ac2O, pryridine, RT, 2 h; (v) Et3N-3HF, CH3CN, RT, 12 h, 67% over two steps; (vi) TPAP, NMO, 
CH2Cl2, RT, 20 min; (vii) NaClO2, NaH2PO4, 2-methyl-2-butene, ButOH-H2O, RT, 12 h, 88% over two 
steps; (viii) TFAA, DCE, RT, 1 h, 90%; (ix) CBr4, PriOH, 84°C, 1 h; (x) Pd/C, air, EtOAc, RT, 30 min, 
70% over two steps; (xi) TBSNHNHTBS, Sc(OTf)3, CH2Cl2 (xii) PhIF2, 2-chloropyridine, CH2Cl2, 35% 
over two steps. 
 
Another example in which a Friedel-Crafts cyclisation reaction was used as a key step was in the 
synthesis of prekinamycin 278. In their synthesis, Kimura and co-workers performed a Suzuki 
cross coupling reaction between boronic acid 279 and bromide 280 to furnish biaryl 281.131 The 
aldehyde was then oxidised to the carboxylic acid 282. The conversion to the acid chloride 
followed by the intramolecular Friedel-Crafts cyclisation reaction provided the tetracyclic 
compound 283. Deprotection with BBr3 followed by hydrazone formation and subsequent 
oxidation afforded prekinamycin 278 (Scheme 5.8). 
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Scheme 5.8: Reagents and conditions: (i) Pd(PPh3)4, 2M Na2CO3,DME, 90°C, 48 h, 97%; (ii) 15% 
NaOH, 30% H2O2, MeOH, 120°C, 1 h, 80%; (iii) (COCl)2, CH3CN, 80°C, 10 min; (iv) AlCl3, CH2Cl2, 
RT, 2.5 h, 81% over two steps; (v) BBr3, CH2Cl2, –40°C, 24 h; (vi) TsNHNH2, 1M HCl, EtOH, 90°C, 2 h; 
(vii) Fetizon’s reagent, Et3N, CH3CN, RT, 30 min, 47% over three steps. 
 
5.4.4. Transition metal catalyzed strategies 
 
Transition metal catalysed C-C bond formation strategies have become a useful tool for organic 
chemists in recent years. A recent example involving a Michael addition, elimination and Heck 
coupling was described by Herzon and co-workers in the synthesis of kanamycin F 284.132 The 
construction of kanamycin F 284 commenced with a tris(diethylamino)sulfonium 
trimethyldifluorosilicate [TASF(Et) ] mediated Michael addition reaction between quinone 285 
and hexenone 286 to afford intermediate 287. Intermediate 287 was then subjected to a Heck 
cross coupling reaction to afford benzofluorene 288. A diazo functionality was introduced 
followed by oxidation to the quinone. Reduction of the carbonyl group followed by deprotection 
yielded kanamycin F 284 (Scheme 5.9).  
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Scheme 5.9: Reagents and conditions: (i) TASF(Et), CH2Cl2, –78°C, 79%; (ii) Pd(OAc)2, polymer-
supported PPh3, Ag2CO3, toluene, 80°C, 66%; (iii) TfN3, DIPEA, CH3CN, 24°C, 99%; (iv) TIPSOTf, 
CH2Cl2, 0°C, DMDO, CH2Cl2-CH3OH, –40°C, 76%; (v) BH3.THF, THF, –20°C, 58%; (vi) AcCl, 
CH3OH, –12° to 0°C, 65%. 
 
5.4.5. Intramolecular cyclisation reaction strategies 
 
[4+2] Cycloaddition or [2+2+2] intramolecular reactions have also been used for the one-step 
synthesis of the angucylinone skeleton. Transition metals like cobalt or gold have generally been 
used to facilitate these reactions. The stereoselective synthesis of (-)-tetrangomycin 230, shown 
in Scheme 5.10, by Groth and co-workers involved a cobalt mediated cycloaddition as the key 
step.133 Chiral triyne 289 was prepared from the initial addition of lithiated octadiyne 290 to 
benzaldehyde 291 followed by a base mediated TMS removal and subsequent TBS protection of 
the newly formed secondary alcohol to afford intermediate 289. Cyclisation of intermediate 289 
affforded intermediate 292, which was oxidised followed by MOM deprotection to furnish 
angucyclinone compound 293. A TBS deprotection and regioselective photooxidation completed 
the synthesis of 230.  
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Scheme 5.10: Reagents and conditions: (i) K2CO3, MeOH, RT, 16h, 96%; (ii) TBSOTf, 2,6-lutidine, 
CH2Cl2, 0°C to RT, 12h, 91%; (iii) CpCo(C2H4)2, Et2O, –60°C to 0°C, 4h, 93%; (iv) Ag(py)2MnO4, SiO2, 
CH2Cl2, RT, 8h, 48%; (v) AcCl, MeOH, RT, 2h, 96%; (vi) aq. HF, CH3CN, 50°C, 5h, 86%; (vii) air, hν, 
CHCl3, RT, 48h, 60%. 
 
5.5. Proposed Aims of the project 
 
Due to the biological activities and diverse structures of these landomycin antibiotics, our first 
aim for this section of the PhD project was the development of novel synthetic methodology for 
the preparation of this tetracyclic skeleton. Using a retrosynthetic approach, (Scheme 5.11) 
tetracyclic skeleton 294 can be obtained from an intramolecular cross metathesis reaction of 
diene 295. We envisaged that diene 295 could be prepared using a Suzuki cross coupling 
reaction of an appropriately substituted boronic acid 296 and arylbromide 212. This specific 
brominated naphthalene precursor was available as it had been synthesised by us in Chapter 4. 
 
 
 
Scheme 5.12 
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The success of this initial synthetic route will allow us to build a mini-library of tetracyclic 
compounds which resemble the landomycin antibiotics. The variation in these compounds can 
arise from different substituents in either the aryl bromide or boronic acid. A general synthetic 
route is shown in Scheme 5.12. 
 
 
 
Scheme 5.12 
 
Our second aim would be to use this developed methodology to prepare the natural product, 
tetrangulol. We envisage that we would need to prepare an appropriate boronic acid 297 as well 
as the aryl bromide 298. Once prepared, a Suzuki reaction between 297 and 298 would afford 
our biaryl compound 299 which would then undergo a Wittig reaction followed by an 
isomerisation reaction to afford a diene 300 which we can subject to a cross metathesis reaction 
to afford our tetracyclic tetrangulol analogue 301, as shown in Scheme 5.13. 
 
 
 
Scheme 5.13 
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Chapter 6: Synthetic strategies towards the angucycline antibiotics 
 
6.1. Introduction and background 
 
In this section, we will discuss our research conducted towards developing a synthetic strategy to 
access the angucycline antibiotics. This discussion will entail firstly, the development of the 
synthetic methodology and secondly, our attempts at synthesizing the natural product, terangulol 
231. Finally, some suggestions for future work will follow. 
 
This project builds on previous studies conducted in our research group at Wits University.134 
The key steps in the previous study were a Suzuki cross coupling reaction followed by a ring 
closure reaction using potassium tert-butoxide in DMF at 80°C, which ultimately yielded 
analogues of the angucycline antibiotics. Scheme 6.1 shows this reaction sequence where a 
Suzuki coupling between 2-bromobenzaldehyde and boronic acid 302 afforded the biaryl 
aromatic compound 303. This biaryl aromatic compound 303 was subjected to the conditions of 
our novel aromatic ring closing reaction to form the final tetracyclic compound 294. 
 
 
 
Scheme 6.1: Reagents and conditions: (i) Pd(PPh3)4, Na2CO3, DME-EtOH, 100%, KOBut, DMF, 80°C, 
hv, 87%. 
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We planned to synthesise the model benz[a]anthracene 294 again by utilising the key Suzuki 
coupling step already developed, but using ring closing metathesis as the final step to construct 
the last aromatic ring. Retrosynthetic analysis of 294, shown in Scheme 6.2, led to the biaryl 
precursor 295. This biaryl precursor 295 obtained via a Suzuki coupling reaction could be further 
disconnected to aromatic halide 212 and boronic acid 296.  
 
 
Scheme 6.2 
 
If successful, this synthetic scheme could be utilized in the preparation of the more substituted 
natural product tetrangulol 231, which can be disconnected to aromatic halide 304 and the 
naphthalene boronic acid 305. The proposed retrosynthesis of tetrangulol 231 is shown in 
Scheme 6.3. 
  
 
 
Scheme 6.3 
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6.2. A brief look at the key steps in our synthesis: Suzuki-Miyaura reaction and RCM 
 
Since its publication in 1979, the Suzuki coupling reaction has been used extensively as one of 
the most important cross-coupling reactions in organic synthesis, which resulted in Suzuki being 
jointly awarded the 2010 Nobel Prize in Chemistry. The key aspect of the Suzuki reaction is the 
coupling of a boronic acid with an aromatic halide or triflate in the presence of a palladium 
catalyst. The catalytic cycle is outlined in Scheme 6.4. The cycle commences with the oxidative 
addition of Pd0 306 to the aryl halide 307. This results in the formation of the trans σ-palladium 
complex 309 (Step A).135 Complex 309 undergoes reaction with a base producing intermediate 
310. This is followed by transmetallation with the boron-ate complex 311 (produced from the 
corresponding boronic acid) resulting in intermediate 312 (Step B). The desired biaryl product 
313 is obtained by reductive elimination of palladium regenerating the palladium (0) catalyst 
(Step C). 
 
 
 
Scheme 6.4 
 
As mentioned above, the Suzuki coupling reaction is a powerful tool for carbon-carbon bond 
formation in organic synthesis. The inorganic by-product which is formed is non-toxic and is 
easily removed from the reaction mixture making the process suitable for both research 
laboratories and large scale industrial processes. 
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The second key step involves the use of RCM to facilitate the formation of the desired tetracyclic 
compound. The catalytic cycle of RCM was earlier discussed in Section 2.3 and is briefly shown 
in Scheme 6.5.  
 
 
Scheme 6.5 
 
6.3. Synthesis of angucycline analogues 7,12-dimethoxytetraphene 294 and 3,7,12-
trimethoxytetraphene 314 
 
 
 
Figure 6.1 
 
The first step in the synthesis of 294 and 314 (Figure 6.1) was to subject arylhalide 212, 
prepared earlier in our attempted synthesis of 185, to a Suzuki cross coupling reaction. Our first 
attempt at the Suzuki reaction involved conventional heating using an oil bath, palladium 
catalyst, tetrakis(triphenylphosphine)palladium(0) as catalyst and aqueous sodium carbonate 
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solution as base. However, under these reaction conditions, only starting material was recovered. 
By comparison, the use of microwave radiation proved successful in facilitating our Suzuki cross 
coupling reaction in the presence of cesium fluoride as base. 
  
Thus, a microwave tube was charged with aromatic halide 212, cesium fluoride, a commercially 
available boronic acid and tetrakis(triphenylphosphine)palladium(0). DME was then added to the 
reaction vessel and the mixture was subjected to microwave irradiation (150W, 150°C, 20 min). 
Purification of the crude reaction mixture yielded the biaryl compounds 315 and 316 as yellow 
oils and in mediocre yields, as shown is Scheme 6.6. 
 
 
 
Scheme 6.6 Reagents and conditions: Pd(PPh3)4, BA, CsF, 150W, 150°C, 20 min, 50% (for 315) and 
43% (for 316).  
 
A moderate yield of 50% was obtained for 315 and attempts to improve 
this yield were not successful. We suspect that the steric interference 
provided by the allyl chain contributes to this moderate yield. However, we 
were pleased by the appearance of a deshielded singlet at δ 9.74 ppm in the 
1H NMR spectrum corresponding to the aldehyde proton, which was the 
initial indicator to the success of the coupling reaction. The protons corresponding to the allyl 
chain all showed an upfield shift. Methylene protons H1 were now observed at δ 3.39 ppm as a 
doublet of triplets showing coupling to H2 and H3 with coupling constants of 5.8 and 1.7 Hz, 
respectively. We could therefore assign the signal at δ 5.68 ppm to H2, while the signals at δ 4.56 
and δ 4.81 ppm were assigned to H3. Due to overlapping of the aromatic signals, this region of 
the 1H NMR spectrum was not unambiguously assigned. Nonetheless, the overall integration for 
this region accounted for all the aromatic protons. In the 13C NMR spectrum, the clear presence 
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of the deshielded carbonyl carbon was observed at δ 192.20 ppm. The presence of the carbonyl 
group was further confirmed by an absorption at 1664 cm–1 in the IR spectrum. Finally, the mass 
determination by high resolution mass spectrometry correlated well with the expected value 
(Found M+ + H of 333.1496 amu, expected 333.1479). 
 
Similarly, a low yield of 43% was obtained for 316. In the analysis of 
the 1H NMR spectrum of this product, the deshielded aldehyde proton at 
δ 9.67 ppm was clearly present. This was corroborated by the analysis of 
the 13C NMR spectrum which showed the deshielded carbonyl carbon at 
δ 192.08 ppm as well as by IR spectroscopy where an absorption at 
1688 cm–1 was observed. Once again, the results of the mass spectral analysis afforded an 
accurate mass of 363.1588 amu, which was in good agreement with the expected mass of 
363.1579 amu for C23H22O4. 
 
Satisfied by the success of the Suzuki cross coupling reaction, we were now able to continue 
with the preparation of 294. In order to form the last aromatic ring by ring closing metathesis, we 
required two styrene moieties. To achieve this, we envisaged that we could perform a Wittig 
reaction on our newly formed biaryl aldehyde containing products 315 and 316 which would 
furnish the dialkene substrates on which we could perform an isomerization reaction followed a 
ring closing metathesis (RCM) reaction. Scheme 6.7 illustrates the proposed route including the 
Witting and RCM reactions. 
 
 
 
Scheme 6.7: Reagents and conditions: (i) MTPPBr, BunLi, THF, 0°C–RT; (ii) Grubbs II, toluene, ∆.  
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To this end, conversion of both aldehydes 315 and 316 to alkenes 317 and 318 was achieved 
using traditional Wittig conditions. Methyltriphenylphosphonium bromide 319 was added to dry 
THF, followed by the dropwise addition of  n-butyllithium resulting in the dissolution of 319 and 
the appearance of a yellow colour. After thirty minutes, the reaction was cooled to 0°C before the 
addition of our starting aldehydes 315 or 316, which were dissolved in dry THF. Purification of 
the two crude reaction mixtures afforded alkenes 317 and 318 in excellent yields of 88 and 84%, 
respectively. 
 
A positive sign that we had formed alkene 317 was the loss of the 
aldehyde proton previously observed at δ 9.74 ppm and the concominant 
appearance of new signals in the mid region of the 1H NMR spectrum. 
The first of these new signals was observed as a doublet of doublets at 
δ 6.41 ppm integrating for one proton. This signal showed cis and trans 
coupling of 11.0 and 17.6 Hz respectively and was therefore assigned to H4. Using a COSY 
spectrum we observed that H4 coupled to two other signals, those being a multiplet at δ 5.76–
5.59 ppm which integrated for two protons, and a doublet of doublets integrating for one proton 
at δ 5.07 ppm. The former multiplet contains two overlapping signals where one proton 
corresponds to H5a while the other proton corresponds to H2. The signal for the remaining proton 
corresponding to H5b was seen at δ 5.07 ppm. The 13C NMR spectrum confirmed the presence of 
our newly formed alkene with two signals observed at δ 135.12 and δ 114.55 ppm, 
corresponding to C4 and C5, respectively. The carbonyl carbon was also noticeably absent. The 
final piece of evidence was obtained from the IR spectrum where we no longer observed an 
absorption characteristic of a carbonyl group. 
 
We observed similar changes in the 1H and 13C NMR spectra as well as 
the IR spectrum of 318. In the 1H NMR spectrum, the aldehyde proton 
was unmistakably absent. We again noticed the appearance of a new 
signal at δ 6.37 ppm corresponding to H4 as well as signals at δ 5.76–
5.61 ppm and δ 5.07 ppm due to H5. The 13C NMR spectrum further 
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confirmed this observation by the lack of a downfield deshielded carbonyl carbon signal. A 
molecular ion peak was observed at 361.1799 amu (100%) for 318 which correlated with the 
expected mass of 361.1779 amu for C23H22O2. 
 
Having prepared our dienes 317 and 318, we could now turn our attention to the formation of the 
final aromatic ring of the tetracyclic skeleton. In order to achieve this, we would need to 
isomerise the allyl chain before attempting the ring closure to allow for the formation of an 
aromatic six-membered ring. To this end, we subjected our dienes 317 and 318 individually to 
heating at 70°C in the presence of Grubb’s first generation catalyst. This we hoped, would result 
in the isomerisation of the allyl chain in each diene as literature indicates that this was 
possible.136 TLC analysis in both cases showed the formation of a new spot which we assumed 
was our desired product containing an isomerised double bond. After stirring for 2 hours, we 
added Grubbs second generation catalyst and toluene to each reaction mixture, to facilitate the 
ring closing metathesis reaction. These reaction mixtures were then heated under reflux for 18 
hours. Purification of the reaction mixtures afforded pale yellow solids, which we expected to be 
our tetracyclic aromatic products. 
 
However, during the analysis of the spectroscopic data of the isolated products, we discovered 
that we had formed a seven-membered ring instead of the desired six-membered ring system, as 
shown in Scheme 6.8. TLC analysis of the products showed no change to that seen when TLC 
analysis was conducted before the addition of Grubbs II. We therefore assumed that a tetracyclic 
compound containing a seven-membered ring had been formed under the Grubbs I conditions. 
When the reaction was repeated on diene 317 using only Grubbs I as catalyst, once again the 
undesired seven-membered ring containing compound 320 had been formed.  
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Scheme 6.8 Reagents and conditions: Grubbs I, Grubbs II, toluene, ∆, 18h, 98% (for 320) and 
87% (for 321).  
 
The tetracyclic compound, 8,13-dimethoxy-7H-benzo[3,4]cyclohepta[1,2-
b]naphthalene 320 was isolated in 98% yield as a pale yellow solid. In the 
1H NMR spectrum, we noticed the presence of upfield signals at δ 3.87 and 
δ 2.70 ppm each integrating for one proton. Using a COSY spectrum, we 
observed that these signals coupled to each other as well as to two other protons. Owing to the 
upfield position of these signals we assigned these to H1 where each of the protons at H1 couple 
to H2 and H3. We could therefore assign the signals at δ 6.31 and δ 6.61 ppm to H2 and H3 
respectively. The only remaining non-aromatic signals were two singlets each integrating for 
three protons at δ 3.26 and δ 3.97 ppm which corresponded to each of the methoxy groups. The 
signals found in the aromatic region integrated for eight protons as was expected. The 13C NMR 
spectrum confirmed the presence of the methylene protons with a signal at δ 25.52 ppm being 
observed. The HRMS showed a molecular ion at 303.1387 amu which was in good agreement 
with the expected molecular formula, C21H18O2 (requires 303.1379 amu). 
 
Similarly, 3,8,13-trimethoxy-7H-benzo[3,4]cyclohepta[1,2-b]naphthalene 
321 was isolated as a pale yellow solid in a yield of 87%. As observed in 
the spectroscopic data for 320, we observed two upfield signals integrating 
for one proton each and assigned these signals to the methylene protons 
H1. This was corroborated by the 13C NMR spectrum with the presence of 
an upfield signal at δ 25.57 ppm corresponding to C1.  
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Our initial aim when attempting the ring closure was to obtain a six membered aromatic ring as 
this would resemble the angucycline antibiotics more closely. In order to achieve this, we needed 
to isomerise the allyl chains in diene 317 and 318 before attempting the ring closure. We 
subjected each of our dienes to potassium tert-butoxide in THF while stirring at ambient 
temperature. Upon completion of the reaction, as monitored by TLC, purification of the crude 
mixtures led to the isolation of the isomerised dienes 322 and 323 (Shown in Scheme 6.9). 
 
 
 
Scheme 6.9 Reagents and conditions: KOBut, THF, RT, 94% (for 322) and 84% (for 323).  
 
The most distinctive feature in the 1H NMR spectrum of (E)-1,4-
dimethoxy-2-(prop-1-en-1-yl)-3-(2-vinylphenyl)naphthalene 322 was the 
presence of a downfield signal at δ 1.65 ppm which integrated for three 
protons and corresponded to H3. This signal was observed as a doublet of 
doublets and showed coupling of 6.2 Hz and 0.9 Hz to H2 and H1 
respectively. We could therefore assign the multiplet at δ 6.07–5.93 ppm and doublet at 
δ 6.13 ppm to H2 and H1 respectively. A C-H correlation spectrum was used to assign all the 
remaining carbon signals. 
As observed for 322, in the analysis of the 1H NMR spectrum of (E)-
1,4-dimethoxy-2-(4-methoxy-2-vinylphenyl)-3-(prop-1-en-1-yl) 
naphthalene 323, we observed an upfield signal at δ 1.69 ppm which 
integrated for three protons and which we assigned to H3. We also 
observed the presence of three singlets at δ 3.47, δ 3.84 and 
δ 3.89 ppm each integrating for three protons,  and these signals were assigned to the protons of 
the methoxy groups. The remaining signals were found downfield and corresponded to the 
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aromatic and alkene protons. Mass determination by high resolution mass spectrometry was in 
good agreement with the expected value (361.1804 amu, for C24H24O3). 
 
Having successfully prepared our isomerised dienes 322 and 323, we were now in a position to 
perform the ring closing metathesis which we hoped would result in the formation of our desired 
six membered ring containing compound. To this end, we dissolved dienes 322 and 323 
seperately in toluene under an atmosphere of argon. A catalytic amount of Grubbs second 
generation catalyst was added to each reaction and the reaction mixtures were stirred under 
reflux for 18 hours. Satisfyingly, our tetracyclic products 294 and 314 were obtained as yellow 
solids in 85% and 43% yield respectively, as shown in Scheme 6.10. 
 
 
 
Scheme 6.10 Reagents and conditions: Grubbs II, toluene, ∆, 18 h, 85% (for 294) and 43% (for 314).  
 
The 1H NMR spectrum of 7,12-dimethoxytetraphene 294 confirmed the formation of the last 
aromatic six membered ring. In the 1H NMR spectrum, we observed two singlets at δ 3.97 and 
δ 4.12 ppm each integrating for three protons. These signals were assigned to the methoxy group 
protons. The only other signals present in the spectrum were found downfield in the aromatic 
region. These signals integrated for ten protons which was expected for 294. The 13C NMR 
spectrum further confirmed this as we no longer observed any downfield signals besides those 
owing to the carbons of the methoxy groups which were found at δ 60.89 and δ 63.15 ppm. The 
spectroscopic data obtained compared well with that found in the literature.134 
 
 
 
Chapter 6: Synthetic strategies towards the angucycline antibiotics 
 
 
137 
 
The formation of tetraphene 314 was similarly confirmed by both the 1H and 13C NMR spectra as 
we only observed signals in the aromatic region of both spectra, apart from the three methoxy 
groups. These were observed as signals at δ 3.96, δ 3.98 and δ 4.11 ppm in the 1H NMR 
spectrum, and at δ 55.38, δ 60.72 and δ 63.18 ppm in the corresponding 13C NMR spectrum. 
 
6.4. Attempted synthesis of tetrangulol 231  
 
 
 
Figure 6.2 
 
Having developed a feasible synthetic scheme that was used to prepare tetraphenes 294 and 314, 
we could now turn our attention to the preparation of tetrangulol 231 (Figure 6.2). We envisaged 
that in order to utilize our developed methodology, we would require the aryl bromide 304. This 
aryl halide could then be used in a Suzuki coupling reaction with an appropriate boronic acid 305 
to afford our biaryl intermediate 325 which could be converted into tetrangulol 231 over several 
steps. Scheme 6.11 shows the proposed retrosynthetic route resulting in two moieties 305 and 
304, which would need to be synthesised. The first precursor 305, closely resembles 212 used in 
our model study but contains an extra methoxy substituent on the naphthalene nucleus. 
 
 
 
Scheme 6.11 
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6.4.1. Preparation of 3-allyl-2-bromo-1,4,5-trimethoxynaphthalene 330137 
 
 
 
Scheme 6.12 Reagents and conditions: (i) pyridine, Ac2O, RT, 18h, 81%; (ii) NBS, AcOH–H2O, 65°C, 
45 min, 95%; (iii) 3 N HCl, EtOH, ∆, 90 min, 69%; (iv) AgO, MeI, CH2Cl2, RT, 24 h, 43%.  
 
Using methodology described by Jung,137 the preparation of 2-bromo-5-methoxy-1,4-
naphthoquinone 326 was achieved over five steps from commercially available 1,5-
dimethoxynaphthalene 327 (Scheme 6.12). The synthesis commenced with the acetylation of 
1,5-dihydroxynaphthalene 327 using pyridine and acetic anhydride to afford 1,5-
diacetoxynaphthalene 328 in 81% yield, which was an improvement on the yield of 44% 
reported in the literature. The identity of 328 was confirmed by the presence of a downfield 
signal at δ 169.26 ppm in the 13C NMR spectrum which corresponds to the carbonyl carbon of 
the acetate group. Treatment of 328 with N-bromosuccinimide in aqueous acetic acid furnished 
2-bromojuglone acetate 251 in a 95% yield. The structure of the product was confirmed by the 
13C NMR spectrum which showed a signal at δ 134.03 ppm owing to the carbon bonded to the 
bromine. This newly formed 2-bromojuglone acetate 251 was subjected to an acidic hydrolysis 
resulting in the formation of 2-bromojuglone 329 in a moderate yield of 69%. A downfield signal 
at δ 11.81 ppm in the 1H NMR spectrum attested to the presence of a phenolic proton. The 
unprotected 2-bromojuglone 329 was then protected using methyl iodide in dichloromethane in 
the presence of silver oxide to afford the product, 2-bromo-5-methoxy-1,4-naphthoquinone 326, 
as a yellow solid in 43% yield. In the 1H NMR spectrum we clearly observed a singlet at 
δ 4.02 ppm which unambiguously proved the formation of the O-methylated product. 
 
The next step in our synthesis involved the introduction of the allyl chain to the quinone 326. To 
achieve this, we again employed a modified Hunsdiecker reaction, by reacting 326 with vinyl 
acetic acid and ammonium persulfate in the presence of silver nitrate in aqueous acetonitrile. 
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This gave the allyl containing quinone 329 as a yellow solid in a yield of 79% (shown in 
Scheme 6.13).138 
 
 
 
Scheme 6.13 Regeants and conditions: vinyl acetic acid, ammonium persulfate, AgNO3, H2O-MeCN, 
60°C, 79%.  
 
Interpretation of the 1H NMR spectrum showed the unmistakable presence 
of new signals in the mid- and up-field regions of the spectrum. The most 
upfield signal which integrated for two protons was observed as a doublet 
of triplets at δ 3.60 ppm and was assigned to H4. Using a COSY spectrum 
we noted that H4 coupled to a signal integrating for one proton at δ 5.86 ppm corresponding to 
H5. H4 was also seen to couple to signals at δ 5.27 and δ 5.13 ppm which were the protons due to 
H6. Each of these protons showed different coupling constants to H5 and H4. The 13C NMR 
spectrum further confirmed the presence of the allyl chain with three additional signals appearing 
in the spectrum. The first of these signals was found at δ 35.76 ppm corresponding to C4. The 
two other additional signals were found at δ 118.8 and δ 134.94 ppm and corresponded to C6 and 
C5 respectively. All the remaining spectroscopic data compared well with literature.138 
 
 
 
Scheme 6.14 Reagents and conditions: sodium dithionite, TBAI, aq. KOH, Me2SO4, THF, 18 h, RT, 
75%. 
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With naphthoquinone 329 in hand, all that remained was the protection of the quinone moiety 
329 using dimethyl sulfate to afford the aromatic ether 330. To this end, shown in Scheme 6.14, 
naphthoquinone 329 was dissolved in THF and was allowed to stir under an atmosphere of 
argon. Sodium dithionite and tetra-butylammonium iodide in water were then added to the 
reaction flask to reduce the quinone to the hydroquinone. After one hour, aqueous potassium 
hydroxide solution was added to the reaction mixture to facilitate the deprotonation of the 
hydroquinone. After the addition of dimethyl sulfate the reaction mixture was allowed to stir at 
room temperature for 18 hours. Purification of the crude reaction mixture afforded naphthalene 
330 in 75% yield. 
 
The first indication of the success of the reaction was the loss of the 
carbonyl carbon signals in the 13C NMR spectrum, and the concomitant 
appearance of four new signals. These newly introduced signals 
corresponded to the methoxy groups and appeared at δ 62.86 and δ 61.08 
ppm and two signals at δ 151.19 and δ 149.69 ppm were observed for the aromatic carbons 
attached to the methoxy groups. The IR spectrum corroborated this observation as no stretches 
owing to the carbonyl groups of the quinone of the starting material were present. 
 
In our initial retrosynthesis we proposed that we would need to prepare naphthalene boronic acid 
305 before we could perform the Suzuki coupling with the appropriately substituted aromatic 
bromide 304, as shown in Scheme 6.15. However, aromatic bromide 330 could also be used in a 
Suzuki coupling reaction with boronic acid 331 to afford the desired biaryl compound 325. 
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Scheme 6.15 
 
6.4.2. Preparation of tetrangulol analogue 336. 
 
With aromatic bromide 330 in hand, we decided to prepare an analogue of tetrangulol to test the 
methodology developed in the earlier sections of this chapter on a more highly oxygenated 
naphthalene precursor. To achieve this, we subjected aromatic bromide 330, (preparation 
discussed in Section 6.4.1) to a Suzuki cross coupling reaction with commercially available 4-
methoxy-2-formylphenyl boronic acid 332 using the conditions described in Section 7.4.1. The 
product, 2-(3-allyl-1,4,5-trimethoxynaphthalen-2-yl)-5-methoxybenzaldehyde 333, was isolated 
as a yellow solid in a moderate yield of 46%, as shown in Scheme 6.16. However, we were 
pleased that the reaction was successful as the more electron-rich naphthalene precursor may 
have hindered the oxidative addition step. 
 
 
Scheme 6.16 Reagents and conditions: Pd(PPh3)4, 150W, 150°C, 20 min, 46%. 
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The 13C NMR spectrum of the product 333 unequivocally proved that 
the desired coupling reaction had occurred due to the presence of both a 
signal at δ 192.11 ppm, which was characteristic of an aldehyde carbon, 
and signals from the methoxy groups and the allyl chains of the starting 
material. The presence of the carbonyl was further confirmed by the 1H 
NMR spectrum which showed a deshielded singlet at δ 9.65 ppm corresponding to the aldehyde 
proton. Finally, the IR spectrum showed a stretch at 1686 cm–1 owing to the carbonyl group. An 
increase in the molecular mass was observed where mass spectrometry afforded an accurate 
mass of 393.1699 amu, which was in agreement with the expected mass of 393.1679 amu for 
C24H24O5.  
 
Pleased that our Suzuki coupling reaction had been successful, we continued with our synthesis. 
We subjected aldehyde 333 to a Wittig reaction using TMPPBr and n-BuLi which afforded the 
diene 334 in a 69% yield as a yellow oil (Scheme 6.17). 
 
 
 
Scheme 6.17: Reagents and conditions: (i) MTPPBr, BunLi, THF, 0°C–RT, 69%.  
 
As before, in the analysis of the 1H NMR spectrum of 334, the 
unmistakable loss of the aldehyde proton confirmed the success of the 
Wittig reaction. In the 1H NMR spectrum, we now observed newly 
formed signals in the mid-region of the spectrum. A mutiplet integrating 
for one proton was observed at δ 6.41–6.30 ppm which corresponded to 
H4. This signal showed coupling to two other signals found at δ 5.66 ppm (which showed trans 
coupling of 17.5 Hz to H4) and δ 5.06 (which showed cis coupling of 11.2 Hz to H4). These 
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signals were therefore assigned to H5. The 13C NMR spectrum confirmed the loss of the aldehyde 
functional group with the loss of the signal previously observed at δ 192.11 ppm. 
 
As we wanted to form the six membered ring system in the subsequent RCM reaction, we 
subjected our diene 334 to an isomerization reaction using potassium tert-butoxide in THF. TLC 
analysis of the reaction showed a downward shift in the Rf of the product indicating formation of 
the isomerized diene 335. Purification of the reaction mixture afforded the isomerised diene 335 
as a yellow oil in an excellent yield of 73%. 
 
 
 
Scheme 6.18 Reagents and conditions: KOBut, THF, RT, 73%.  
 
The interpretation of the 1H NMR spectrum of the product 335 showed 
the disappearance of the methylene protons previously observed at 
δ 3.11 ppm in starting material 334 and the concomitant appearance of 
a multiplet at δ 1.65–1.62 integrating for three protons. This multiplet 
was found significantly upfield and can therefore not be due to the 
methoxy group protons. We could therefore assign this signal as H3. The mid-region of the 
spectrum was characterised by a multiplet at δ 6.09–6.22 which was assigned to H1 as well as 
doublet of quartets (dq) which was found at δ 5.84 as was assigned to H2. The latter signal 
showed coupling of 15.9 Hz and 6.5 Hz to H1 and H3, respectively. In the aromatic region of the 
spectrum, we observed five different signals which collectively integrated for six protons as 
expected. The remaining signals which integrated for three protons each were found at δ 4.02, 
δ 3.89, δ 3.75 and δ 3.42 ppm and corresponded to the methoxy groups. All the carbon signals 
were assigned using a C-H correlation spectrum. 
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With the isomerised diene 335 in place, we could perform our ring closure using Grubb’s II as 
catalyst. This catalyst was chosen owing to it being the known catalyst to facilitate RCM and 
moreover, we anticipated that the reaction would require harsher conditions as diene 335 was 
now more electron rich due to the added methoxy group on the naphthalene nucleus. To achieve 
the ring closure, we stirred diene 335 in the presence of Grubbs II catalyst, in toluene. The 
reaction was heated under reflux for 18 hours. After this time the reaction was purified using 
column chromatography to afford our tetraphene 336 as a yellow solid in an excellent yield of 
84%. 
 
 
 
Scheme 6.19 Reagents and conditions: Grubbs II, toluene, ∆, 18 h, 84%. 
 
The most distinctive aspect of the 1H NMR spectrum was the presence 
of signals mainly in the aromatic region. In the 1H NMR spectrum, 
four singlets were observed at δ 4.09, δ 4.00, δ 3.98 and δ 3.91 ppm. 
Each of these singlets integrated for three protons and were assigned as 
the methoxy group protons. The aromatic region contained seven signals which collectively 
integrated for eight protons as was expected for the product 336. In the analysis of both the 1H 
NMR and 13C NMR spectra of the product we noticed the loss of the methyl protons previously 
observed at δ 1.62–1.65 ppm. Also absent were the alkene protons previously found in the mid-
region of the 1H NMR spectrum of the starting material. The results of the mass spectral analysis 
gave an accurate mass for C25H26O4 of 391.1426 amu, which was in good agreement with the 
expected mass of 391.1479 amu.. 
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6.4.3. Attempted synthesis of 2-bromo-3-methoxy-5-methylbenzaldehyde 304 
 
Having completed the synthesis of the tetrangulol analogue 336, we continued with the synthesis 
of tetrangulol itself. The required bromide 304, was not commercially available and therefore 
needed to be prepared. A study by Koyama has described the preparation of the desired 
bromide139 and we therefore adopted this methodology for the formation of bromide 304. Our 
synthesis commenced with the benzylic bromination of 3,5-dimethyl anisole 337 using NBS and 
a catalytic amount of benzoyl peroxide in refluxing carbon tetrachloride to furnish 3-
bromomethyl-5-methylanisole 338 in 75% yield (Scheme 6.20). 
 
 
 
Scheme 6.20 Reagents and conditions: NBS, benzoyl peroxide, CCl4, ∆, 4 h, 75%. 
 
The 1H NMR spectrum confirmed that the reaction was a success. The 1H NMR 
spectrum was characterized by six singlets indicating the loss of symmetry in 
the molecule which was present in the starting material 337. The most 
downfield signals at δ 6.78, δ 6.72 and δ 6.64 ppm each integrated for one 
proton and corresponded to the aromatic protons of the product. The singlet observed in the mid-
region of the spectrum found at δ 4.40 ppm integrating for two protons was assigned as the 
benzylic protons. The remaining signals each integrating for three protons were due to the 
methoxy protons and the methyl protons and were found at δ 3.76 and δ 2.29 ppm respectively. 
The IR spectrum confirmed the addition of the bromine with the presence of an absorption at 
644 cm–1 which is characteristic of a C–Br stretch.  
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Using the procedure developed by Koyama, 3-bromomethyl-5-methylanisole 338 was oxidised 
to 3-methoxy-5-methylbenzaldehyde using 2-nitropropane and sodium ethoxide. The product 
339 was furnished as a pale yellow oil, however always in a consistently low yield of 30% 
(Scheme 6.21). 
 
 
 
Scheme 6.21 Reagents and conditions: 2-Nitropropane, NaOEt, EtOH, RT, 30%. 
 
The 13C NMR spectrum unequivocally proved the formation of the aldehyde 
with the presence of a downfield signal at δ 192.30 ppm indicating the presence 
of a carbonyl group. The signal previously observed owing to the benzylic 
carbons was also noticeably absent, further attesting to the formation of the 
aldehyde. Analysis of the 1H NMR and IR spectra explicitly confirmed the formation of the 
aldehyde with the presence of a singlet at δ 9.92 ppm in the 1H NMR spectrum and an absorption 
at 1697 cm–1 in the IR spectrum.  
 
We then attempted the bromination of 3-methoxy-5-methylbenzaldehyde 339, employing the 
ortho-directed metallation methodolgy described by Comins,140 but using a different source of 
bromine. Unfortunately, treatment of the lithium α-amino alkoxide, which was formed using 
lithium N,N,N’-trimethylethylene diamine, with 1,1,2,2-tetrabromoethane did not result in the 
formation of the expected bromide. The electrophilic source of bromine employed by Koyama 
was 1,2-dibromotetrafluoroethane, which is not readily available commercially in South Africa. 
Review of the literature139,141 led us to believe that this bromination was indeed challenging as 
the best yield obtained was 69% when 1,2-dibromotetrafluoroethane was used as the 
electrophilic source of bromine. We attempted this reaction using various other sources of 
bromine, including NBS, bromine as well as 1,2-dibromotetrachloroethane, but these too met 
with disappointing results. At this stage, we decided to prepare the stannane 340 which would 
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allow us to perform a Stille coupling reaction to access the natural product tetrangulol.141 To 
achieve this, we prepared the lithium α-amino alkoxide as described earlier and reacted it with 
tributyltin chloride. Unfortunately, purification of the reaction mixture again resulted in the 
isolation of our starting aldehyde 339 (Scheme 6.22).  
 
 
 
Scheme 6.22 
 
Owing to time constraints, we were not able to prepare the required coupling partner for the 
synthesis of tetrangulol. This is an area for further development in our laboratories. 
 
6.5. Oxidation of tetraphenes 
 
With the tetraphenes 294, 314 and 336 in hand, we decided to oxidise the six memebered 
compounds to the corresponding quinone systems as this motif is commonly found in natural 
products of this class. We also decided to oxidise one of the seven-membered rings to test the 
oxidation reaction on this class of compounds. The oxidation reactions were achieved by 
individually dissolving our ring closure products in acetonitrile. Ceric ammonium nitrate in 
water was then added to each reaction flask and the reaction mixtures were allowed to stir at 
room temperature for ten minutes. Work-up and purification of each reaction resulted in the 
formation of the oxidised products 341, 342, 343 and 344 in good overall yields (Scheme 6.23). 
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Scheme 6.23 Reagents and conditions: CAN, CH3CN–H2O, RT, 76% (for 341), 87% (for 342), 84% (for 
343), 70% (for 344). 
 
In the analysis of the 1H NMR spectra of 341, 342 and 343, the loss of two signals corresponding 
to methoxy groups was observed for each analogue. The 13C NMR spectra further confirmed that 
the oxidation was successful with the appearance of downfield signals in the region δ 180–185 
ppm which were characteristic of carbonyl carbons. Furthermore, the IR spectra contained 
stretches at 1728 and 1661 cm–1, 1734 and 1657 cm–1 and 1654 and 1618 cm–1 for 341, 342 and 
343 respectively, also indicating the presence of the carbonyl groups. We were therefore 
confident that our oxidation reactions were a success. 
 
When we analysed the product isolated from the oxidation reaction of 344, 
the NMR spectroscopic data was not as clear as we would have expected. 
In the analysis of 344, the 1H NMR spectrum clearly showed the loss of the 
methoxy protecting groups as we no longer observed singlets at δ 3.26 and 
δ 3.97 ppm. The spectrum also showed signals in the alkene region which indicated that our 
seven membered ring system was still intact, with a doublet showing cis coupling of 9.6 Hz 
visible at δ 6.74 ppm. This doublet was assigned as H3 and coupled to H2 which was observed as 
a signal at δ 6.18 ppm. Upon closer inspection of the spectrum we observed that H2 coupled to 
another signal as it showed a second coupling constant of 6.9 Hz. It can be assumed that this 
coupling occurred with the methylene protons at H1. However, we could not find any resolved 
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signals which would account for our methylene protons in the 1H NMR spectrum. What we in 
fact observed were two broad signals at δ 4.26–3.70 and δ 2.81–1.62 ppm each integrating for 
one proton. We therefore assigned these two signals as H1 as the methylene protons at H1 would 
be non-equivalent in this system. In the analysis of the 13C NMR spectrum we observed two 
clear signals at δ 184.14 and δ 183.51 ppm corresponding to the carbonyl carbons of our 
quinone. We also observed a signal at δ 23.70 ppm which was assigned as C1 using a DEPT135 
NMR spectrum. Finally the structure of quinone 344 was unequivocally confirmed by X-ray 
crystallography. Figure 6.3 clearly shows the presence of the quinone and as well as evidence 
that the methylene protons are indeed present. 
 
 
 
Figure 6.3 
 
6.6. Conclusions and future work pertaining to Chapter 6 
 
Our main aim in this section of the PhD thesis was the development of novel methodology for 
the preparation of angucycline antibiotics and their analogues. This synthetic route involved the 
use of Suzuki cross coupling chemistry to afford an aromatic compound containing a biaryl axis 
which allowed for a ring closure achieved using metathesis. We also attempted the preparation of 
a naturally occurring angucycline, tetrangulol 231. 
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Our synthesis commenced with the preparation of arylbromide 212, which we subjected to 
Suzuki reactions to afford aldehydes 315 and 316, shown in Scheme 6.24. The yields of these 
reactions were mediocre which may have been as a result of steric effects provided by the allyl 
substituent. 
 
 
Scheme 6.24 
 
The formation of the biaryl aldehydes was followed by a well-known Wittig reaction, which 
provided us with dienes 317 and 318 in excellent yields on which we could perform our ring 
closing metathesis reaction. (Scheme 6.25) 
 
 
 
Scheme 6.25 
 
Our final steps involved the use of ruthenium based catalysts to facilitate isomerization and 
RCM. Grubb’s I catalyst was initially utilized to hopefully accomplish the isomerisation of the 
allyl double bond, and then Grubb’s catalyst II we hoped would facilitate the ring closure. 
However, isolation of our initial ring closure products yielded compounds 320 and 321 
containing seven membered rings (Scheme 6.26). Not unexpectedly, Grubbs I facilitated the 
RCM before isomerization of the allyl chain. 
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Scheme 6.26 
 
In order to achieve the desired six membered ring containing compounds, we subjected dienes 
317 and 318 to an isomerisation reaction using potassium tert-butoxide in THF. This resulted in 
the formation of dienes 322 and 323 which, when reacted with Grubbs II, formed our desired six 
membered ring compounds 294 and 314 (Scheme 6.27). 
 
 
 
Scheme 6.27 
 
Confident that we had developed feasible methodology for the preparation of analogues of 
angucycline, we turned our attention to the preparation of tetrangulol. We proposed that we 
would require two moieties 305 and 304 which could be coupled together using a Suzuki 
coupling reaction. Preparation of arylbromide 330 progressed smoothly using the methodology 
described by Jung and Sato (Scheme 6.28).138 
 
Chapter 6: Synthetic strategies towards the angucycline antibiotics 
 
 
152 
 
 
 
Scheme 6.28 
 
To test the reaction methodology, the prepared arylbromide 330 was reacted with commercially 
available 4-methoxy-2-formylphenyl boronic acid 332 under Suzuki reaction conditions which 
afforded biaryl aldehyde 333. Subjecting aldehyde 333 to a Wittig reaction yielded diene 334 
which, after isomerisation with potassium tert-butoxide, afforded diene 335. Our final step was 
the formation of the tetraphene 336 using Grubbs II to facilitate the ring closure in a yield of 
84% (Scheme 6.29). 
 
 
 
Scheme 6.29 
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The preparation of bromoaldehyde 304 proved less successful. After numerous attempts at 
synthesising this aldehyde we were convinced that the proposed electrophilic source of bromine 
used by Koyama was needed to facilitate the formation of the desired bromoaldehyde 304 
(Scheme 6.30). 
 
 
 
Scheme 6.30 
 
For completeness, we oxidised our prepared tetraphenes using CAN to the corresponding 
quinones. Analysis of the isolated products yielded quinones 341, 342 and 343 in excellent yields 
of 76%, 87% and 84% respectively (Figure 6. 4). 
 
 
 
Figure 6.4 
 
The seven membered ring systems were not as discernible using NMR spectroscopy. Hence, we 
obtained a crystal structure of 344 which unambiguously confirmed the oxidation of 320 to 
quinone 344.  
 
Future work for the preparation of tetrangulol 231 would involve the preparation of 
bromoaldehyde 304 which will provide us with the correct substitution pattern required for this 
natural product A review of the literature showed that we require a specific electrophilic source 
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of bromine, 1,2-dibromo-tetrafluroroethane, which will need to be sourced, to allow for the 
preparation of bromoaldehyde 304. With bromoaldehyde 304 in hand we could continue with the 
synthesis of 231 by preparing the boronic acid 305 of arylbromide 330. A Suzuki reaction of this 
boronic acid 305 and bromoaldehyde 304 would provide us with biaryl aldehyde 345. A Wittig 
reaction followed by an isomerisation reaction would furnish diene 346. Ring closing metathesis 
of diene 346 would afford tetraphene 347. All that would remain would be the oxidation to the 
quinone 348 followed by the final deprotection of the phenolic groups to afford the naturally 
occurring tetrangulol 231 (Scheme 6.31). 
 
 
 
Scheme 6.31 
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Chapter 7: Experimental procedures 
 
7.1. General Procedures 
 
7.1.1. Purification of solvents and reagents 
 
All solvents used for chromatographic purposes were distilled prior to use by conventional 
distillation procedure. Solvents used for reaction purposes were dried over an appropriate drying 
agent and then distilled under a nitrogen atmosphere. Tetrahydofuran and diethyl ether were 
distilled from sodium wire using benzophenone as the indicator. Toluene was distilled from 
sodium metal. Acetonitrile, dichloromethane, dimethylformamide, ethanol and methanol were 
distilled from calcium hydride. Triethylamine was distilled from and stored over potassium 
hydroxide. Pyridine was distilled from potassium hydroxide. All reagents were obtained from 
commercial sources and used without further purification and when necessary purified by 
standard methods as recommended by Armarego et al.142  
 
7.1.2. Chromatography 
 
Macherey-Nagel Kieselgel 60, Sigma-Aldrich or Fluka silica-gel (particle size 0.063-0.200 mm) 
was used for standard column chromatography, while silica gel (particle size 0.035-0.070 mm) 
was used when performing flash column chromatography. Rf values quoted were obtained using 
TLC on aluminium-backed Macherey-Nagel ALUGRAM Sil G/UV254 plates pre-coated with 
0.25 mm silica gel 60. Compounds were detected by viewing the absorbed compounds under UV 
light or by dipping or staining plates with various TLC staining solutions. 
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7.1.3. Spectroscopic and physical data 
 
1H NMR and 13C NMR spectra were recorded on a Bruker AVANCE 300 at 300.132 MHz for 
1H and 75.473 for 13C or on a Bruker AVANCE III 500 at 500.13 MHz for 1H and 125.75 for 
13C. Spectra were recorded in deuterated chloroform unless otherwise stated. The chemical shift 
values for all spectra obtained are reported in parts per million and referenced against the internal 
standard, TMS, which occurs at zero parts per million for 1H NMR and relative to the central 
solvent signal taken as δ77.00 for 13C NMR spectra. Coupling constants quoted are given in 
Hertz.  
 
Infra-red spectra were recorded using a Bruker Tensor 27 Fourier Transform spectrometer 
equipped with a diamond ATR attachment. Measurements were made by loading the sample 
directly onto the diamond cell. All signals are reported on the wavenumber scale (ν/cm–1).  
 
High resolution mass spectra were recorded on a Waters Synapt G2. All data was quoted in 
relative abundance (m/z). 
 
Melting points of all solid compounds were obtained using a JM 626 meting-point apparatus 
with a microscope and digital thermometer, and are uncorrected. 
 
For X-ray crystallography, intensity data were collected on a Bruker Apex II CCD area detector 
diffractometer with graphite monochromated Mo Kα radiation (50 kV, 30 mA) using the 
APEX 2 data collection software. The collection method involved ω-scans of width 0.5° and 
512X512 bit data frames. Data reduction was carried out using the program SAINT+ and face 
indexed absorption corrections were made using the program XPREP. The crystal structure was 
solved by direct methods using SHELXTL. Non-hydrogen atoms were first refined isotropically 
followed by anisotropic refinement by full matrix least-squares calculations based on F2 using 
SHELXTL. Hydrogen atoms were first located in the difference map then positioned 
geometrically and allowed to ride on their respective parent atoms. Diagrams and publication 
material were generated using SHELXTL, PLATON and ORTEP-3. 
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7.1.4. High pressure liquid chromatography 
 
High pressure liquid chromatography (HPLC) was performed on a Dionex HPLC at a flow rate 
of 1.0 ml.min–1. A C18 column Luna 5µ 150 x 4.6 mm was used to monitor reactions using 
mobile phases consisting of acetonitrile and water. A Chiralcel OJ 10µ 250 x 4.6 or Chiral 
column Lux 5µ Cellulose-1 250 x 4.6 mm was used to monitor reactions using mobile phases 
consisting of isopropyl alcohol and hexane. Detection of the eluted analytes was achieved using 
a TSP variable wavelength UV detector at 215 nM. All calculations were based on peak area.  
 
7.1.5. Additional experimental procedures and techiniques 
 
Unless otherwise stated, all reactions were carried out under an argon atmosphere. All reaction 
vessels were either flame dried or dried in an oven. Microwave reactions were performed using a 
CEM Discovery microwave reactor (see relevant experimental sections). The term “in vacuo” 
refers to the removal of solvent by rotary evaporation followed by the removal of residual 
solvent using a high vacuum pump at ca. 1 mm Hg.. 
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7.2. Experimental procedures pertaining to Chapter 2 
 
7.2.1. Preparation of allyl 5-(allyloxy)-2-hydroxybenzoate 76 
 
In a 1000 cm3 (1 litre) RB flask equipped with a reflux condenser, potassium carbonate (11.95 g, 
86.3 mmol, 2.2 equiv.) was added to a clear yellow solution of 2,5 dihydroxybenzoic acid 64 
(6.05 g, 39.25 mmol) in dry acetone (600 cm3). The resulting mixture was heated to 30oC while 
stirring under Ar(g). Allyl bromide (7.45 cm3, 10.45 g, 86.36 mmol, 2.2 equiv.) was added to the 
solution using a dropping funnel. The reaction mixture was then heated at reflux overnight, 
during which time it became a cream paste. The reaction was then cooled, filtered through celite 
and the acetone removed in vacuo. The residue was purified by silica gel column 
chromatography (10% EtOAc /Hexane) to yield the diallylated product 76 as white needle-like 
crystals (7.52 g, 82%). 
 
 Rf = 0.61 (20% EtOAc /Hexane); mp. 42–45°C, (lit 43.5–44.5°C)143; IR 
(CHCl3): νmax(cm–1): 3567 (OH), 1672 (C=O), 1650 (C=C); 1H NMR 
(300 MHz, CDCl3): δH = 10.36 (1H, s, OH), 7.36 (1H, d, J = 3.1 Hz, H6), 
7.11 (1H, dd, J = 9.1, 3.1 Hz, H4), 6.92 (1H, d, J = 9.1 Hz, H3), 6.11–
5.97 (2H, m, H2' and H2" overlapped), 5.48–5.24 (4H, m, H3' and H3" 
overlapped), 4.85 (1H, dt, J = 5.7, 1.3 Hz, H1'), 4.50 (2H, dt, J = 5.3, 1.4 Hz, H1"); 13C NMR (75 
MHz): δC = 169.51 (C=O), 156.30 (C-2), 150.95 (C-5) , 133.19 (C-2"), 131.57 (C-2'), 124.68 (C-
6), 118.51 (C-4), 117.81 (C-3"), 113.51 (C-3'), 111.92 (C-1), 69.66 (C-1"), 65.87 (C-1'). 
 
7.2.2. Preparation of allyl 2-allyl-3,6-dihydroxybenzoate 77 
 
In a 100 cm3 RB flask equipped with a reflux condenser, neat allyl 5-(allyloxy)-2-
hydroxybenzoate 76 (6.85 g, 19.4 mmol) was heated at 170oC for 18 h, under an argon 
atmosphere. The white powder melted to first form a yellow oil and then turned to a dark orange 
liquid that became a black viscous oil. This was allowed to cool before purifying by silica gel 
column chromatography (5→10% EtOAc /Hexane) to yield 2-allyl-3,6-dihydroxybenzoate 77 as 
a viscous orange oil (5.53 g, 78%). 
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 Rf = 0.28 (20% EtOAc /Hexane);  IR (CHCl3):  νmax(cm–1): 3412 (OH), 
1662 (C=O), 1611 and 1461 (C=C); 1H NMR (300 MHz, CDCl3):  δH = 
10.40 (1H, s, 2-OH), 6.99 (1H, d, J = 8.9 Hz, H5), 6.81 (1H, d, J = 8.9 
Hz, H4), 6.09–5.93 (2H, m, H2′ and H2″ overlapped), 5.47–5.28 (2H, m, 
H3′), 5.12–5.00 (2H, m, H3″), 4.86 (2H, ddd, J = 9.0, 5.1, 1.3 Hz, H1′), 3.73 (2H, dt, J = 5.7, 1.6 
Hz, H1″); 13C NMR (75 MHz): δC = 170.57 (C=O), 156.21 (C-2), 147.33 (C-5), 136.29 (C-2′), 
131.22 (C-2″), 126.36 (C-6), 123.52 (C-4), 119.75 (C-3), 116.63 (C-3′), 115.61 (C-3″), 112.96 
(C-1), 66.54 (C-1′), 32.47 (C-1″).  
 
7.2.3. Preparation of allyl 2-allyl-3,6-dimethoxybenzoate 78 
 
In a 250 cm3  RB flask equipped with a reflux condenser, potassium carbonate (6.97 g, 
50.0 mmol, 2.5 equiv.) was added to a clear yellow solution of allyl 2-allyl-3,6-
dihydroxybenzoate 77 (4.67 g, 20.0 mmol) in acetone (100 cm3). The solution was stirred at RT 
until it turned brown. Dimethyl sulfate (5 cm3, 6.34 g, 52.6 mmol, 2.6 equiv.) was then added 
and the resulting mixture was refluxed for 24 h. The crude reaction mixture which was light 
brown in colour was filtered through celite and the solvent removed in vacuo. Once the residue 
was cooled, diethyl ether (65 cm3) was added. The ether layer was washed with 10% aqueous 
ammonia solution (65 cm3) until frothing stopped. The aqueous layer was thoroughly extracted 
with diethyl ether and dichloromethane. The organic extracts were combined and dried with 
anhydrous MgSO4 before filtering through celite. The solvent was then removed in vacuo. The 
residue was purified by silica gel column chromatography (20% EtOAc /Hexane) to afford 2-
allyl-3,6-dimethoxybenzoate 78 as an orange oil (4.98 g, 95%).  
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Rf = 0.50 (20% EtOAc /Hexane);  IR (CHCl3): νmax(cm–1): 1728 (C=O), 
1638 and 1481  (C=C); 1H NMR (300 MHz, CDCl3): δH =  6.84 (1H, d, 
J = 9.0 Hz, H5), 6.75 (1H, d, J = 9.0 Hz, H4), 6.12–5.74 (2H, m, H2′ and 
H2″ overlapped), 5.45–5.35 (2H, m, H3′), 5.27–4.90 (2H, m, H3″), 4.81 
(2H, dt,  J = 5.8, 1.3 Hz, H1′), 3.78 (3H, s, OCH3), 3.77 (3H, s, OCH3), 3.35 (2H, dt, J = 6.3, 1.4 
Hz, H1″);   13C NMR (75 MHz): δC = 167.46 (C=O), 151.63 (C-2), 150.26 (C-5), 135.91 (C-2′), 
131.95 (C-2″), 127.08 (C-6), 125.11 (C-4), 118.70 (C-3), 115.35 (C-3′), 112.35 (C-3″), 109.81 
(C-1), 65.87 (C-1′), 56.38 (OCH3), 56.26 (OCH3) 31.77 (C-1″).   
 
7.2.4. Preparation of (2-allyl-3,6-dimethoxyphenyl)methanol 65 
 
In a 500 cm3 RB flask fitted with a reflux condenser, 2-allyl-3,6-dimethoxybenzoate 78 (5.23 g, 
19.9 mmol) was dissolved in THF (250 cm3). The solution was cooled to 0oC and lithium 
aluminium hydride (1.51 g, 39.8 mmol, 2 equiv.) was added slowly. The resulting suspension 
was heated to 40oC and stirred for 2 h. The mixture was cooled to 0oC again before a 10% 
aqueous hydrochloric acid solution (10%, 15cm3) was added slowly. THF was removed in vacuo 
before the remaining aqueous layer was extracted with diethyl ether (4 × 30 cm3) and 
dichloromethane (3 × 30 cm3). The organic extracts were combined and dried with anhydrous 
MgSO4 before filtering through celite. The solvent was then removed in vacuo. The residue was 
purified by silica gel column chromatography (20% EtOAc /Hexane) to afford (2-allyl-3,6-
dimethoxyphenyl) methanol 65 as a light yellow oil (3.17 g, 77%).  
 
Rf = 0.21 (20% EtOAc /Hexane); IR (CHCl3): νmax(cm–1): 3424 (OH), 1638 
and 1478 (C=C); 1H NMR (300 MHz, CDCl3): δH = 6.82 (1H, d, J = 8.9 Hz, 
H5), 6.77 (1H, d, J = 8.9 Hz, H4), 6.04–6.91 (1H, ddt, J = 17.0, 10.2, 5.8 Hz, 
H2′) , 5.00–4.88 (2H, m, H3′), 4.71 (2H, s, Ar-CH2-O-), 3.85 (3H, s, OCH3), 
3.78 (3H, s, OCH3), 3.54 (2H, m, H1′), 2.36 (1H, s, OH); 13C NMR (75 MHz): δC = 152.33 (C-
6), 151.79 (C-3), 137.41 (C-2′) , 128.82 (C-1), 128.26 (C-2), 114.74 (C-3′), 110.66 (C-4), 108.78 
(C-5), 57.45 (OCH3), 56.27 (OCH3), 55.81 (Ar-CH2-O-), 29.91 (C-1′).  
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7.2.5. Preparation of (2-allyl-3,6-dimethoxybenzyloxy)(tert-butyl)dimethylsilane 79 
 
In a 250 cm3 RB flask fitted with a reflux condenser, (2-allyl-3,6-dimethoxyphenyl)methanol 65 
(1.97 g, 9.52 mmol) and TBDMSCl (1,7363 g, 11.52 mmol, 1.2 equiv.) were dissolved in THF 
(100 cm3). Sodium hydride (60% in oil, 1.14 g, 28.5 mmol, ca. 3.0 equiv.) was added and the 
solution was refluxed for 24 h under an argon atmosphere, while stirring. The reaction was 
worked up by adding distilled water (20 cm3) and then extracting the material with ethyl acetate 
(4 × 20 cm3). The organic extracts were combined and dried with anhydrous MgSO4 before 
filtering through celite and the solvent removed in vacuo. The residue was purified by silica gel 
column chromatography by using hexane as the initial eluent to remove the sodium hydride oil 
from the column and then 20% EtOAc /Hexane to afford (2-allyl-3,6-dimethoxybenzyloxy)(tert-
butyl)dimethylsilane 79 as a light yellow oil (2.71 g, 90%).  
 
Rf = 0.72 (20% EtOAc /Hexane); IR (CHCl3): νmax(cm–1): 1638 (C=C), 
834 (Si-C);  1H NMR (300 MHz, CDCl3): δH = 6.81 (1H, d, J = 8.9 Hz, 
H5), 6.74 (1H, d, J = 8.9 Hz, H4), 6.01 (1H, ddt, J = 16.6, 10.7, 6.0 Hz, 
H2), 4.99–4.97 (1H, m, H3), 4.94 (1H, dq, J = 8.9, 1.7 Hz, H3), 4.77 (2H, s, 
H6), 3.80 (3H, s, OCH3), 3.80 (3H, s, OCH3), 3.59 (2H, dt, J = 5.9, 1.6 Hz, H1), 0.93 (9H, s, 
C(CH3)3), 0.10 (4H, s, Si(CH3)2); 13C NMR (75 MHz): δC = 152.0 (ArCO), 151.9 (ArCO), 137.3 
(C-2) , 129.9 (ArC), 128.8 (ArC), 114.3 (C-3), 110.8 (C-4), 109.4 (C-5), 56.2 (OCH3), 56.1 
(OCH3), 30.9 (C-1), 25.9 (C(CH3)3), 18.5 (C(CH3)3), -5.3 (Si(CH3)2); HRMS (ESI+): Found M+ 
+ Na 345.1866, C18H30O3Si (M+ + Na) requires 345.1864, m/z 345.1866 (M+ + Na, 17%). 
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7.2.6. Preparation of (E)-ethyl 4-(2-((tert-butyldimethylsilyloxy) methyl)-3,6-
dimethoxyphenyl)but-2-enoate 94 
 
A 100cm3 RB flask fitted with a reflux condenser was set under an argon atmosphere. Neat (2-
allyl-3,6-dimethoxybenzyloxy)(tert-butyl)dimethylsilane 79 (1.71 g, 5.32 mmol) and ethyl 
acrylate (1.5 cm3, 1.38 g, 13.78 mmol, 2.6 equiv.) was dissolved in dry toluene (50 cm3) with 
stirring. Second generation Grubbs catalyst (67.8 mg, 7.99 × 10-5 mol, 5 mol%) was then added 
to the flask and the solution was heated at 90oC and left at this temperature for 18 h. The crude 
product was dried onto silica while removing the solvent in vacuo. The material was purified by 
silica gel column chromatography (10% EtOAc /Hexane) to afford (E)-ethyl 4-(2-((tert-
butyldimethylsilyloxy)methyl)-3,6-dimethoxyphenyl)but-2-enoate 94 as a clear oil (1.63 g, 
78%).  
 
Rf = 0.31 (10% EtOAc /Hexane); IR (CHCl3): νmax(cm–1): 1716 
(C=O), 1602 (C=C), 1243 (C-O); 1H NMR (300 MHz, CDCl3): δH 
= 7.13 (1H, dt, J = 15.6, 6.1 Hz, H5), 6.80 (1H, d, J = 9.0 Hz, H1), 
6.75 (1H, d, J = 9.0 Hz, H2), 5.68 (1H, dt, J = 15.6, 1.6 Hz, H6), 
4.74 (2H, s, H3),  4.15 (2H, q, J = 7.1 Hz, H7), 3.79 (3H, s, OCH3), 3.78 (3H, s, OCH3), 3.71 (2H, 
dd, J = 6.1, 1.7 Hz, H4), 1.26 (3H, t, J = 7.1 Hz, H8), 0.90 (9H, s, C(CH3)3), 0.07 (6H, s, 
Si(CH3)2) ; 13C NMR (75MHz): δC = 166.9(C=O), 151.9 (ArCO), 151.7 (ArCO), 148.0 (C-5), 
133.6 (ArC), 128.9 (ArC), 121.1 (C-6), 110.5 (ArCH), 109.9 (ArCH), 61.3 (C-7), 56.2 (OCH3), 
56.1 (OCH3), 55.9 (ArCH2OSi), 29.0 (C-4), 26.0 (C(CH3)3), 18.4 (C(CH3)3),  14.2 (C-8), -5.3 
(Si(CH3)2);  HRMS (ESI+): Found M+ – tBu 338.1490, C17H26O5Si (M+ – tBu) requires 
338.4744, m/z 338.1490 (M+ – tBu, 25%). 
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7.2.7. Preparation of (E)-methyl 4-(2-(hydroxymethyl)-3,6-dimethoxyphenyl)but-2-enoate 
66 
 
In a 100cm3 RB flask fitted with a reflux condenser was set under an argon atmosphere. Neat (2-
allyl-3,6-dimethoxyphenyl)methanol 65 (1.03 g, 4.97 mmol) and ethyl acrylate (1.50 cm3, 1.34 g, 
13.38 mmol, 2.7 equiv.) was dissolved in dry CH2Cl2 (30 cm3) with stirring. Second generation 
Grubbs catalyst (211.1 mg, 2.49 × 10-4 mol, 5 mol%) was then added to the flask and the 
solution was heated at reflux and left at this temperature for 4 h. The crude product was dried 
onto silica while removing the solvent in vacuo. The material was purified by silica gel column 
chromatography (5% EtOAc /Hexane) to afford (E)-methyl 4-(2-(hydroxymethyl)-3,6-
dimethoxyphenyl)but-2-enoate 66 (1.19 g, 86%). 
 
 Rf = 0.52 (50% EtOAc /Hexane); IR (CHCl3): νmax(cm–1): 3428 
(OH), 1714 (C=O), 1599 and 1468 (C=C); 1H NMR (300 MHz, 
CDCl3): δH = 7.10 (1H, dt, J = 15.6, 5.9 Hz, H5), 6.81 (1H, d, 
J = 9.0 Hz, H1), 6.77 (1H, d, J = 9.1 Hz, H2), 5.63 (1H, dt, J = 15.6, 
1.7 Hz, H6), 4.66 (2H, s, H3), 4.14 (2H, q, J = 7.1 Hz, H7), 3.84 (3H, s, OCH3),  3.78 (1H, s, 
OCH3), 3.68 (2H, dd, J = 5.9, 1.8 Hz, H4), 2.26 (1H, s, OH), 1.26 (3H, t, J = 7.1 Hz, H8); 13C 
NMR (75MHz) δC = 171.2 (C=O), 152.2 (ArCO), 151.7 (ArCO), 147.4 (C-5), 128.8 (ArC), 
126.2 (ArC), 121.4 (C-6), 110.5 (ArCH), 109.3 (ArCH), 61.3 (C-7), 57.4 (C-3), 56.1 (OCH3), 
56.0 (OCH3), 28.6 (C-4), 14.2 (C-8); HRMS (ESI+): Found M+ + Na 303.1198, C15H20O5 (M+ + 
Na) requires 303.1211, m/z 303.1198 (M+ + Na, 60%) 263.1279 (55). 
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7.2.8. Preparation of ethyl 2-(5,8-dimethoxyisochroman-3-yl)acetate 67 
 
 
 
(E)-ethyl 4-(2-((tert-butyldimethylsilyloxy)methyl)-3,6-dimethoxyphenyl)but-2-enoate 94 
(1.17 g, 2.96 mmol) was dissolved in dry THF (100 cm3) containing acetic acid (0.20 cm3, 3.49 
mmol, 1.2 equiv.) in a dry two neck round bottom flask under argon. The reaction mixture was 
cooled to 0°C and TBAF solution (0.5 M in THF, 30 cm3, 15.0 mmol, 5 equiv.) was added to the 
reaction mixture in one portion. The reaction mixture was allowed to warm up to room 
temperature and was stirred for 18 hours under argon. The reaction mixture was then extracted 
into EtOAc (4 × 50 cm3). The organic layers were then combined, dried with anhydrous MgSO4, 
filtered through celite and the solvent removed in vacuo. The crude material was purified by 
flash silica gel column chromatography (10% EtOAc/Hexane) to yield the product 67 as a clear 
oil (0.73 g, 88%). 
 
 
 
In a 50 cm3 RB flask, the (E)-methyl 4-(2-(hydroxymethyl)-3,6-dimethoxyphenyl)but-2-enoate  
66 (2.40 g, 8.56 mmol) was dissolved in dry THF (50 cm3). The reaction mixture was cooled to 
0°C and sodium hydride (60% in oil, 0.70 g, 17.5 mmol, 2.0 equiv.) was slowly added to the 
reaction mixture. The reaction mixture was allowed to stir for 30 minutes at room temperature 
under argon. The reaction mixture was then quenched with H2O and diluted with EtOAc. The 
organic material was then extracted into EtOAc (4 × 50 cm3) before being washed with brine 
(20 cm3). The organic extracts were combined, dried with anhydrous MgSO4, filtered through 
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celite and the solvent removed in vacuo. The crude material was purified by flash silica gel 
column chromatography (10% EtOAc/Hexane)
 
to yield the product 67 as a clear oil (2.06 mg, 
86%). 
 
Rf = 0.17 (10% EtOAc /Hexane); IR (CHCl3): νmax(cm–1): 2940 (C-
H), 1734 (C=O), 1607 and 1435 (C=C), 1254 and 1121 (C-O); 
1H NMR (300 MHz, CDCl3): δH = 6.65 (1H, d, J = 9.0 Hz, H1), 
6.61 (1H, d, J = 9.0 Hz, H2), 4.91 (1H, d, J = 15.9 Hz,  H3a), 4.62 
(1H, d, J = 16.0 Hz, H3b), 4.19 (1H, dq, J = 7.1, 2.0 Hz, H6), 4.11–3.99 (1H, m H8), 3.77 (1H, s, 
OCH3), 3.75 (1H, s, OCH3), 2.83 (1H, dd, J = 16.9, 1.8 Hz,, H4a), 2.71 (1H, dd, J = 15.5, 7.8 Hz, 
H5a), 2.60 (1H, dd, J = 15.5, 5.2 Hz, H5b), 2.44 (1H, dd, J = 16.9, 10.9 Hz, H4b), 1.28 (3H, t, 
J = 7.2 Hz, H7); 13C NMR (75 MHz): δC = 171.1 (C=O), 150.9 (ArCO), 149.4 (ArCO) , 124.4 
(ArC), 123.1 (ArC), 107.5 (ArCH), 107.0 (ArCH), 70.7 (C-8), 64.7 (C-3), 60.5 (C-6), 56.5 
(OCH3), 55.4 (OCH3), 41.1 (C-5), 28.2 (C-4), 14.2 (C-7); HRMS (ESI+): Found M+ + H 
281.1381, C15H20O5 (M+ + H) requires 281.13904, m/z 281.1381 (M+ + H, 100%) 279.1220 (25), 
235.0958 (22). 
 
7.2.9. Preparation of 2-(5,8-dimethoxyisochroman-3-yl)acetic acid 71 
 
In a 25 cm3 RB flask, the acetate 67 (1.03 g, 3.68 mmol) was dissolved in dry methanol (5 cm3) 
and to this was added potassium hydroxide (1.51 g, 26.9 mmol, 7.2 equiv.). The reaction mixture 
was stirred for 3 hours at room temperature under an argon atmosphere. Upon completion the 
reaction mixture was quenched with H2O and diluted with EtOAc. The aqueous layer was 
washed with EtOAc (2 × 20 cm3) to remove any unreacted starting material. The aqueous phase 
was acidified to pH 2 using 6N HCl which resulted in a white precipitate. The organic material 
was extracted into EtOAc (4 × 50 cm3) and the organic extracts combined and dried with 
anhydrous MgSO4, filtered through celite and the solvent removed in vacuo to afford the acid 71 
as a white powder (0.88 mg, 95%). 
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Rf = 0.46 (50% EtOAc /Hexane); mp. 155–157°C; IR (CHCl3): 
νmax(cm–1): 3015 (OH), 1694 (C=O), 1488 (C=C), 1326 (C-O); 1H NMR 
(300 MHz, CDCl3): δH = 11.00 (1H, s, OH), 6.67 (1H, d, J = 8.9 Hz, 
H1), 6.63 (1H, d, J = 8.9 Hz, H2), 4.96 (1H, d, J = 15.9 Hz, H3a), 
4.65 (1H, d, J = 15.9 Hz, H3b), 4.05 (1H, ddt, J = 7.8, 5.1, 3.3 Hz, H6), 3.78 (1H, s, OCH3), 
3.76 (1H, s, OCH3), 2.86 (1H, dd, J = 16.9, 1.9 Hz, H4a), 2.77 (2H, dd, J = 15.2, 7.0 Hz, H5a), 
2.70 (2H, dd, J = 15.2, 4.6 Hz, H5b), 2.48 (2H, dd, J = 16.9, 10.9, H4b); 13C NMR (75 MHz): 
δC = 176.2 (C=O), 150.9 (ArCO), 149.4 (ArCO) , 124.4 (ArC), 122.8 (ArC), 107.7 (ArCH), 
107.2 (ArCH), 70.5 (C-6), 64.7 (C-3), 56.6 (OCH3), 55.5 (OCH3), 40.8 (C-5), 28.2 (C-4); 
HRMS (ESI+): Found M+ + H 253.1087, C13H16O5 (M+ + H) requires 253.1077, m/z 253.1087 
(M+ + H, 40%) 236.1021 (15). 
  
7.2.10. Preparation of 6,9-dimethoxy-3,3a,5,9b-tetrahydro-2H-furo[3,2c]isochromen-2-one 
72 
 
In a 50 cm3 RB flask, the 2-(5,8-dimethoxyisochroman-3-yl)acetic acid 71 (0.20 g, 0.80 mmol) 
and KBr (0.11 g, 0.88 mmol, 1.1 equiv.) were suspended in dry CH2Cl2 (8 cm3), to this was 
added p-anisiodine diacetate (0.34 g, 0.96 mmol, 1.2 equiv.) and the resulting reaction mixture 
was allowed to stir at room temperature for 18 hours. Sat. aq. NaHCO3 (5 cm3) was then added 
to the reaction mixture and stirred for an additional 5 minutes. The organic layer was then 
separated and washed sequentially with sat. aq. NaHCO3 (5 cm3) and dilute aq. sodium 
thiosulfate (5 cm3). The organic extracts were combined and dried with anhydrous MgSO4 before 
being filtered through celite and the solvent removed in vacuo. The crude material was purified 
by flash silica gel column chromatography (10% EtOAc/Hexane) to yield the product 72 as a 
white solid (58.5 mg, 29%). 
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Rf = 0.31 (50% EtOAc /Hexane); mp. 173–175°C (lit 162–165°C)42; IR 
(CHCl3): νmax(cm–1): 1767 (C=O), 1605 and 1489 (C=C), 1326 (C-O); 1H 
NMR (300 MHz, CDCl3): δH = 6.84 (1H, d, J = 8.9 Hz, H1), 6.77 (1H, d, 
J = 9.0 Hz, H2), 5.33 (1H, d, J = 2.4 Hz, H4), 4.98 (1H, d, J = 16.1 Hz, H5a), 
4.47 (1H, d, J = 16.1 Hz, H5b), 4.34 (1H, dd, J = 4.7, 2.8 Hz, H3), 3.84 (3H, s, 
OCH3), 3.78 (3H, s, OCH3), 2.91 (1H, dd, J = 17.5, 4.9 Hz, H6a), 2.71 (1H, d, J = 17.5 Hz, H6b); 
13C NMR (75 MHz): δC = 175.2 (C=O), 152.8 (ArCO), 148.9 (ArCO) , 125.2 (ArC), 117.7 
(ArC), 111.2 (ArCH), 109.0 (ArCH), 72.7 (C-5), 71.8 (C-4), 62.6 (C-3), 56.1 (OCH3), 55.7 
(OCH3), 37.6 (C-6). 
 
7.2.11. Preparation of 2-allyl-3,6-dimethoxybenzaldehyde 97 
 
PCC (4.57 g, 21.17 mmol, 2.1 equiv.) was dissolved in MeCN (30 cm3) and adsorbed onto 
neutral Al2O3 (50 g). This solid was then added to a solution of the (2-allyl-3,6-
dimethoxyphenyl)methanol 65 (2.09 g, 10.08 mmol) in dry CH2Cl2 (150 cm3). The reaction 
mixture was allowed to stir at room temperature for 18 hours under argon. Upon completion of 
the reaction, the mixture was filtered through celite and the solvent removed in vacuo. The crude 
material was purified by silica gel column chromatography (20–30% EtOAc/Hexane) to yield the 
product 97 as a clear yellow oil (1.86 g, 90%). 
 
Rf = 0.41 (250% EtOAc /Hexane); IR (CHCl3): νmax(cm–1): 2940 (C-H), 1680 
(C=O) ; 1H NMR (300 MHz, CDCl3): δH = 10.57 (1H, s, CHO), 7.06 (1H, d, 
J = 9.0 Hz,  H1), 6.83 (1H, d, J = 9.0 Hz, H2), 5.97 (1H, ddt, J = 16.2, 10.1, 
6.1 Hz, H4), 4.96 (2H, ddq, J = 9.9, 6.3, 1.7 Hz, H5), 3.85 (3H, s, OCH3), 
3.80 (3H, s, OCH3), 3.78 (2H, dt, J = 6.1, 1.6 Hz, H3); 13C NMR (75 MHz): δC = 192.5 (C=O), 
156.9 (ArCO), 151.7 (ArCO), 136.7 (C-4), 131.5 (ArC), 124.0 (ArC), 117.2 (ArCH), 114.8 (C-
5), 109.8 (ArCH), 56.6 (OCH3), 56.1 (OCH3), 29.4 (C-3); HRMS (ESI+): Found M+ + H 
207.1026, C12H14O3 (M+ + H) requires 207.1022, m/z 207.1026 (M+ + H, 100%) 191.1075 (15), 
189.0923 (72). 
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7.2.12. Preparation of rac-1-(2-allyly-3,6-dimethoxyphenyl)ethanol ±68 
 
Under an argon atmosphere, Mg metal (0.70g, 28.90 mmol, 1.8 equiv.) was placed in an oven 
dried 250 cm3 two-necked RB flask fitted with a condenser and dropping funnel. Dry E2O 
(60 cm3) followed by MeI (3.42g, 1.5 cm3, 24.10 mmol, 1.5 equiv.) was added to the reaction 
flask. The reaction mixture became cloudy with a temperature increase. Once all the Mg metal 
was consumed, the dropping funnel was charged with a solution containing 2-allyl-3,6-
dimethoxybenzaldehyde 97 (3.31g, 16.05 mmol) in dry THF (65 cm3). This solution was added 
dropwise to the newly formed Grignard reagent. The solution was allowed to stir at room 
temperature for 18 hours after which time it was placed in an ice-bath and H2O was added 
dropwise to quench any excess Grignard reagent. The reaction mixture was diluted with EtOAc 
(2 × 100 cm3) and the organic material was washed with brine (100 cm3). The organic extracts 
were combined, dried with anhydrous MgSO4, filtered through celite and the solvent removed 
in vacuo. The crude material was purified by silica gel column chromatography 
(20% EtOAc/Hexane) to yield the product ±68 as a clear oil (2.83 g, 84%). 
 
 Rf = 0.26 (20% EtOAc /Hexane); IR (CHCl3): νmax(cm–1): 3549 (OH); 1H 
NMR (300 MHz, CDCl3): δH = 6.79 (2H, dd, J = 9.0 Hz, H1),  6.74 (2H, dd, 
J = 9.0 Hz, H2), 5.94 (1H, ddt, J = 16.2, 10.2, 5.8 Hz, H6), 5.12-4.88 (3H, m, 
H7 and H4 overlapping), 4.07 (1H, d, J = 11.2 Hz, OH), 3.84 (3H, s, OCH3), 
3.76 (1H, s, OCH3), 3.46 (2H, m, H5), 1.53 (3H, d, J = 6.7 Hz, H3); 13C NMR (75 MHz): δC = 
152.0 (ArCO), 151.9 (ArCO), 136.6 (C-6), 132.7 (ArC), 126.1 (ArC), 115.0 (C-7), 109.5 
(ArCH), 109.4 (ArCH), 67.3 (C-4), 56.2 (OCH3), 55.6 (OCH3), 29.8 (C-5), 23.7 (C-3).  
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7.2.13. Preparation of (E)-methyl-4-(2-(1-hydroxyethyl)-3,6-dimethoxyphenyl)but-2-enoate 
±69 
 
In a 50 cm3 RB flasked fitted with a condenser was added the alkene ±68 (0.90 g, 4.268 mmol) 
and ethyl acrylate (1.07 g, 1.2 cm3, 10.67 mmol, 2.5 equiv.) dissolved in dry CH2Cl2 (20 cm3). 
Grubbs II catalyst (0.18 g, 0.213 mmol, 5 mol%) was then added to this solution and the mixture 
was allowed to stir at 90°C for 18 h under an argon atmosphere. After this time, the mixture was 
cooled to room temperature and the solvent removed in vacuo. The residue was purified by flash 
silica column chromatography (10–20% EtOAc/ Hexane) to yield the product ±69 as a brown oil 
(1.18 g, 94%). 
 
Rf = 0.59 (50% EtOAc /Hexane); IR (CHCl3): νmax(cm–1): 3538 
(OH), 1712 (C=O); 1H NMR (300 MHz, CDCl3): δ 7.05 (1H, dt, 
J = 15.6, 6.0 Hz, H6), 6.77 (2H, 2 x d, J = 9.0 Hz, H1 and H2 
overlapping signals), 5.66 (1H, dt, J = 15.6, 1.8 Hz, H7), 4.95 (1H, 
dq, J = 11.1, 6.7 Hz, H3), 4.13 (2H, q, J = 7.1 Hz, H8), 3.97 (1H, d, J = 10.9 Hz, OH), 3.85 (3H, 
s, OCH3), 3.76 (3H, s, OCH3), 3.60 (2H, ddd, J = 7.7, 6.0, 1.8 Hz, H5), 1.51 (3H, d, J = 6.7 Hz, 
H4), 1.24 (3H, t, J = 7.1 Hz, H9); 13C NMR (126 MHz, CDCl3): δC = 166.66  (C=O), 151.90 
(ArCO), 151.76 (ArCO), 147.03 (C-6), 132.77 (ArC), 124.08 (ArC), 121.62 (C-7), 110.09 
(ArCH), 109.27 (ArCH), 67.26 (C-3), 60.15 (C-8), 56.02 (OCH3), 55.65 (OCH3), 28.50 (C-5), 
23.75 (C-4), 14.24 (C-9); HRMS (ESI+): Found M+ + Na 317.1360, C16H22O5 (M+ + Na) 
requires 317.1367, m/z 317.1360 (M+ + Na, 35%) 312.1810 (18), 277.1437 (100), 203.1070 (72). 
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7.2.14. Preparation of cis and trans ethyl 2-(5,8-dimethoxy-1-methylisochroma-3-yl)acetate 
rac-70 
 
In a 50 cm3 RB flask, the acetate ±69 (6.04 g, 20.51 mmol) was dissolved in dry THF (150 cm3). 
The reaction mixture was cooled to 0°C and sodium hydride (60% in oil, 1.66 g, 41.03 mmol, 
2.0 equiv.) was slowly added to the reaction mixture. The reaction mixture was allowed to warm 
up to room temperature and was stirred for 16 hours under argon. The reaction mixture was 
quenched with H20 and diluted with EtOAc. The organic material was extracted into EtOAc (4 × 
50 cm3) before being washed with brine (20 cm3). The organic extracts were combined, dried 
with anhydrous MgSO4, filtered through celite and the solvent removed in vacuo. The crude 
material was purified by flash silica gel column chromatography (10% EtOAc/Hexane) to yield 
the product rac-70 as a clear oil (5.13 g, 85%). 
 
Rf = 0.76 (50% EtOAc /Hexane); IR (CHCl3): νmax(cm–1): 2937 (C-
H), 1732 (C=O), 1603 and 1437 (C=C), 1254 and 1114 (C-O); 
1H NMR (300 MHz, CDCl3): δH = 6.66 (4H, m, 2 × ArCH, H1 and 
H2), 5.08 (2H, 2 × q, J = 6.6 Hz, 2 x H3), 4.99 (1H, dt, J = 6.3, 
1.5 Hz, H3), 4.44–4.34 (1H, m, H6), 4.25–4.10 (4H, m, 2 × H8), 4.00–3.88 (1H, m, H6), 3.78–
3.76 (12H, m, 2 × (2 × OCH3)), 2.90–2.31 (8H, m, 2 × H5 and 2 × H7), 1.53 (3H, d, J = 1.3 Hz, 
H4), 1.50 (3H, d, J = 1.0 Hz, H4), 1.28 (6H, dt, J = 7.1, 5.8 Hz, 2 × H9); 13C NMR (75 MHz): 
δC = 171.27 (C=O), 171.23 (C=O), 150.86 (ArCO), 150.67 (ArCO), 150.25 (ArCO), 149.44 
(ArCO), 129.22 (ArC), 129.03 (ArC), 124.53 (ArC), 122.71 (ArC), 108.09 (ArCH), 107.73 
(ArCH), 107.55 (ArCH), 107.40 (ArCH), 71.18 (C-6), 69.78 (C-6), 68.50 (C-3), 63.42 (C-3), 
60.52 (C-8), 60.42 (C-8), 55.69 (OCH3), 55.58 (OCH3), 55.43 (OCH3), 55.40 (OCH3), 41.44 (C-
7), 41.21 (C-7), 29.23 (C-5), 28.26 (C-5), 21.63 (C-4), 19.23 (C-4), 14.24 (C-9); HRMS (ESI+): 
Found M+ + H 295.1545, C16H22O5 (M+ + H) requires 295.1505, m/z 295.1545 (M+ + H, 100%) 
293.1384 (40), 251.1282 (85), 205.0858 (25). 
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7.2.15. Preparation of 2-(5,8-dimethoxyisochroman-3-yl)acetic acid rac-98 
 
In a 50cm3 RB flask, the ester rac-70 (0.27 g, 0.91 mmol) was dissolved in dry THF (3 cm3). 
Potassium hydroxide (0.39 g, 6.35 mmol, 7.0 equiv.) was slowly added to the reaction mixture. 
The reaction mixture was allowed stir at room temperature for 2 hours under argon The aqueous 
phase was acidified to pH 2 using 6N HCl which resulted and the organic material extracted into 
EtOAc (4 × 50 cm3). The organic extracts were combined and dried with anhydrous MgSO4, 
filtered through celite and the solvent removed in vacuo to afford the acid rac-98 as a light 
brown oil (0.18 g, 73%). 
 
Rf = 0.64 (50% EtOAc /Hexane); IR (CHCl3): νmax(cm–1): 2974 (OH), 
1703 (C=O), 1603 and 1482 (C=C), 1339 (C-O); 1H NMR (300 MHz, 
CDCl3): δH = 10.42 (2H, s, OH), 6.75–6.55 (4H, m, 2 x H1 and 2 x H2), 
5.12 (1H, q, J = 6.5 Hz, H3), 5.03 (1H, q, J = 6.2 Hz, H3), 4.39 (1H, m, 
H6), 3.94 (1H, dddd, J = 10.7, 7.5, 5.2, 2.1 Hz, H6), 3.81–3.72 (6H, m, OCH3), 2.93–2.34 (8H, m, 
2 × H5 and 2 × H7), 1.53 (6H, dd, J = 6.5, 1.3 Hz, 2 × H4); 13C NMR (75 MHz): δC = 176.10 
(C=O), 175.78 (C=O), 150.85 (ArCO), 150.63 (ArCO), 150.19 (ArCO), 149.38 (ArCO), 128.73 
(ArC), 128.65 (ArC), 124.00 (ArC), 122.25 (ArC), 108.26 (ArCH), 107.91 (ArCH), 107.69 
(ArCH), 107.55 (ArCH), 71.36 (C-6), 69.53 (C-6), 68.74 (C-3), 63.30 (C-3), 55.58 (OCH3), 
55.44 (OCH3), 41.02 (C-7), 40.78 (C-7), 29.10 (C-5), 28.19 (C-5), 21.69 (C-4), 19.24 (C-4); 
HRMS (ESI+): Found M+ + H 267.1223, C14H18O5 (M+ + H) requires 267.1279, m/z 267.1223 
(M+ + H, 45%) 223.0967.1384 (50), 205.0862 (100), 177.0904 (30). 
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7.2.16. Preparation of (3aR, 5R, 9bR)-6,9-dimethoxy-5-methyl-3,3a,5,9b-tetrahydro-2H-
furo[3,2-c]isochromen-2-one rac-75 
 
In a 50 cm3 RB flask, p-anisiodine diacetate (0.80 g, 2.27 mmol, 1.2 equiv.) was added to a 
stirred suspension of the acid rac-98 (0.50g, 1.89 mmol) and KBr (0.23, 1.91 mmol, 1.0 equiv.) 
in dry CH2Cl2 (20 cm3). The reaction mixture was stirred at room temperature for 18 hours. After 
this time, sat. aq. NaHCO3 (10 cm3) was added and the reaction mixture stirred for an additional 
5 minutes. The organic layer was separated and washed sequentially with another portion of sat. 
aq. NaHCO3 (10 cm3) and dilute aq. sodium thiosulfate (10 cm3). The organic extracts were 
combined, dried with anhydrous MgSO4, filtered through celite and the solvent removed 
in vacuo. The crude material was purified by flash silica gel column chromatography 
(10% EtOAc/Hexane) to yield the product rac-75 as a white solid (0.13 g, 26%). 
 
Rf = 0.49 (50% EtOAc /Hexane); mp. 131–133°C; IR (CHCl3): νmax(cm–1): 
1768 (C=O), 1604 and 1487 (C=C), 1321 (C-O); 1H NMR (300 MHz, 
CDCl3): δH = 6.84 (1H, d, J = 8.9 Hz, H1), 6.77 (1H, d, J = 8.9 Hz, H2), 5.34 
(1H, d, J = 2.8 Hz, H5), 5.15 (1H, q, J = 6.7 Hz, H3), 4.69 (1H, dd, J = 4.9, 
2.9 Hz, H6), 3.84 (3H, s, OCH3), 3.79 (3H, s, OCH3), 2.92 (1H, dd, J = 17.5, 
5.0 Hz, H7a), 2.65 (1H, d, J = 17.5 Hz, H7b), 1.47 (3H, d, J = 6.7 Hz, H4); 13C NMR (75 MHz): 
δC = 175.48 (C=O), 152.64 (ArCO), 148.66 (ArCO), 130.13 (ArC), 116.98 (ArC), 111.51 
(ArCH), 109.05 (ArCH), 71.52 (C-5), 67.36 (C-3), 65.99 (C-6), 56.12 (OCH3), 55.70 (OCH3), 
37.69 (C-7), 18.45 (C-4).  
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7.2.17. Preparation of 1-(2-allyl-3,6-dimethoxyphenyl)ethyl acetate ±102 
 
1-(2-allyl-3,6-dimethoxyphenyl)ethanol ±68 dissolved in dry THF (25 cm3) was placed in a 
50 cm3 two necked RB flask fiited with a rubber septum. To this was added 4-
dimethylaminopyridine (DMAP) (0.03 g, 0.24 mmol, 5 mol%) followed by aectic anhydride  
(1.95 g, 1.8 cm3, 18.82 mmol, 4 equiv.) and triethylamine (4.83 g, 6.7 cm3, 47.05 mmol, 
10 equiv.). The reaction mixture was stirred at room temperature for 18 hours. The reaction 
mixture was then quenched with H2O and the organic material extracted with EtOAc (3 × 
50 cm3). The organic extracts were combined, dried with anhydrous MgSO4, filtered through 
celite and the solvent removed in vacuo. The residue was purified by flash silica gel column 
chromatography (10% EtOAc/Hexane) to yield the product ±102 as a clear oil (0.89 g, 75%). 
 
Rf = 0.59 (50% EtOAc /Hexane); IR (CHCl3): νmax(cm–1): 2938 and 2836 
(C–H stretch), 1732 (C=O), 1597 and 1478 (C=C), 1239 (C–O); 1H NMR 
(300 MHz, CDCl3): δH = 6.81–6.71 (2H, m, H1 and H2 overlapping), 6.39 
(1H, q, J = 6.8 Hz, H4), 5.97 (1H, ddt, J = 17.1, 10.3, 5.6 Hz, H6), 4.92 (2H, 
ddq, J = 33.5, 17.2, 1.8 Hz, H7), 3.81 (3H, s, OCH3), 3.76 (3H, s, OCH3), 3.65 (2H, ddd, J = 7.5, 
4.3, 1.7 Hz, H5), 2.02 (3H, s, H8), 1.56 (3H, d, J = 6.8 Hz, H3); 13C NMR (75 MHz): δC = 170.57 
(C=O), 152.28 (ArCO), 151.95 (ArCO), 137.41 (C-6), 129.37, 128.21, 114.46 (C-7), 110.62 
(ArCH), 110.33 (ArCH), 67.53 (C-3), 56.49, 30.93, 30.54, 21.52 (C-3), 20.18. 
 
7.2.18. Preparation of (E)-1-(3,6-dimethoxy-2-(prop-1-en-yl)phenyl)ethanol ±104 
 
A 50 cm3 RB flask, potassium tert-butoxide (1.38 g, 12.05 mmol, 4 equiv.) was added to a clear 
solution of  1-(2-allyl-3,6-dimethoxyphenyl)ethanol ±68 (0.63 g, 3.012 mmnol) dry THF   (20 
cm3). The resulting reaction mixture was allowed to stir at room temperature for 2 h, under 
argon. The mixture was poured into sat. aq. ammonium chloride (20 cm3) and the organic 
material extracted into EtOAc (4 × 50 cm3). The organic extracts were combined, dried over 
MgSO4 and filtered through celite. The solvent was removed in vacuo and the residue purified by 
flash silica gel column chromatography (10% EtOAc/Hexane) to yield the product ±104 as a 
clear oil (0.89 g, 75%). 
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Rf = 0.20 (20% EtOAc /Hexane); IR (CHCl3): νmax(cm–1): 3535 (OH), 2962 
and 2836 (C-H), 1598 and 1447  and 927 (C=C), 1366 (C-O); 1H NMR (300 
MHz, CDCl3): δH = 6.73 (2H, q, J = 9.0 Hz, H1 and H2 overlapping), 6.35 
(1H, dd, J = 16.1, 1.7 Hz, H5), 5.74 (1H, dq, J = 16.0, 6.5 Hz, H6), 5.16 (1H, 
dq, J = 13.4, 6.7 Hz, H4), 3.96 (1H, d, J = 11.6 Hz, OH), 3.86 (3H, s, OCH3), 3.76 (3H, s, 
OCH3), 1.91 (3H, dd, J = 6.5, 1.7 Hz, H7), 1.55 (3H, d, J = 6.7 Hz, H3); 13C NMR (75 MHz): δC 
= 151.91 (ArCO), 151.70 (ArCO), 131.97 (C-6), 127.22 (ArC), 124.32 (C-5), 109.59 (ArCH), 
109.10 (ArCH), 67.60 (C-4), 56.08 (OCH3), 55.60 (OCH3), 23.84 (C-3), 19.07 (C-7).  
 
7.2.19. Preparation of (E)-1-(3,6-dimethoxy-2-(prop-1-en-yl)phenyl)ethyl acetate ±103 
 
In a 25 cm3 RB flask was added (E)-1-(3,6-dimethoxy-2-(prop-1-en-yl)phenyl)ethanol ±104 
(0.35 g, 1.56 mmol) followed by pyridine (0.31 g, 0.35 cm3, 3.94 mmol, 2.5 equiv.) and acetic 
anhydride ( 0.40 g, 0.37 cm3, 3.94 mmol, 2.5 equiv.). the reaction was allowed to stir at room 
temperature for 18 h. After this time, H2O (50 cm3) was added to quench the reaction and the 
organic material extracted into EtOAc (3 × 50 cm3). The organic extracts were combined and 
washed with brine (50 cm3) before being dried over MgSO4, filtered through celite and the 
solvent removed in vacuo. The resulting residue was purified by flash silica gel column 
chromatography (10% EtOAc/Hexane) to yield the product ±103 as a clear oil (0.28 g, 68%). 
 
Rf = 0.31 (20% EtOAc /Hexane); IR (CHCl3): νmax(cm–1): IR (CHCl3): 
νmax(cm–1): 2938 and 2837 (C–H stretch), 1727 (C=O), 1594 and 1478 
(C=C), 1241 (C–O); 1H NMR (300 MHz, CDCl3): δH = 6.76 (2H, s, H1 and 
H2 overlapping), 6.53 (1H, dd, J = 16.0, 1.7 Hz, H5), 6.36 (1H, q, J = 6.8 
Hz, H4), 5.86 (2H, dq, J = 16.0, 6.5 Hz, H6), , 3.86 (3H, s, OCH3), 3.76 (3H, s, OCH3), 2.01 (3H, 
s, H8), 1.93 (3H, dd, J = 6.5, 1.7 Hz, H7), 1.60 (3H, d, J = 6.8 Hz, H3); 13C NMR (75 MHz): δC = 
170.40 (C=O), 152.35 (ArCO), 151.63 (ArCO), 131.66 (C-6), 128.45 (ArC), 128.37 (ArC), 
124.64 (C-5), 110.90 (ArCH), 110.82 (ArCH), 68.45 (C-4), 56.59 (OCH3), 56.15 (OCH3), 21.33 
(C-8), 19.66 (C-3), 19.27 (C-7). 
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7.2.20. Preparation of 1-(2,5-dimethoxyphenyl)ethanol ±106 
 
In a 250 cm3 RB flask, 2,5-dimethoxyphenylacetophenone 105 (5.70 g 5.0 cm3, 31.60 mmnol) 
was dissolved in dry THF (100 cm3). The solution was cooled to 0°C and lithium aluminium 
hydride (2.97 g, 78.20 mmol, 2.5 equiv.) was slowly added. The reaction mixture was stirred at 
40°C for 2 h, under argon. After completion, the reaction was cooled to 0°C before the slow 
addition of aq. NaOH solution (2M, 20 cm3). The aqueous layer was extracted with diethyl ether 
(4 × 40cm3) and dichloromethane (4 × 40cm3). The organic extracts were combined, dried over 
MgSO4 and filtered through celite. The solvent was removed in vacuo. The residue was purified 
by silica gel column chromatography (10% EtOAc/Hexane) to yield the product ±106 as an 
orange oil (5.99 g, 99%). 
 
Rf = 0.14 (20% EtOAc /Hexane); IR (CHCl3): νmax(cm–1): 3410 (OH), 2967 and 
2834 (C–H), 1592 and 1493 (C=C), 1242 (C-O); 1H NMR (300 MHz, CDCl3): 
δH = 6.94 (1H, d, J = 2.8 Hz, H3), 6.81–6.70 (2H, m, H1 and H3 overlapping), 
5.05 (1H, d, J = 6.5 Hz, H4), 3.79 (3H, s, OCH3), 3.76 (3H, s, OCH3), 3.01 (1H, 
s, OH), 1.46 (3H, d, J = 6.5 Hz, H5); 13C NMR (126 MHz): δC = 153.81 (ArCO), 150.62 
(ArCO), 134.84 (ArC), 112.43 (ArCH), 112.31 (ArCH), 111.44 (ArCH), 67.28 (C-4), 65.99 (C-
6), 55.79 (OCH3), 55.71 (OCH3), 23.06 (C-5).  
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7.2.21. Preparation of 1-(2,5-dimethoxyphenyl)ethyl acetate ±99 
 
In a 25 cm3 RB flask, 1-(2,5-dimethoxyphenyl)ethanol ±106 (2.05 g, 11.23 mmol) was dissolved 
in dry THF (100 cm3). To this stirred solution was added a catalytic amount of 4-
dimethylaminopyridine (DMAP) (0.14 g, 1.12 mmol, 10 molar %), followed by acetic anhydride 
(4.58 g, 4.30 cm3, 44.97 mmol, 4 equiv.) and triethylamine (11.35 g, 15.7 cm3, 112.25 mmol, 
10 equiv.). The reaction mixture was allowed to stir at room temperature for 2 h, under argon. 
The mixture was then quenched with distilled H2O (30 cm3) and the organic material extracted 
into EtOAc (4 × 50 cm3). The organic extracts were combined and dried over MgSO4 before 
being filtered through celite. The solvent was removed in vacuo and the residue purified by flash 
silica gel column chromatography (20% EtOAc/Hexane) to yield the product ±99 as a clear oil 
(2.46 g, 98%). 
 
Rf = 0.40 (20% EtOAc /Hexane); IR (CHCl3): νmax(cm–1): 2937 and 2836 
(C–H stretch), 1736 (C=O), 1592 and 1498 (C=C), 1234 (C–O); 1H NMR 
(300 MHz, CDCl3): δH = 6.94 (1H, d, J = 2.7 Hz, H3), 6.83–6.71 (2H, m, 
H1 and H5 overlapping), 6.20 (1H, d, J = 6.5 Hz, H4), 3.79 (3H, s, OCH3), 
3.77 (3H, s, OCH3), 2.09 (3H, s, H6), 1.46 (3H, d, J = 6.5 Hz, H5); 13C NMR (75 MHz): δC = 
170.07 (C=O), 153.72 (ArCO), 150.17 (ArCO), 131.75 (ArC), 112.42 (ArCH), 112.36 (ArCH), 
111.64 (ArCH) 67.14 (C-4), 56.03 (OCH3), 55.67 (OCH3), 21.30 (C-6), 21.25 (C-5).  
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7.2.22. General procedure for the kinetic resolution of racemic alcohols using CALB 
 
 
 
To a stirred solution of racemic alcohol ±99 in toluene (5 cm3/200 mg) was added a buffer 
solution of tris(hydroxymethyl)amino methane (0.1 M, pH 7.5, 40 cm3/200 mg). to this reaction 
mixture was added the lipase enzyme CALB (100 µl/200 mg) and the reaction was allowed to 
stir at 30°C. Completion of the reaction was determined by HPLC on a C18 column (70% 
acetonitrile/water) which showed a 50% conversion of the racemic acetate to the alcohol. The 
organic material was extracted into EtOAc (4 × 50 cm3). The organic extracts were combined 
and dried with anhydrous MgSO4, filtered through celite and the solvent removed in vacuo. The 
crude material was purified silica gel chromatography (10% EtOAc/Hexane) to give the 
unreacted acetate (0.42 g, 56%) and enantioselectively hydroylsed alcohol (0.26 g, 43%). The 
enantiomeric excess for each product was determined by HPLC analysis on a Chiralcel OD 
colum (200 × 46 mm) using 7.5% isopropyl alcohol in hexane as the mobile phase. Both 
products were analysed spectroscopically and characterized as described above.  
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7.3. Experimental procedures pertaining to Chapter 4 
 
7.3.1. Preparation nitroalkene via a Henry reaction 
 
Method A 
In a 100cm3 RB flask equipped with a reflux condenser, aldehyde (33.90 mmol) and ammonium 
acetate (3 equiv.) was added to glacial acetic acid (60cm3). Nitromethane (1.7 equiv.) was then 
added to the reaction, and the reaction mixture stirred at reflux for 6 hours under argon during 
which time it became a deep red solution. The reaction was then cooled and diluted with EtOAc 
before being transferred to a separating funnel. The organic layer was then washed with water (3 
× 100cm3), dried over anhydrous MgSO4, filtered through celite and the solvent removed in 
vacuo. The resulting residue was the recrystallized from diethyl ether-hexane to afford the nitro 
compounds as bright yellow solids. 
 
Method B 
In a 100cm3 RB flask equipped with a dean stark trap and reflux condenser, aldehyde 
(39.28 mmol) and ammonium acetate (3 equiv.) was added to dry toluene (65cm3). 
Nitrocompound (1.7 equiv.) was then added to the reaction, and the reaction mixture stirred at 
reflux for 6 hours under argon during which time it became a deep red solution.  The reaction 
was then cooled and diluted with EtOAc before being transferred to a separating funnel. The 
organic layer was then washed with water (3 × 100cm3), dried over anhydrous MgSO4, filtered 
through celite and the solvent removed in vacuo. The resulting residue was the recrystallized 
from diethyl ether-hexane to afford the nitro compounds as bright yellow solids. 
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7.3.1.1. Preparation of (E)-5-(2-nitrovinyl)benzo[d][1,3]dioxole 189 
 
Method A: Yellow solid (2.81g, 43%); Rf = 0.45 (20% EtOAc 
/Hexane); mp. 161–162°C, (lit 164–165°C)92; IR (CHCl3): νmax(cm–1): 
3118 and 2919 (C–H), 1602, 1487 and 965 (C=C), 1500 and 1368 
(NO2), 1240 (C–O); 1H NMR (500 MHz, CDCl3): δH = 7.92 (1H, d, J = 13.6 Hz, H5), 7.47 (1H, 
d, J = 13.6 Hz, H4), 7.08 (1H, dd, J = 8.0, 1.4 Hz, H2), 7.00 (1H, d, J = 1.5 Hz, H1), 6.87 (1H, d, 
J = 8.0 Hz, H3), 6.06 (2H, s, H6); 13C NMR (126MHz) δC = 151.40 (ArCO), 148.80 (ArCO), 
139.08 (C-4) , 135.44 (C-5), 126.61 (ArC), 124.23 (C-2), 109.09 (C-3), 107.03 (C-1), 102.07 (C-
6). 
 
7.3.1.2.  Preparation of (E)-1-methoxy-4-(2-nitrovinyl)benzene 190 
 
Method A:Yellow solid (3.77g, 51%); Rf = 0.39 (20% EtOAc 
/Hexane); mp. 86–88°C, (lit 46–48°C)93; IR (CHCl3): νmax(cm–1): 3017 
(C–H), 1601 and 1493 (C=C), 1571 and 1324 (NO2), 1248 (C–O); 1H 
NMR (500 MHz, CDCl3): δH = 7.97 (1H, d, J = 13.6 Hz, H4), 7.51 (3H, dd, J = 11.1, 7.3 Hz, H5, 
H2 and H2’ overlapping), 6.95 (2H, d, J = 8.8 Hz, H1 and H1’), 3.87 (3H, s, OCH3); 13C NMR 
(126MHz) δC = 162.99 (ArCO), 139.03 (C-3), 135.07 (C-4) , 131.18 (C-2 and C-2’), 122.58 
(ArC), 114.96 (C-1 and C-1’), 55.54 (C-5). 
 
7.3.1.3. Preparation of (E)-1-isopropoxy-2-methoxy-4-(2-nitrovinyl)benzene 191  
 
Method A: Yellow solid (4.19g, 44%); Rf = 0.45 (20% EtOAc 
/Hexane); mp. 84–86, (lit 82–83)144; IR (CHCl3): νmax(cm–1): 3120 and 
2977 (C–H), 1624 and 1489 (C=C), 1596 and 1330 (NO2), 1259 (C–
O); 1H NMR (500 MHz, CDCl3): δH = 7.96 (1H, d, J = 13.5 Hz, H5), 
7.52 (1H, d, J = 13.5 Hz, H4), 7.14 (1H, dd, J = 8.3, 1.9 Hz, H2), 7.01 (1H, d, J = 1.8 Hz, H1), 
6.91 (1H, d, J = 8.4 Hz, H3), 4.65 (1H, sept, J = 6.1 Hz, H7), 3.90 (3H, s, OCH3), 1.41 (6H, d, J 
= 6.1 Hz, H8); 13C NMR (126MHz) δC = 151.49 (ArCO), 150.48 (ArCO), 139.41 (C-4) , 135.05 
(C-2), 124.45 (C-5), 122.56 (ArC), 111.12 (C-1), 71.45 (C-7), 56.12 (C-6), 21.93 (C-8). 
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7.3.2. Preparation of nitroalkane compounds 
 
In a 250cm3 RB flask, nitroalkene (14.55 mmol) was dissolved in dry chloroform (160 cm3) and 
dry isopropanol (30 cm3). To this solution was added silica gel (20 g) followed by the addition of 
sodium borohydride (2 equiv.). The reaction mixture was then stirred for 2 hours under argon at 
room temperature. Upon completion, as monitored by TLC, the reaction mixture was filtered 
through celite aand washed with EtOAc (100 cm3). The organic phase was then washed with 
water (2 × 100cm3) followed by brine (100cm3), dried over anhydrous MgSO4, filtered through 
celite and the solvent removed in vacuo. The resulting residue was the purified by flash column 
chromatography (10% EtOAc/Hexane) to afford the pale yellow nitroalkane compounds. 
 
7.3.2.1. Preparation of 5-(2-nitroethyl)benzo[d][1,3]dioxole 195 
 
Yellow soild (2.02 g, 71%); Rf = 0.41 (20% EtOAc /Hexane); mp. 55–
57, (lit 43.5-44.5)94; IR (CHCl3): νmax(cm–1): 2897 (C–H), 1609 and 
1499 (C=C), 1543 and 1362 (NO2), 1243 (C–O); 1H NMR (500 MHz, 
CDCl3): δH = 6.74 (1H, d, J = 7.9 Hz, H3), 6.68–6.62 (2H, m, H1 and H2 overlapping), 5.92 (2H, 
s, H6), 4.55 (2H, t, J = 7.3 Hz, H5), 3.21 (2H, t, J = 7.3 Hz, H4); 13C NMR (126 MHz): δC 148.05 
(ArCO), 146.93 (ArCO), 129.29 (ArC) , 121.73 (C-3), 108.91 (C-1), 108.62 (C-6), 101.15 (C-5), 
33.20 (C-4). 
 
7.3.2.2. Preparation of 1-methoxy-4-(2-nitroethyl)benzene 196 
 
Yellow oil (2.96 g, 76%); Rf = 0.48 (20% EtOAc /Hexane); IR 
(CHCl3): νmax(cm–1): 2937 and 2837 (C–H), 1612 and 1512 (C=C), 
1546 and 1342 (NO2), 1245 (C–O); 1H NMR (500 MHz, CDCl3): δH = 
7.11 (2H, d, J = 8.6 Hz, H2 and H2’), 6.85 (2H, d, J = 8.6 Hz, H1 and H1’), 4.55 (2H, t, J = 7.4 
Hz, H4), 3.78 (3H, s, OCH3), 3.24 (2H, t, J = 7.4 Hz, H3); 13C NMR (126 MHz) δC = 158.92 
(ArCO), 129.63 (C-2 and C-2’), 127.62 (ArC), 114.36 (C-1 and C-1’) , 76.59 (C-4), 55.26 
(OCH3), 32.69 (C-3). 
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7.3.2.3. Preparation of 1-isopropoxy-2-methoxy-4-(2-nitroethyl)benzene 197 
 
Yellow oil (3.03g, 72%); Rf = 0.35 (20% EtOAc /Hexane); IR 
(CHCl3): νmax(cm–1): 2976 and 2935 (C–H), 1588 and 1510 (C=C), 
1548 and 1376 (NO2), 1231 (C–O); 1H NMR (500 MHz, CDCl3): δH = 
6.85–6.82 (1H, m, H3), 6.72-6.69 (2H, m, H1, H2 overlapping), 4.58 
(2H, t, J = 7.4 Hz, H5), 4.48 (1H, hept, J = 6.1 Hz, H7), 3.84 (3H, s, OCH3), 3.25 (2H, t, J = 7.4 
Hz, H4), 1.35 (6H, d, J = 6.1 Hz, H8); 13C NMR (126 MHz) δC = 150.67 (ArCO), 146.69 
(ArCO), 128.53 (ArC), 120.66 (C-2), 116.22 (C-3) , 112.55 (C-1), 76.53 (C-5), 71.56 (C-7), 
56.01 (OCH3), 33.18 (C-4), 22.09 (C-8). 
 
7.3.3. Preparation of (Z)-5-(3-(2,4-dimethoxyphenyl)-2-nitroallyl)benzo[d][1,3]dioxole 199 
 
Method B: Yellow solid (2.02 g, 71%); Rf = 0.25 (50% 
CH2Cl2 /Hexane); mp. 80–82; IR (CHCl3): νmax(cm-1): 2902 
and 2838 (C–H), 1601, 1490 and 696 (C=C), 1574 and 1317 
(NO2), 1258 (C–O); 1H NMR (500 MHz, CDCl3): δH = 8.52 
(1H, s, H1), 7.25 (2H, d, J = 7.8 Hz, ArH), 6.78-6.59 (3H, m, ArH), 6.52-6.39 (2H, m, ArH), 5.93 
(2H, s, H6), 4.14 (2H, s, H2), 3.88 (3H, s, OCH3), 3.83 (3H, s, OCH3); 13C NMR (126 MHz): δC 
163.36 (ArCO), 160.09 (ArCO), 148.10 (ArCO), 147.46 (ArCO), 146.44 (C-NO2), 131.38 (C-1), 
130.51 (ArCH), 130.47 (ArC), 120.42 (ArCH), 113.92 (ArC), 108.55 (ArCH), 108.25 (ArCH), 
105.24 (ArCH), 101.04 (C-6), 98.50 (ArCH), 55.71 (OCH3), 55.53 (OCH3), 32.93 (C-2); HRMS 
(ESI+): Found M+ + H 344.1129, C18H17NO6 (M+ + H) requires 344.1179, m/z 344.1129 (M+ + 
H, 35%), 297.1132 (85), 233.0061 (75), 206.0470 (100), 191.5347 (95). 
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7.3.4. Preparation of (Z)-2,4-dimethoxy-1-(3-(4-methoxyphenyl)-2-nitroprop-1-en-1-
yl)benzene 200 
 
Method B: Yellow solid (3.45 g, 87%); Rf = 0.39 (30% EtOAc 
/Hexane); mp. 78–79; IR (CHCl3): νmax(cm–1): 3020 and 2950 
(C–H), 1605 and 1499 (C=C), 1570 and 1297 (NO2), 1247 (C–
O); 1H NMR (500 MHz, CDCl3): δH = 8.52 (1H, s, H1), 7.27-
7.23 (1H, m, H5), 7.12 (2H, d, J = 8.3 Hz, H3), 6.85 (2H, d, J = 8.5 Hz, H4), 6.49 (1H, d, J = 2.2 
Hz, H7),  6.44 (1H, dd, J = 8.7, 2.2 Hz, H6), 4.16 (2H, s, H2), 3.87 (3H, s, OCH3), 3.82 (2H, s, 
OCH3), 3.78 (3H, s, OCH3); 13C NMR (126 MHz) δC = 163.29 (ArCO), 160.06 (ArCO), 158.45 
(ArCO), 147.75 (C-NO2), 131.11 (C-1), 130.48 (C-5), 128.60 (ArC), 128.60 (C-3), 114.29 
(ArC), 114.02 (C-4), 105.20 (C-6), 98.47 (C-7), 55.70 (OCH3), 55.52 (OCH3),  55.28 (OCH3), 
32.43 (C-2); HRMS (ESI+): Found M+ + H 330.1346, C18H19NO5 (M+ + H) requires 330.1379, 
m/z 330.1346 (M+ + H, 100%) 
 
7.3.5. Preparation of (Z)-2,4-dimethoxy-1-(3-(4-methoxyphenyl)-2-nitroprop-1-en-1-
yl)benzene 201 
 
Method B: Yellow oil (4.24 g, 72%); Rf = 0.35 (CH2Cl2); IR 
(CHCl3): νmax(cm–1): 2974 (C–H), 1604, 1502 and 827 (C=C), 
1553 and 1294 (NO2), 1232 (C–O); 1H NMR (300 MHz, 
CDCl3): δH = 8.54 (1H, s, H1), 7.27 (1H, d, J = 7.7 Hz, ArH), 
6.87–6.64 (3H, m, ArH), 6.45 (2H, ddd, J = 8.0, 6.8, 2.5 Hz, 
ArH), 4.54–4.40 (1H, m, H6), 4.17 (2H, s, H2), 3.87 (3H, s, OCH3), 3.82 (3H, s, OCH3), 3.81 
(3H, s, OCH3), 1.35 (6H, d, J = 6.1 Hz, H7); 13C NMR (75 MHz): δC = 163.33 (ArCO), 160.05 
(ArCO), 150.68 (ArCO), 147.62 (ArCO), 146.19 (C-NO2), 131.26 (C-1), 130.53 (ArCH), 129.69 
(ArC), 119.32 (ArCH), 116.20 (ArCH), 114.00 (ArC), 111.81 (ArCH), 105.22 (ArCH), 98.45 
(ArCH), 71.51 (C-6), 55.96 (OCH3), 55.69 (OCH3), 55.52 (OCH3), 32.81 (C-2), 22.13 (C-7). 
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7.3.6. Novel Nef reaction experimental conditions 
 
In a 100cm3 RB flask, nitroalkene (3.000 mmol) was dissolved in 96% ethanol (65 cm3). To this 
solution was added cyclohexene (1.2 equiv.). Palladium hydroxide on carbon (10 mol %), and 
one drop of conc. HCl. The reaction mixture was exposed to a hydrogen atmosphere (1atm) 
using a balloon. Upon completion, as monitored by TLC, the reaction mixture was filtered 
through celite and washed with EtOAc (100 cm3). The organic phase was dried over anhydrous 
MgSO4, filtered through celite. The solvent was removed in vacuo and flash column 
chromatography with a 10% EtOAc/Hexane solution afforded three products, oximes, carbonyl 
compounds and the reduced nitroalkane compounds. 
 
7.3.6.1. Preparation of 1-(benzo[d][1,3]dioxol-5-yl)-3-(2,4-dimethoxyphenyl)propan-
2-one 204 
 
Yellow oil (0.27 g, 29%); Rf = 0.39 (30% EtOAc /Hexane); 
IR (CHCl3): νmax(cm-1): 2901 (C–H), 1715 C=O), 1612 and 
1488 (C=C), 1244 (C–O); 1H NMR (500 MHz, CDCl3): δH = 
6.98 (1H, d, J = 8.7 Hz, H8), 6.74 (1H, d, J = 7.9 Hz, H5), 
6.64-6.56 (2H, m, H3 and H4), 6.44 (2H, dd, J = 7.2, 1.7 Hz, H7 and H9), 5.93 (2H, s, H6), 3.80 
(3H, s, OCH3), 3.76 (2H, s, OCH3), 3.61 (2H, s, H1), 3.59 (2H, s, H2); 13C NMR (126MHz) δC = 
206.71 (C=O), 160.30 (ArCO), 158.25 (ArCO), 147.72 (ArCO), 146.49 (ArCO), 131.50 (C-7), 
128.13 (ArC), 122.61 (ArCH), 115.76 (ArC), 109.94 (ArCH), 108.28 (C-5), 104.30 (ArCH), 
100.95 (C-6), 98.65 (ArCH), 55.39 (OCH3),  55.32 (OCH3), 48.33 (C-2), 43.30 (C-1); HRMS 
(ESI+): Found M+ + H 315.1232, C18H18O5 (M+ + H) requires 315.1279, m/z 315.1232 (M+ + H, 
100%), 297.1136 (15). 
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7.3.6.2. Preparation of 1-(benzo[d][1,3]dioxol-5-yl)-3-(2,4-dimethoxyphenyl)propan-
2-one oxime 203 
 
Yellow oil (0.36 g, 37%); Rf = 0.25 (30% EtOAc /Hexane); 
IR (CHCl3): νmax(cm-1): 3220 (OH), 2999 and 2934 (C–H), 
1610 (C=N), 1587 and 1462 (C=C), 1244 (C–O); 1H NMR 
(500 MHz, CDCl3): δH = 9.47 (2H, s, N-OH), 7.02 (2H, d, J = 
8.7 Hz, 2 × H7), 6.65 (6H, m, 2 × (H3, H4 and H5)), 6.44–6.36 (4H, m, 2 × (H8 and H9)), 5.89 
(4H, s, 2 × H6), 3.76 (12H, m, 4 × OCH3), 3.60 (2H, s, 2 × H1), 3.55 (2H, s, 2 × H1), 3.41 (2H, s, 
2 × H2), 3.32 (2H, s, 2 × H2); 13C NMR (126 MHz, CDCl3): δ = 159.93 and 159.72 (ArCO), 
159.60 and 158.93 (ArCO), 158.42 and 158.31 (C=N), 147.58 and 147.52 (ArCO), 146.17 and 
145.97 (ArCO), 131.31 and 131.08 (C-7), 130.73 and 130.49 (ArC), 122.22 and 122.18 (ArCH), 
117.38 and 117.03 (ArC), 109.84 and 109.61 (ArCH), 108.04 and 108.01 (ArCH), 104.28 and 
104.20 (ArCH), 100.80 and 100.78 (C-6), 98.56 and 98.34 (ArCH), 55.35 and 55.34 (OCH3), 
55.24 and 55.20 (OCH3), 39.36 and 33.00 (C-2), 32.52 and 26.50 (C-1). 
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7.3.7. Preparation of 5-(3-(2,4-dimethoxyphenyl)2-nitropropyl)benzo[d][1,3]dioxole 202 
 
Yellow solid (0.05 g, 5%); Rf = 0.61 (30% EtOAc /Hexane); 
mp. 59–61, (lit 43.5-44.5); IR (CHCl3): νmax(cm-1): 2997 and 
2929 (C–H), 1610 and 1503 (C=C), 1591 and 1288 (NO2), 
1245 (C–O); 1H NMR (300 MHz, CDCl3): δH = 6.95 (1H, d, 
J = 8.2 Hz, H7), 6.74–6.51 (3H, m, ArH), 6.45–6.29 (2H, m, ArH), 5.90 (2H, s, -OCH2O-), 5.03–
4.87 (1H, m, H10), 3.78 (3H, s, OCH3), 3.76 (3H, s, OCH3), 3.24–2.86 (4H, m, H1 and H2 
overlapping).; 13C NMR (75 MHz) δC = 160.51 (ArCO), 158.33 (ArCO), 147.85 (ArCO), 146.79 
(ArCO), 131.24 (ArCH), 129.49(ArC), 122.03 (ArCH), 116.11(ArC), 109.13 (ArCH), 108.43 
(ArCH), 104.03 (ArCH), 101.03 (C-6), 98.65 (ArCH), 89.73 (C-10), 55.33 (OCH3), 55.32 
(OCH3), 39.47 (C-2)*, 34.67(C-1)*; HRMS (ESI+): Found M+ + H 346.1296, C18H19NO6 (M+ + 
H) requires 346.1279, m/z 346.1296 (M+ + H, 100%), 299.1307 (15). 
 
7.3.8. Preparation of 1-(2,4-dimethoxyphenyl)-3-(4-dimethoxyphenyl)propan-2-one 205 
 
Yellow oil (0.22 g, 24%); Rf = 0.41 (30% EtOAc /Hexane); IR 
(CHCl3): νmax(cm-1): 2936 and 2836 (C–H), 1716 C=O), 1612 
and 1463 (C=C), 1246 (C–O); 1H NMR (300 MHz, CDCl3): δH 
= 7.06 (2H, d, J = 8.7 Hz, H3), 7.00–6.92 (1H, m, ArH), 6.83 
(2H, d, J = 8.7 Hz, H4), 6.47–6.39 (2H, m, ArH), 3.78 (3H, s, OCH3), 3.77 (3H, s, OCH3), 3.72 
(3H, s, OCH3), 3.62 (2H, s, H1), 3.60 (2H, s, H2); 13C NMR (75 MHz): δC = 206.97 (C=O), 
160.26 (ArCO), 158.53 (ArCO), 158.28 (ArCO), 131.52 (C-3), 130.52 (ArCH), 126.59 (ArC), 
115.87 (ArC), 113.96 (C-4), 104.28 (ArCH), 98.60 (ArCH), 55.39 (OCH3), 55.27 (OCH3), 55.22 
(OCH3), 47.92 (C-2), 43.27 (C-1); HRMS (ESI+): Found M+ + H 301.1443, C18H20O4 (M+ + H) 
requires 301.1479, m/z 301.1443(M+ + H, 100%). 
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7.3.9. Preparation of 1-(2,4-dimethoxyphenyl)-3-(4-dimethoxyphenyl)propan-2-one oxime 
206 
 
Yellow oil (0.24 g, 25%); Rf = 0.28 (30% EtOAc /Hexane); IR 
(CHCl3): νmax(cm-1): 3226 (OH), 2999 and 2934 (C–H), 1610 
(C=N), 1587 and 1462 (C=C), 1244 (C–O); 1H NMR (300 
MHz, CDCl3): δH = 9.17 (2H, s, N-OH), 7.13 (2H, d, J = 8.7 
Hz, ArH), 7.06–6.94 (4H, m, ArH), 6.86–6.71 (4H, m, ArH), 6.42 (4H, dd, J = 4.1, 2.0 Hz, 
ArH), 3.77 (18H, m, 6 × OCH3), 3.73 (2H, s, 2 × H1), 3.59 (2H, s, 2 × H1), 3.40 (2H, s, 2 × H2), 
3.35 (2H, s, 2 × H2); 13C NMR (75 MHz) δC = 159.90 and 159.81 (ArCO), 159.70 and 159.25 
(ArCO), 158.46 and 158.35 (ArCO), 158.30 and 158.12 (C=N), 131.31 and 131.09 (ArCH), 
130.27 and 130.16 (ArCH), 129.07 and 128.86 (ArC), 117.49 and 117.09 (ArC), 113.79 and 
113.73 (ArCH), 104.21 and 104.15 (ArCH), 98.55 and 98.33 (ArCH), 55.35, 55.28 and 55.24 
(OCH3), 38.85 and 33.04 (C-2), 32.03 and 26.54 (C-1); HRMS (ESI+): Found M+ + H 316.1555, 
C18H21NO4 (M+ + H) requires 316.1579, m/z 316.1555(M+ + H, 100%). 
 
7.3.10. Preparation of 2,4-dimethoxy-1-(3-(4-methoxyphenyl)-2-nitropropyl)benzene 207 
 
Yellow solid (0.48 g, 47%); Rf = 0.50 (30% EtOAc /Hexane); 
mp. 75–77, (lit 43.5-44.5); IR (CHCl3): νmax(cm-1): 2934 and 
2836 (C–H), 1613 and 1505 (C=C), 1585 and 1284 (NO2), 
1247 (C–O); 1H NMR (300 MHz, CDCl3): δH 7.06 (2H, d, J = 
8.6 Hz, H3), 6.96 (1H, d, J = 8.2 Hz, H5), 6.82 (2H, d, J = 8.6 Hz, H4), 6.45–6.34 (2H, m, H6 and 
H7 overlapping), 5.03–4.91 (1H, m, H8), 3.78 (3H, s, OCH3), 3.77 (3H, s, OCH3), 3.76 (3H, s, 
OCH3), 3.26–2.95 (4H, m, H1 and H2 overlapping); 13C NMR (75 MHz): δC = 160.49 (ArCO), 
158.81 (ArCO), 158.36 (ArCO), 131.26 (ArC), 129.89 (C-5), 127.87(C-3) , 116.25 (ArC), 
114.13 (C-4), 104.15 (C-6), 98.65 (C-7), 89.80 (C-8), 55.33 (OCH3), 55.26 (OCH3), 55.21 
(OCH3), 39.01 (C-1), 34.65 (C-1); HRMS (ESI+): Found M+ + H 332.1506, C18H21NO5 (M+ + 
H) requires 332.1479, m/z 332.1506 (M+ + H, 35%), 285.1495 (25), 151.0764 (100). 
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7.3.11. Preparation of 1-(2,4-dimethoxyphenyl)-3-(4-isopropoxy-3-methoxyphenyl)propan-
2-one 208 
 
Yellow solid (0.31 g, 30%); Rf = 0.29 (30% EtOAc /Hexane); 
mp. 67–69, (lit 43.5-44.5); IR (CHCl3): νmax(cm-1): 2974 and 
2936 (C–H), 1714 (C=O), 1612 and 1464 (C=C), 1259 (C–O); 
1H NMR (500 MHz, CDCl3): δH = 6.96 (1H, d, J = 8.9 Hz, 
ArH), 6.82 (1H, d, J = 8.9 Hz, ArH), 6.68-6.64 (2H, m, H5), 
6.45-6.41 (2H, m, ArH), 4.48 (1H, hept, J = 6.1Hz,  H6), 3.80 (3H, s, OCH3), 3.78 (2H, s, 
OCH3), 3.72 (3H, s, OCH3), 3.62 (4H, d, J = 1.8 Hz, H1 and H2), 1.35 (6H, d, J = 6.1 Hz, H7); 
13C NMR (126 MHz) δC = 206.97 (C=O), 160.26 (ArCO), 158.29 (ArCO), 150.38 (ArCO), 
146.22 (ArCO), 131.54 (ArCH), 127.48 (ArC), 121.66 (ArCH), 116.05 (ArCH), 115.79 (ArC), 
113.34 (ArCH), 104.27 (ArCH), 98.58 (ArCH), 71.53 (C-6), 55.89 (OCH3), 55.35 (OCH3),  
55.29 (OCH3), 47.43 (C-2), 43.26 (C-1), 22.12 (C-7); HRMS (ESI+): Found M+ + H 359.1860, 
C21H26O5 (M+ + H) requires 359.1879, m/z 359.1860 (M+ + H, 100%), 317.1388 (25). 
 
7.3.12. Preparation of 1-(2,4-dimethoxyphenyl)-3-(4-isopropoxy-3-methoxyphenyl)propan-
2-one oxime 209 
 
Yellow oil (0.19 g, 17%); Rf = 0.20 (30% EtOAc /Hexane); 
IR (CHCl3): νmax(cm-1): 3233 (OH), 2974 and 2935 (C–H), 
1611 (C=N), 1587 and 1463 (C=C), 1260 (C–O); 1H NMR 
(500 MHz, CDCl3): δH = 9.37 (2H, s, N-OH), 7.00 (2H, dd, J 
= 14.3, 8.6 Hz, ArH), 6.80–6.57 (6H, m, ArH), 6.40 (4H, tt, J 
= 8.3, 4.2 Hz, ArH), 4.50–4.40 (2H, m, 2 × H6), 3.78–3.71 (9H , m, 6 × OCH3), 3.62 (2H, s, 2 × 
H1), 3.59 (2H, s, 2 × H1), 3.43 (2H, s, 2 × H2), 3.35 (2H, s, 2 × H2), 1.34 (24H , t, J = 6.5 Hz, 2 × 
H7); 13C NMR (126 MHz) δC = 159.88 and 159.68, (ArCO), 159.12 (ArCO), 158.43 and 158.35 
(C=N), 150.31 and 150.28 (ArCO), 145.85 and 145.73 (ArCO), 131.33 and 131.02 (ArCH), 
130.11 and 129.86 (ArC), 121.38 and 121.21 (ArCH), 117.48 and 117.06 (ArCH), 116.17 and 
116.08 (ArC), 113.36 and 113.12 (ArCH), 104.20 and 104.09 (ArCH), 98.49 and 98.28 (ArCH), 
71.61 and 71.56 (2 X C-6), 55.83, 55.80 and 55.32 (OCH3), 55.26 and 55.22 (OCH3), 33.01 and 
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32.53 (C-7), 22.14 and 22.12 (C-7), 39.35 (C-2) and 26.71 (C-1).; HRMS (ESI+): Found M+ + H 
374.1978, C21H27NO5 (M+ + H) requires 374.1979, m/z 374.1978(M+ + H, 100%). 
 
7.3.13. Preparation of 4-(3-(2,4-dimethoxyphenyl)-2-nitropropyl)-1-isopropoxy-2-
methoxybenzene 210 
 
Yellow oil (0.08 g, 7.4%); Rf = 0.46 (30% EtOAc /Hexane); 
IR (CHCl3): νmax(cm-1): 2968 and 2904 (C–H), 1614 and 1508 
(C=C), 1588 and 1286 (NO2), 1255 (C–O); 1H NMR (500 
MHz, CDCl3): δH = 6.96 (1H, d, J = 8.2 Hz, H9), 6.80 (1H, d, 
J = 7.9 Hz, H5), 6.68-6.64 (2H, m, H3 and H4), 6.44-6.36 (2H, 
m, H8 and H10), 4.99 (1H, dq, J = 8.8, 7.0 Hz, H11), 4.47 (1H, hept, J = 6.1 Hz, H6), 3.81 (3H, s, 
OCH3), 3.77 (3H, s, OCH3), 3.76 (3H, s, OCH3), 3.21 (1H, dd, J = 14.4, 9.1 Hz, H2), 3.11 (2H, d, 
J = 7.0 Hz, H1), 2.99 (1H, dd, J = 14.4, 5.2 Hz, H2), 1.33 (6H, d, J = 6.1 Hz, H7), ; 13C NMR 
(126MHz) δC = 160.48 (ArCO), 158.34 (ArCO), 150.45 (ArCO), 146.53 (ArCO), 131.23 (C-9), 
128.80 (ArC), 121.02 (ArCH), 116.21 (ArC), 116.03 (C-5), 112.82 (ArCH), 104.16 (ArCH), 
98.62 (ArCH), 89.64 (C-11), 71.47 (C-6), 55.99 (OCH3), 55.31 (OCH3),  55.29 (OCH3), 39.43 
(C-2), 34.63 (C-1), 22.09 (C-7); HRMS (ESI+): Found M+ + H 390.1911, C21H27NO6 (M+ + H) 
requires 390.1879, m/z 390.1911 (M+ + H, 100%), 348.1457 (20), 301.1439 (20). 
 
7.3.14. Preparation of 2-allyl-3-bromonaphthalene-1,4-dione 211 
 
In a 1000 cm3 RB flask, 2-bromo-naphthaquinone (1.03g, 4.35 mmol), vinyl acetic acid (0.61 g, 
0.60 cm3, 7.06 mmol, 1.6 equiv.) and silver nitrate (0.37 g, 2.19 mmol, 0.5 equiv.) was added to 
dry MeCN (100 cm3). The reaction mixture was heated to 65 °C and ammonium persulphate 
(1.79 g, 15.42 mmol, 1.8 equiv.) in distilled water (50 cm3) was added dropwise to the reaction 
mixture. The reaction mixture was maintained at 65°C with stirring for 16 hours under argon. 
The reaction mixture was quenched with H2O (100 cm3) and extracted into EtOAc (4 × 
100 cm3). The combined organic phase was washed sequentially with NaHCO3 (2 × 100 cm3) 
followed by brine (100 cm3). The organic extract was dried with MgSO4, filtered through celite 
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and the solvent removed in vacuo. The crude material was purified by flash silica gel 
chromatography (4% EtOAc/Hexane) to yield the product 211 as a yellow solid (0.95 g, 79%). 
 
Rf = 0.50 (20% EtOAc /Hexane); mp. 78–80 (lit 79°C)29; 1H NMR  (300 
MHz, CDCl3): δ 8.21 – 8.11 (2H, m, ArH), 7.82 – 7.72 (2H, m, ArH), 5.87 
(1H, ddt, J = 16.6, 10.0, 6.6 Hz, H2), 5.27 (1H, ddd, J = 17.1, 2.9, 1.4 Hz, 
H3a), 5.22 – 5.10 (1H, m, H3b), 3.64 (2H, dt, J = 6.6, 1.4 Hz, H1).  
 
 
7.3.15. Preparation of 2-allyl-3-bromo-1,4-dimethoxynaphthalene 212 
 
In a 500 cm3 RB flask, sodium dithionite (21.72 g, 71.85 mmol, 6 equiv.) in H2O (100 cm3) and 
TBAI (0.40 g, 1.08 mmol, 0.09 equiv.) were added to a clear solution of 2-allyl-3-
bromonaphthalene-1,4-dione 211 (3.13 g, 11.98 mmol) in dry THF (250 cm3). The reaction was 
stirred at room temperature under argon for 30 minutes. Potassium hydroxide (26.16 g, 
0.275 mol, 23 equiv.) in H2O (100 cm3) was added and the reaction was stirred for 1 hour. 
Finally, diemethyl sulfate (31.72 g, 24 cm3, 0.252 mol, 21 equiv.) was added and the reaction 
mixture was stirred for 18 hours.  25% ammonia (100 cm3) was added to the reaction and the 
organic material was extracted into EtOAc (3 × 100 cm3). The organic layer was consecutively 
washed with distilled water (100 cm3), 10% HCl (100 cm3), brine (100 cm3) and distilled water 
(100 cm3) and was dried over MgSO4 and filtered through celite. The solvent was removed in 
vacuo and the residue purified by silica gel chromatography (5% EtOAc/Hexane) to afford the 
product 212 as a yellow solid (1.2836g, 75%). 
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Rf = 0.67 (50% EtOAc /Hexane); mp. 56–58 (lit 57°C) 97;IR (CHCl3): 
νmax(cm–1): 3067 (C–H stretch), 1636 (C=C), 1258 (C–O), 993 and 913 
(C–H bend); 1H NMR (300 MHz, CDCl3): δH = 8.13 – 8.02 (2H, m, ArH), 
7.57 – 7.47 (2H, m, ArI), 6.07 (1H, ddt, J = 16.0, 10.2, 5.8 Hz, H2), 5.12 – 
4.98 (2H, m, H3), 3.98 (3H, s, OCH3), 3.92 (3H, s, OCH3), 3.79 (2H, dt, J = 5.8, 1.7 Hz, H1); 
13C NMR (75 MHz): δC = 150.95 (ArCO), 150.17 (ArCO), 135.73 (C2), 128.89 (ArC), 128.06 
(ArC), 127.93 (ArC), 126.56 (ArCH), 126.50 (ArCH), 122.65 (ArCH), 122.55 (ArCH), 116.66 
(ArCBr), 115.88 (C3), 62.69 (OCH3), 61.36 (OCH3), 34.36 (C1). 
 
7.3.16. Preparation of 2-(3-bromo-1,4-dimethoxynaphthalen-2-yl)acetaldehyde 213 
 
To a stirred solution of 2-allyl-3-bromo-1,4-dimethoxynaphthalene 212 (2.86 g, 9.32 mmol) in 
dry CH2Cl2 (400 cm3) under argon was added 0.1% solution of Sudan III (3 drops) in CH2Cl2 
and the reaction cooled to –78°C. Ozone gas was bubbled into the reaction until the colour 
changed from pink to colourless. Argon gas was then passed into the reaction for 10 min and 
dimethyl sulfide (8.86 g, 10.5 cm3, 0.143, 13 equiv.) was added to the reaction at –78°C. The 
reaction was then warmed to room temperature and stirred at room temperature for 1 h. The 
reaction was then concentrated in vacuo and the residue purified by column chromatography 
(15% EtOAc/Hexane) to afford the product 213 as a pale pink solid (1.81g, 63%). 
 
Rf = 0.33 (20% EtOAc /Hexane); mp. 68–70 (lit. 68–70)17; IR (CHCl3): 
νmax(cm–1): 2942 and 2829 (C–H), 1717 (C=O), 1574 and 1492 (C=C), 687 
(C–Br); 1H NMR (500 MHz, CDCl3): δH = 9.86 (1H, s, CHO), 8.16–7.98 
(2H, m, ArH), 7.59–7.52 (2H, m, ArH), 4.13 (2H, d, J = 1.3 Hz, CH2), 3.97 
(3H, s, OCH3), 3.85 (3H, s, OCH3); 13C NMR (126 MHz) δC = 198.54 (C=O), 151.95 (ArCO), 
150.44 (ArCO), 128.81 (ArC), 127.73 (ArC), 127.16 (ArCH), 126.95 (ArCH), 122.98 (ArC), 
122.65 (ArCH), 115.86 (ArCBr), 62.45 (OCH3), 61.41 (OCH3), 45.20 (CH2). 
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7.3.17. Preparation of 2-(3-bromo-1,4-dimethoxynaphthalen-2-yl)ethanol 214 
 
In a 100 cm3 RB flask, 2-(3-bromo-1,4-dimethoxynaphthalen-2-yl)acetaldehyde 213 (1.81 g, 
5.85 mmol) was dissolved in dry methanol (60 cm3). The reaction was cooled to 0°C and sodium 
borohydride (0.45 g, 11.7 mmol, 2.2 equiv.) was added portion wise. The reaction was then 
warmed to room temperature and stirres at this temperature for 30 min. The reaction was 
quenched with H2O (100 cm3) and extracted into EtOAc (2 × 100 cm3) and washed with H2O 
(100 cm3) and brine (100 cm3). The organic phase was dried over anhydrous MgSO4 and filtered 
through celite. The solvent was removed in vacuo and flash column chromatography with a 10% 
EtOAc/Hexane solution afforded the alcohol 214 as a white solid (1.32g, 73%). 
 
Rf = 0.23 (20% EtOAc /Hexane); mp. 107–109; IR (CHCl3): νmax(cm–1): 
3364 (OH), 2936 (C–H), 1572 and 1454 (C=C), 1356 (C–O), 559 (C–Br); 
1H NMR (500 MHz, CDCl3): δH = 8.12–8.01 (2H, m, ArH), 7.58–7.48 
(2H, m, ArH), 3.97 (3H, s, OCH3), 3.95 (3H, s, OCH3), 3.92 (2H, dd, J = 
12.5, 6.7 Hz, H2), 3.31 (2H, t, J = 6.8 Hz, H1), 1.91 (1H, t, J = 5.5 Hz, OH); 13C NMR (126 
MHz) δC 151.35 (ArCO), 150.36 (ArCO), 128.27 (ArC), 127.71 (ArC), 127.39 (ArC), 126.75 
(ArCH), 126.67 (ArCH), 122.63 (ArCH), 116.42 (ArCBr), 62.37 (OCH3), 62.25 (OCH3), 61.36 
(C-2), 33.80 (C-1); HRMS (ESI+): Found M+ + H 374.1978, C21H27NO5 (M+ + H) requires 
374.4479, m/z 374.1978(M+ + H, 100%). 
 
7.3.18. Preparation of 2-(2-(benzyloxy)ethyl)-3-bromo-1,4-dimethoxynaphthalene 215 
 
In a 100 cm3 RB flask, 2-(3-bromo-1,4-dimethoxynaphthalen-2-yl)ethanol 214 (1.25 g, 4.01 
mmol) was dissolved in dry N,N-dimethylformamide (40 cm3). The reaction was cooled to 0°C 
and sodium hydride (60% in oil, 0.18 g, 4.41 mmol, 1.1 equiv.) was slowly added followed by 
benzyl bromide (0.76 g, 0.55 cm3, 4.41 mmol, 1.1 equiv.). The reaction was warmed to room 
temperature and stirred at this temperature for 18 h. The reaction was quenched with H2O (100 
cm3) and the organic material extracted into diethyl ether (2 × 100 cm3). The organic extract was 
washed with H2O (100 cm3) and brine (100 cm3), dried over MgSO4, filtered through celite and 
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the solvent removed in vacuo. Column chromatography with a 10% EtOAc/Hexane solution 
afforded the product 215 as a white solid (0.98g, 61%). 
 
Rf = 0.66 (20% EtOAc /Hexane); mp. 63–65; IR (CHCl3): 
νmax(cm–1): 2941, 2887 and 2864 (C–H), 1567 and 1496 (C=C), 
1355 (C–O), 689( C–Br) ; 1H NMR (300 MHz, CDCl3): δH = 
8.11–8.00 (2H, m, ArH), 7.57–7.44 (2H, m, ArH), 7.37–7.21 (5H, 
m, ArH), 4.58 (2H, s, H3), 3.95 (3H, s, OCH3), 3.91 (3H, s, OCH3), 3.75 (2H, t, J = 7.6 Hz, H2), 
3.36 (2H, t, J = 7.7 Hz, H1); 13C NMR (75 MHz) δC = 151.43 (ArCO), 150.09 (ArCO), 138.45 
(ArC), 128.31 (ArC), 128.13 (ArCH), 127.82 (ArCH), 127.64 (ArCH), 127.50 (ArCH), 127.41 
(ArCH), 126.59 (ArC), 126.53 (ArC), 122.66 (ArCH), 122.55 (ArCH), 116.59 (ArCBr), 72.90 
(C-3), 69.11 (C-2), 62.62 (OCH3), 61.31 (OCH3), 30.94 (C-1); HRMS (ESI+): Found M+ + H 
374.1978, C21H27NO5 (M+ + H) requires 374.4479, m/z 374.1978(M+ + H, 100%). 
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7.4. Experimental prodecures pertaining to Chapter 6 
 
7.4.1. Preparation of Suzuki products 
 
To a sealed microwave vessel was added 2-allyl-3-bromo-1,4-dimethoxynaphthalene 
(1.0 equiv.), boronic acid (1.6 equiv.), cesium fluoride (2 equiv.) and 
tetrakis(triphenylphosphine)palladium(0) (10% mol equiv.) in dimethoxyethane (2 cm3/mmol of 
bromo-compound).  The reaction mixture was irradiated at 150W at 150°C ofr 15 min by 
microwave reactor. The reaction was allowed to cool, diluted with H2O (20 cm3) and extracted 
into EtOAc (2 × 40 cm3). The organic layer was consecutively washed with distilled water 
(40  cm3) and brine (40 cm3) before being dried over MgSO4 and filtered through celite. The 
solvent was removed in vacuo and the residue purified by flash silica gel chromatography (5% 
EtOAc/Hexane) to afford the products as a yellow compounds. 
 
7.4.1.1. Preparation of 2-(3-allyl-1,4-dimethoxynaphthalen-2-yl)benzaldehyde 315 
 
Yellow oil (0.85 g, 50%); Rf = 0.47 (20% EtOAc /Hexane); IR (CHCl3): 
νmax(cm–1): 3072, 2841 and 2747 (C–H stretch), 1664 (C=O), 1597 and 
1482 (C=C), 1222 (C–O), 1000 and 923 (C–H bend); 1H NMR (300 MHz, 
CDCl3): δH = 9.74 (1H, s, CHO), 8.18–8.05 (3H, m, ArH), 7.67 (1H, m, 
ArH), 7.63–7.49 (3H, m, ArH), 7.38 (1H, ddd, J = 7.6, 1.3, 0.5 Hz,  ArH), 
5.68 (1H, ddt, J = 16.2, 10.1, 6.0 Hz, H2), 4.81 (1H, dd, J = 10.1, 1.6 Hz, H3), 4.56 (1H, dd, J = 
17.1, 1.7 Hz, H3), 3.97 (3H, s, OCH3), 3.46 (3H, s, OCH3), 3.39 (2H, dt, J = 5.8, 1.7 Hz, H1); 13C 
NMR (126 MHz): δC = 192.20 (C=O), 150.78 (ArCO), 150.11 (ArCO), 140.21 (ArC), 136.09 
(C-2), 134.40 (ArC), 133.23 (ArCH), 131.72 (ArCH), 128.92 (ArC), 128.15 (ArCH), 127.62 
(ArC), 127.54 (ArC), 127.11 (ArCH), 126.77 (ArCH), 126.28 (ArCH), 122.89 (ArCH), 122.57 
(ArCH), 115.81 (C-3), 62.45 (OCH3), 61.22 (OCH3), 31.84 (C-1); HRMS (ESI+): Found M+ + 
H 333.1496, C22H20O3 (M+ + H) requires 333.1479, m/z 333.1496 (M+ + H, 100%), 301.1233 
(35), 289.1239 (50). 
 
Chapter 7: Experimental procedures 
 
 
194 
 
7.4.1.2. Preparation of 2-(3-allyl-1,4-dimethoxynaphthalen-2-yl)-5-
methoxybenzaldehyde 316 
 
Yellow oil (0.95 g, 43%); Rf = 0.67 (50% EtOAc /Hexane); IR (CHCl3): 
νmax(cm–1): 3078, 2840 and 2765 (C–H stretch), 1688 (C=O), 1601 and 
1498 (C=C), 1233 (C–O), 1000 and 923 (C–H bend); 1H NMR (300 
MHz, CDCl3): δH = 9.67 (1H, s, CHO), 7.62–7.49 (3H, m, ArH), 7.33–
7.18 (2H, m, ArH), 5.69 (1H, ddt, J = 16.1, 10.1, 6.0 Hz, H2), 4.83 (1H, 
dd,, J = 10.1, 1.5 Hz, H3), 4.59 (1H, dd,, J = 17.1, 1.6 Hz, H3), 3.97 (3H, s, OCH3), 3.93 (3H, s, 
OCH3), 3.46 (3H, s, OCH3), 3.40 (2H, dt, J = 5.9, 1.5 Hz, H1); 13C NMR (75 MHz): δC = 192.08 
(C=O), 159.39 (ArCO), 150.74 (ArCO), 150.47 (ArCO), 136.21 (C-2), 132.88 (ArCH), 128.86 
(ArC), 127.98 (ArC), 127.82 (ArC), 127.62 (ArC), 126.71 (ArCH), 126.24 (ArCH), 122.90 
(ArCH), 122.53 (ArCH), 120.96 (ArCH). 115.77 (C-3), 109.60 (ArCH), 62.43 (OCH3), 61.15 
(OCH3), 55.55 (OCH3), 31.86 (C-1); HRMS (ESI+): Found M+ + H 363.1588, C23H22O4 (M+ + 
H) requires 363.1579, m/z 363.1588 (M+ + H, 100%), 319.1336 (30). 
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7.4.1.3. Preparation of 2-(3-allyl-1,4,5-trimethoxynaphthalen-2-yl)-5-
methoxybenzaldehyde 333 
 
Yellow solid (0.68 g, 46%); Rf = 0.36 (20% EtOAc /Hexane); mp. 125–
127; IR (CHCl3): νmax(cm–1): 3094, 2931 and 2839 (C–H stretch), 1686 
(C=O), 1602 and 1499 (C=C), 1265 (C–O); 1H NMR (500 MHz, 
CDCl3): δH =  δ 9.65 (1H, s, CHO), 7.71 (1H, d, J = 8.4 Hz, ArH), 7.56 
(1H, dd, J = 10.0, 2.8 Hz, ArH), 7.43 (1H, t, J = 8.1 Hz, ArH), 7.25 (2H, 
ddd, J = 13.0, 12.5, 6.5 Hz, ArH), 6.94 (1H, d, J = 7.7 Hz, ArH), 5.73 (1H, ddt, J = 16.2, 10.2, 
6.1 Hz, H2), 4.81 (1H, dd, J = 10.1, 1.5 Hz, H3), 4.57 (1H, dd, J = 17.1, 1.6 Hz, H3), 4.04 (s, 3H, 
s, OCH3), 3.93 (3H, s, OCH3), 3.86 (3H, s, OCH3), 3.42 (3H, s, OCH3), 3.40–3.36 (2H, m, H1); 
13C NMR (126 MHz): δC = 192.11 (C=O), 159.36 (ArCO), 156.05 (ArCO), 150.92 (ArCO), 
150.03 (ArCO), 136.67 (C-2), 135.17 (ArC), 132.93 (ArC), 132.80 (ArCH), 129.99 (ArC), 
128.93 (ArC), 128.58 (ArCH), 126.41 (ArCH), 120.94 (ArCH), 115.56 (C-3), 115.26 (ArCH), 
109.49 (ArCH), 106.76 (ArCH), 62.68 (OCH3), 60.95 (OCH3), 56.22 (OCH3), 55.54 (OCH3), 
31.89 (C-1); HRMS (ESI+): Found M+ + H 393.1699, C24H24O5 (M+ + H) requires 393.1679, 
m/z 393.1679 (M+ + H, 100%). 
 
7.4.2. Preparation of Wittig products 
 
In a 50 cm3 two necked RB flask fitted with a rubber septum, n-butyllithium (1.5 M, 1.6 cm3, 
2.37 mmol, 2.5 equiv.) was added dropwise at room temperature to a suspension of  
methyltriphenylphosphonium bromide ( 0.85 g, 2.37 mmol, 2.5 equiv.) in dry THF ( 10 cm3). 
The resulting orange solution was stirred for a further 30 minutes before being cooled to 0°C 
using an ice-bath. Aldehyde (0.95 mmol) in dry THF (5 cm3) was added dropwise at 0°C to the 
resulting ylide. The reaction was then warmed to room temperature and stirred at this 
temperature for 18 h. The reaction was diluted with diethyl ether (50cm3) and washed with H2O 
(50 cm3). The organic extract was dried over MgSO4, filtered through celite and the solvent 
removed in vacuo. The resulting residue was purified by silica gel chromatography (5% 
EtOAc/Hexane) to afford the products as yellow oils. 
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7.4.2.1. Preparation of 2-allyl-1,4-dimethoxy3-(2-vinylphenyl)naphthalene 317 
 
Yellow oil (0.28 g, 88%); Rf = 0.72 (20% EtOAc /Hexane); IR (CHCl3): 
νmax(cm–1): 3072 and 2930 (C–H stretch), 1588, 1483 and (C=C), 1227 
(C–O), 1006 and 910 (C–H bend); 1H NMR (300 MHz, CDCl3): δH = 
8.16–8.11 (2H, m, ArH), 7.72 (1H, dd, J = 7.7, 1.2 Hz, ArH), 7.58–7.47 
(2H , m, ArH), 7.35 (2H, dtd, J = 20.7, 7.3, 1.2 Hz, ArH), 7.25–7.20 (1H, 
m, ArH), 6.41 (1H, dd, J = 17.6, 11.0 Hz, H4), 5.76 – 5.59 (2H, m, H2 and H5 overlapping), 5.07 
(1H, dd, J = 11.0, 1.1 Hz, H5), 4.80 (dd, J = 17.0, 3.4, 1.6 Hz, H3), 4.67 (1H, ddd, J = 10.1, 3.2, 
1.5 Hz, H3), 3.96 (3H, s, OCH3), 3.55–3.44 (4H, m, OCH3 and H1 overlapping), 3.13 (1H, ddt, J 
= 14.9, 6.2, 1.5 Hz, H1); 13C NMR (126 MHz): δC = 150.46 (ArCO), 149.79 (ArCO), 136.45 (C-
2), 136.36 (ArC), 135.62 (ArC), 135.12 (C-4), 131.28 (ArCH), 131.17 (ArC), 128.57 (ArC), 
128.39 (ArC), 127.95 (ArC), 127.79 (ArCH), 127.18 (ArCH), 126.23 (ArCH), 125.82 (ArCH), 
124.60 (ArCH), 122.90 (ArCH), 122.41 (ArCH), 115.20 (C-3), 114.55 (C-5), 62.36 (OCH3), 
61.30 (OCH3), 31.94 (C-1); HRMS (ESI+): Found M+ + H 331.1698, C23H22O2 (M+ + H) 
requires 331.1679, m/z 331.1698 (M+ + H, 95%), 289.1237 (50), 275.1073 (20). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 7: Experimental procedures 
 
 
197 
 
7.4.2.2. Preparation of 2-allyl-1,4-dimethoxy-3-(4-methoxy-2-
vinylphenyl)naphthalene 318 
 
Yellow oil (0.23 g, 84%); Rf = 0.57 (20% EtOAc /Hexane); IR (CHCl3): 
νmax(cm–1): 2928 (C–H stretch), 1603 and 1490 (C=C), 1231 (C–O), 999 
and 913 (C–H bend); 1H NMR (300 MHz, CDCl3): δH = 8.12 (2H, dd, J 
= 7.2, 2.4 Hz, ArH), 7.57–7.47 (2H, m, ArH), 7.24 (2H, d, J = 3.4 Hz, 
ArH), 7.14 (1H, d, J = 8.4 Hz, ArH), 6.90 (1H, dd, J = 8.4, 2.6 Hz, ArH), 
6.37 (1H, dd, J = 17.5, 11.0 Hz, H4), 5.76–5.61 (2H, m, H2 and H5 overlapping), 5.07 (1H, dd, J 
= 11.0, 1.0 Hz, H5), 4.81 (1H, dd, J = 10.1, 1.6 Hz, H3), 4.69 (1H, dd, J = 17.1, 1.7 Hz, H3), 3.96 
(3H, s, OCH3), 3.90 (3H, s, OCH3), 3.51 (3H, s, OCH3), 3.49–3.44 (1H, m, H1), 3.14 (1H, dd, J = 
14.9, 6.2, 1.6  Hz, H1); 13C NMR  (75 MHz): δC = 159.18 (ArCO), 150.40 (ArCO), 150.20 
(ArCO), 137.48 (C-2), 136.57 (ArC), 135.19 (C-4), 132.29 (ArCH), 130.87 (ArCH), 128.86 
(ArC), 128.53 (ArC), 128.26 (ArC), 127.95 (ArC), 126.20 (ArC), 125.79 (ArCH), 122.91, 
(ArCH), 122.40 (ArCH), 115.19 (C-3), 114.70 (C-5), 113.29 (ArCH), 109.48 (ArCH), 62.36 
(OCH3), 61.25 (OCH3), 55.28 (OCH3), 31.96 (C-1); HRMS (ESI+): Found M+ + H 361.1799, 
C24H24O3 (M+ + H) requires 361.1779, m/z 361.1799 (M+ + H, 100%), 279.0945 (75). 
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7.4.2.3. Preparation of 3-allyl-1,4,5-trimethoxy-2-(4-methoxy-2-
vinylphenyl)naphthalene 334 
 
Yellow oil (0.41 g, 69%); Rf = 0.52 (20% EtOAc /Hexane); IR (CHCl3): 
νmax(cm–1): 3078, 2932 and 2836 (C–H stretch), 1602 and 1493 (C=C), 
1266 (C–O); 1H NMR (500 MHz, CDCl3): δH = 7.74 (1H, d, J = 8.4 Hz, 
ArH), 7.39 (1H, t, J = 8.1 Hz, ArH), 7.23 (1H, t, J = 6.5 Hz, ArH), 7.14 
(1H, d, J = 8.4 Hz, ArH), 6.90 (2H, d, J = 6.8 Hz, ArH), 6.41–6.30 (1H, 
m, H4), 5.73 (1H, ddt, J = 16.5, 10.2, 6.2 Hz, H2), 5.66 (d, J = 17.5 Hz, H5), 5.06 (1H, d, J = 11.2 
Hz, H5), 4.79 (1H, dd, J = 10.0, 1.3 Hz, H3), 4.67 (1H, dd, J = 17.1, 1.5 Hz, H3), 4.02 (3H, s, 
OCH3), 3.88 (3H, s, OCH3), 3.84 (3H, s, OCH3), 3.51 (1H, dd, J = 14.8, 6.1 Hz, H1), 3.48 (3H, s, 
OCH3), 3.11 (1H, dd, J = 14.7, 6.3 Hz, H1); 13C NMR (126 MHz): δC = 159.14 (ArCO), 156.01 
(ArCO), 150.60 (ArCO), 149.79 (ArCO), 137.35 (ArC), 137.00 (C-2), 135.20 (C-4), 132.17 
(ArCH), 131.62 (ArC), 130.31 (ArC), 129.84 (ArC), 128.27 (ArC), 125.89 (ArCH), 120.59 
(ArC), 115.33 (ArCH), 114.99 (C-3), 114.59 (C-5), 113.22 (ArCH), 109.45 (ArCH), 106.29 
(ArCH), 62.60 (OCH3), 61.03 (OCH3), 56.16 (OCH3), 55.22 (OCH3), 31.92 (C-1);HRMS 
(ESI+): Found M+ + H 391.1898, C25H26O4 (M+ + H) requires 391.1879, m/z 391.1898 (M+ + H, 
100%). 
 
7.4.3. Preparation of Isomerisation products 
 
A 50 cm3 RB flask, alkene (0.760 mmol) was dissolved in dry THF (10 cm3).  Potassium tert-
butoxide (4 equiv.) in dry THF (10 cm3) was slowly added and the resulting reaction mixture 
was stirred at room temperature for 4 h, under argon. The mixture was poured into sat. aq. 
ammonium chloride (20 cm3) and the organic material extracted into EtOAc (4 × 50 cm3). The 
organic extract was washed in succession with H2O (100 cm3) and brine (100 cm3), dried over 
MgSO4 and filtered through celite. The solvent was removed in vacuo and the residue purified by 
flash silica gel column chromatography (10% EtOAc/Hexane) to yield the products as clear oils 
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7.4.3.1. Preparation of (E)-1,4-dimethoxy-2-(prop-1-en-1yl)-3-
(2vinylphenyl)naphthalene 322 
 
Yellow oil (0.38 g, 94%); Rf = 0.72 (20% EtOAc /Hexane); IR (CHCl3): 
νmax(cm–1): 3066 (C–H stretch), 1626 and 1480 (C=C), 1269 (C–O), 967 
and 910 (C–H bend); 1H NMR (300 MHz, CDCl3): δH = 8.13 (2H, m, 
ArH), 7.71–7.64 (1H, m, ArH), 7.55–7.41 (2H, m, ArH), 7.38–7.26 (2H, 
m, ArH), 7.21 (1H, dd, J = 7.3, 1.7 Hz, ArH), 6.46 (1H, dd, J = 17.5, 11.0 
Hz, H4), 6.13 (1H, d, J = 17.1 Hz, H1), 6.07–5.93 (1H, m, H2), 5.64 (1H, dd, J = 17.5, 0.9 Hz, 
H5), 5.03 (1H, dd, J = 11.0, 0.9 Hz, H5), 3.83 (3H, s, OCH3), 3.45 (3H, s, OCH3), 1.65 (3H, dd, J 
= 6.2, 0.9 Hz, H3); 13C NMR (75 MHz): δC = 149.96 (ArCO), 149.60 (ArCO), 136.54 (ArC), 
136.23 (ArC), 135.30 (C-4), 131.82 (C-2), 131.23 (ArCH), 130.11 (ArC), 128.92 (ArC), 127.76 
(ArC), 127.56 (ArCH), 127.33 (ArCH), 126.79 (ArC), 126.32 (ArCH), 125.97 (ArCH), 124.77 
(C-1), 124.61 (ArCH), 122.67 (ArCH), 122.58 (ArCH), 114.28 (C-5), 61.01 (OCH3), 60.59 
(OCH3), 19.67 (C-3); HRMS (ESI+): Found M+ + H 331.1693, C23H22O2 (M+ + H) requires 
331.1679, m/z 331.1679 (M+ + H, 45%), 317.1543 (85), 315.1390 (80), 289.1237 (50). 
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7.4.3.2. Preparation of (E)-1,4-dimethoxy-2-(4-methoxy-2vinylphenyl)-3-(prop-1-en-
1yl)naphthalene 323 
 
 
Yellow oil (0.23 g, 84%); Rf = 0.63 (20% EtOAc /Hexane); IR 
(CHCl3): νmax(cm–1): 2931 and 2837 (C–H stretch), 1602 and 1492 
(C=C), 1228 (C–O), 967 and 908 (C–H bend); 1H NMR (300 MHz, 
CDCl3): δH = 8.19–8.06 (2H, m, ArH), 7.55–7.45 (2H, m, ArH), 7.25–
7.21 (1H, m, ArH), 7.13 (1H, dd, J = 8.4, 2.9 Hz, ArH), 6.92 (1H, dd, J 
=8.4, 2.4 Hz, ArH), 6.46–6.37 (1H, m, H4), 6.12 (1H, dd, J = 15.9, 1.9 Hz, H2), 6.08–5.98 (1H, 
m, H1), 5.65 (1H, dd,, J = 17.5, 2.4 Hz, H5), 5.06 (1H, dd,, J = 11.0, 1.0 Hz, H5), 3.89 (3H, s, 
OCH3), 3.84 (3H, s, OCH3), 3.47 (3H, s, OCH3), 1.69 (3H, dd, J = 4.8, 2.6 Hz, H3); 13C NMR 
(126 MHz): δC = 159.02(ArCO), 149.95 (ArCO), 149.87 (ArCO), 137.65 (ArC), 135.39 (C-4), 
132.26 (ArC), 131.77 (C-1), 129.82 (ArC), 128.86 (ArC), 128.80 (ArC), 127.72 (ArC), 127.18 
(ArC), 126.26 (ArCH), 125.91 (ArCH), 124.86 (C-2), 122.67 (ArCH), 122.56 (ArCH), 114.37 
(C-5), 113.42 (ArCH), 109.54 (ArCH), 61.02 (OCH3), 60.63 (OCH3), 55.24 (OCH3), 19.76 (C-
3); HRMS (ESI+): Found M+ + H 361.1804, C24H24O3 (M+ + H) requires 361.1779, m/z 
361.1804 (M+ + H, 100%), 345.1495 (50), 319.1352 (35), 305.1188 (15). 
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7.4.3.3. Preparation of (E)-1,4-dimethoxy-2-(4-methoxy-2vinylphenyl)-3-(prop-1-en-
1yl)naphthalene 335 
 
Yellow oil (86.3 mg, 73%); Rf = 0.34 (20% EtOAc /Hexane); IR 
(CHCl3): νmax(cm–1): 2993, 2934and 2837 (C–H stretch), 1605 and 
1495 (C=C), 1244 (C–O); 1H NMR (500 MHz, CDCl3): δH = 7.71 
(1H, d, J = 8.4 Hz, ArH), 7.42–7.32 (1H, m, ArH), 7.21 (1H, d, J = 2.6 
Hz, ArH), 7.12 (1H, t, J = 6.6 Hz, ArH), 6.93–6.84 (2H, m, ArH), 6.40 
(1H, dd, J = 17.5, 11.0 Hz, H4), 6.22–6.09 (1H, m, H1), 5.84 (1H, dqd, J = 15.9, 6.5, 1.0 Hz, H2), 
5.63 (1H, d, J = 17.5 Hz, H5), 5.05 (1H, d, J = 11.2 Hz, H5), 4.02 (3H, s, OCH3), 3.89 (3H, s, 
OCH3), 3.75 (3H, s, OCH3), 3.42 (3H, s, OCH3), 1.65–1.62 (3H, m, H3);13C NMR (126 MHz): 
δC = 158.93 (ArCO), 156.50 (ArCO), 150.32 (ArCO), 149.70 (ArCO), 137.49 (ArC), 135.41 (C-
4), 132.22 (ArCH), 131.64 (C-2), 130.48 (ArC), 130.14 (ArC), 128.87 (ArC), 128.77 (ArC), 
126.02 (ArCH), 124.70 (C-1), 120.76 (ArC), 115.28 (ArCH), 114.31 (C-5), 113.35 (ArCH), 
109.48 (ArCH), 106.51 (ArCH), 61.18 (OCH3), 60.82 (OCH3), 56.26 (OCH3), 55.23 (OCH3), 
19.70 (C-3); ); HRMS (ESI+): Found M+ + H 391.1896, C25H26O4 (M+ + H) requires 391.1879, 
m/z 391.1896 (M+ + H, 100%), 376.1648 (20), 375.1589 (35), 3.49.1436(35). 
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7.4.4. General Method for RCM ring closure 
  
In a 50 cm3 RB flasked fitted with a condenser was added the di-alkene (0.83 mmol) in dry 
CH2Cl2 (10 cm3/ mmol of dialkene). To this was added Grubbs II catalyst (15% mol equiv.) and 
the reaction was heated under relux for 18 h under an argon atmosphere. The reaction was cooled 
to room temperature and the solvent removed in vacuo. The residue was purified by flash silica 
column chromatography (5% EtOAc/ Hexane) to yield the products as off white solids. 
 
7.4.4.1. Preparation of 8,13-dimethoxy-7H-benzo[3,4]cyclohepta[1,2-b]naphthalene 
320 
 
Pale yellow solid (0.23 g, 98%); Rf = 0.67 (20% EtOAc /Hexane); mp. 
121–123;IR (CHCl3): νmax(cm–1): 3019, 2994 (C–H aromatic stretch), 2928 
and 2837 (CH2 stretch), 1588 and 1496 (C=C), 1225 (C–O), 965 and 925 
(C–H bend); 1H NMR (300 MHz, CDCl3): δH = 8.23–8.17 (1H, m, ArH), 
8.11 (1H, dd, J = 7.2, 1.9 Hz, ArH), 7.97 (1H, d, J = 8.0 Hz, ArH), 7.56–7.45 (2H, m, ArH), 
7.43–7.29 (3H, m, ArH), 6.61 (1H, dd, J = 9.9, 1.5 Hz, H3), 6.31 (1H, ddd, J = 9.9, 8.2, 5.8 Hz, 
H2), 3.97 (3H, s, OCH3), 3.87 (1H, ddd, J = 12.9, 8.2, 0.7 Hz, H1), 3.26 (3H, s, OCH3), 2.70 (1H, 
ddd, J = 12.9, 5.7, 2.1, H1); 13C NMR (75 MHz): δC = 150.73 (ArCO), 146.40 (ArCO), 136.78 
(ArC), 135.42 (ArC), 135.20 (ArC), 132.36 (ArCH),132.18 (C-2), 129.88 (C-3), 128.46 (ArCH), 
128.35 (ArC), 127.94 (ArC), 127.83 (ArC), 127.08 (ArCH), 126.37 (ArCH), 125.57 (ArCH), 
125.46 (ArCH), 122.91 (ArCH), 121.94 (ArCH), 62.55 (OCH3), 60.50 (OCH3), 25.52 (C-1); 
HRMS (ESI+): Found M+ + H 303.1387, C21H18O2 (M+ + H) requires 303.1379, m/z 303.1387 
(M+ + H, 100%), 288.1122 (75), 247.1677 (50), 229.1394 (30). 
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7.4.4.2. Preparation of 3,8,13-trimethoxy-7H-benzo[3,4]cyclohepta[1,2-b]naphthalene 
321 
 
Pale yellow solid (0.12 g, 87%); Rf = 0.59 (20% EtOAc /Hexane); mp. 
138–140; IR (CHCl3): νmax(cm–1): 3073, 3024 (C–H aromatic stretch), 
2929 and 2835 (CH2 stretch), 1632 (C=C, conjugated), 1602 and 1494 
(C=C), 1237 (C–O), 966 and 919 (C–H bend); 1H NMR (300 MHz, 
CDCl3): δH = 8.22–8.07 (2H, m, ArH), 7.91 (1H, d, J = 8.7 Hz, H6), 7.55–
7.43 (2H, m, ArH), 6.91 (1H, dd, J = 8.7, 2.8 Hz, H5), 6.85 (1H, d, J = 2.7 Hz, H4), 6.57 (1H, dd, 
J = 9.7, 1.4 Hz, H3), 6.30 (1H, ddd, J = 9.9, 8.2, 5.8 Hz, H2), 3.96 (3H, s, OCH3), 3.94–3.81 (4H, 
m, H1 and OCH3), 3.28 (3H, s, OCH3), 2.70 (1H, ddd, J = 12.9, 5.7, 2.1 Hz, H1); 13C NMR (75 
MHz): δC = 158.37 (ArCO), 150.44 (ArCO), 146.45 (ArCO), 138.04, 134.71 (C-6), 133.69 
(ArC), 132.23 (C-2), 129.85 (C-3), 128.20 (ArC), 128.08 (ArC), 127.81 (ArC), 127.66 (ArH), 
126.11 (ArCH), 125.48 (ArCH), 122.78 (ArCH), 121.90 (ArCH), 112.28 (ArCH), 62.50 (OCH3), 
60.33 (OCH3), 55.24 (OCH3), 25.57 (C-1); HRMS (ESI+): Found M+ + H 333.1485, C22H20O3 
(M+ + H) requires 333.1479, m/z 333.1485 (M+ + H, 100%), 332.1442 (50). 
 
7.4.4.3. Preparation of 7,12-dimethoxytetraphene 294 
 
 
Yellow solid (0.13 g, 85%); Rf = 0.61 (20% EtOAc /Hexane); mp. 125–127 
(lit 136–137)134; IR (CHCl3): νmax(cm–1): 2931and 2837 (C–H aromatic 
stretch), 1593, 1495 and 1448 (C=C), 1252 (C–O); 1H NMR (500 MHz, 
CDCl3): δH = 9.67 (1H, d, J = 8.4 Hz, ArH), 8.50–8.41 (1H, m, ArH), 8.37–
8.31 (1H, m, ArH), 8.14 (1H, d, J = 9.2 Hz, ArH), 7.84 (1H, d, J = 7.3 Hz, ArH), 7.71–7.65 (1H, 
m, ArH), 7.65–7.59 (4H, m, ArH), 4.12 (3H, s, OCH3), 3.97 (3H, s, OCH3);13C NMR (125 
MHz): δC = 151.14 (ArCO), 148.64 (ArCO), 132.67 (ArC), 130.00 (ArC), 128.42 (ArCH), 
128.22 (ArCH), 127.62 (ArCH), 127.37 (ArC), 127.29 (ArCH), 127.02 (ArCH), 126.51 (ArC), 
126.04 (ArCH), 125.93 (ArCH), 124.26 (ArC), 123.19 (ArCH), 122.29 (ArCH), 121.05 (ArCH), 
120.76 (ArC), 63.15 (OCH3), 60.89 (OCH3); HRMS (ESI+): Found M+ + H 289.1010, C20H16O2 
(M+ + H) requires 289.1279, m/z 289.1010 (M+ + H, 100%), 273.0919 (90). 
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7.4.4.4. Preparation of 3,7,12-trimethoxytetraphene 314 
 
 
Yellow solid (0.030 g, 43%); Rf = 0.63 (20% EtOAc /Hexane); mp. 
157–159 (lit 164–165)145; IR (CHCl3): νmax(cm–1): 2933 (C–H aromatic 
stretch), 1606 and 1494 (C=C), 1267 (C–O); 1H NMR (500 MHz, 
CDCl3): δH = 9.58 (1H, d, J = 9.2 Hz, ArH), 8.43 (1H, dd, J = 7.4, 1.8 
Hz, ArH), 8.32 (1H, dd, J = 7.3, 1.8 Hz, ArH), 8.13 (1H, d, J = 9.3 Hz, ArH), 7.64–7.53 (3H, m, 
ArH), 7.31–7.23 (2H, m, ArH), 4.11 (3H, s, OCH3), 3.98 (3H, s, OCH3), 3.96 (3H, s, OCH3); 13C 
NMR (126 MHz): δC = 158.32 (ArCO), 150.08 (ArCO), 148.76 (ArCO), 134.39 (ArC), 129.86 
(ArCH), 127.41 (ArC), 127.37 (ArCH),  125.91 (ArCH), 125.61 (ArCH), 125.44 (ArC), 123.74 
(ArC), 123.72 (ArC), 122.98 (ArCH), 122.31 (ArCH), 121.72 (ArCH), 120.88 (ArC). 115.95 
(ArCH), 110.03 (ArCH), 63.18 (OCH3), 60.72 (OCH3), 55.38 (OCH3); HRMS (ESI+): Found 
M+ + H 319.1259, C21H18O3 (M+) requires 319.1379, m/z 319.1259 (M+ , 90%), 318.1262 (100), 
303.1032 (25). 
 
7.4.4.5. Preparation of 3,7,8,12-tetramethoxytetraphene 336 
 
 
Yellow solid (53 mg, 84%); Rf = 0.41 (20% EtOAc /Hexane); mp. 
176–178; IR (CHCl3): νmax(cm–1): 3005, 2934 and 2834 (C–H), 1608 
and 1499 (C=C), 1253 (C–O); 1H NMR (500 MHz, CDCl3): δH = 9.56 
(1H, d, J = 9.1 Hz, ArH), 8.23 (1H, d, J = 9.3 Hz, ArH), 8.04 (1H, d, J 
= 8.6 Hz, ArH), 7.55 (1H, d, J = 9.3 Hz, ArH), 7.51–7.43 (1H, m, ArH), 7.28 (2H, dd, J = 9.2, 
2.8 Hz, ArH), 6.90 (1H, d, J = 7.5 Hz, ArH), 4.09 (3H, s, OCH3), 4.00 (3H, s, OCH3), 3.98 (3H, 
s, OCH3), 3.91 (3H, s, OCH3); 13C NMR (126 MHz): δC = 158.41 (ArCO), 156.35 (ArCO), 
149.60 (ArCO), 149.14 (ArCO), 134.68 (ArC), 129.96 (ArCH), 129.65 (ArC), 127.09 (ArCH), 
125.79 (ArCH), 124.78 (ArC), 123.38 (ArC), 122.24 (ArCH), 121.41 (ArC), 118.25 (ArC), 
115.88 (ArCH), 115.34 (ArCH), 109.71 (ArCH), 104.60 (ArCH), 63.39 (OCH3), 60.45 (OCH3), 
56.21 (OCH3), 55.37 (OCH3); HRMS (ESI+): Found M+ + H 349.1426, C22H20O4 (M+) requires 
349.1479, m/z 349.1479 (M+ , 100%), 334.1201 (30). 
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7.4.5. General Method for oxidation of naphthalenes 
  
In a 50 cm3 RB flasked arene (0.83 mmol) was dissolved in acetonitrile (10 cm3/ mmol of arene). 
CAN (2.5 equiv.) was added and the reaction was stirred for 5 min. Sodium bicarbonate was 
added and the organic material extracted in EtOAc (3 × 10 cm3). The organic layer was then 
dried over anhydrous MgSO4 before being purified by silica column chromatography (10% 
EtOAc/ Hexane) to yield the products as yellow solids. 
 
7.4.5.1. Preparation of tetraphene-7,12-dione 341 
 
Yellow solid (19.1 mg, 76%); Rf = 0.61 (20% EtOAc /Hexane); mp.       
166–169 (lit 168–169)134; IR (CHCl3): νmax(cm–1): 2918 and 2850 (C–H), 
1728 and 1661 (C=O), 1587 and 1507 (C=C), 1277 (C–O); 1H NMR (500 
MHz, CDCl3): δH = 9.72 (1H, d, J = 8.8 Hz, ArH), 8.39 (1H, d, J = 8.5 Hz, 
ArH), 8.29 (2H, dd, J = 24.2, 7.3 Hz, ArH), 8.21 (1H, d, J = 8.5 Hz, ArH), 7.92 (1H, d, J = 8.1 
Hz, ArH), 7.78 (3H, tdd, J = 9.4, 5.4, 4.3 Hz, ArH), 7.67 (1H, t, J = 7.3 Hz, ArH); 13C NMR 
(126 MHz): δC = 186.21 (C=O), 184.00 (C=O), 136.71 (ArC), 135.33 (ArCH), 135.09 (ArC), 
134.22 (ArCH), 134.06 (ArC), 133.50 (ArCH), 132.25 (ArC), 130.55 (ArC), 129.95 (ArCH), 
129.39 (ArC), 128.78 (ArCH), 128.73 (ArCH), 127.25 (ArCH), 126.49 (ArCH), 122.53 (ArCH); 
HRMS (ESI+): Found M+ + H 259.0747, C18H10O2 (M+ + H) requires 259.0779, m/z 259.0747 
(M+ + H, 100%), 234.2048 (25), 224.1323 (10). 
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7.4.5.2. Preparation of 3-methoxytetraphene-7,12-dione 342 
 
Yellow solid (0.023 g, 87%); Rf = 0.61 (20% EtOAc /Hexane); mp.       
158–160 (lit 162–163)146; IR (CHCl3): νmax(cm–1): 3010, 2917 and 2849 
(C–H), 1734 and 1657 (C=O), 1610 and 1503 (C=C), 1264 (C–O); 1H 
NMR (500 MHz, CDCl3): δH = 9.61 (1H, d, J = 9.6 Hz, ArH), 8.34 (1H, 
d, J = 8.6 Hz, ArH), 8.30–8.21 (2H, m, ArH), 8.06 (1H, d, J = 8.6 Hz, 
ArH), 7.82–7.71 (2H, m, ArH), 7.38 (1H, dd, J = 9.6, 2.8 Hz, ArH), 7.18 (1H, t, J = 5.0 Hz, 
ArH), 3.97 (3H, s, OCH3); 13C NMR (126 MHz): δC = 186.38 (C=O), 183.81 (C=O), 159.60 
(ArCO), 138.88 (ArC), 135.04 (ArC), 134.01 (ArCH), 133.77 (ArCH), 133.46 (ArCH), 132.38 
(ArC), 132.09 (ArC), 130.40 (ArCH), 129.45 (ArC), 127.17 (ArCH), 126.41 (ArCH), 125.69 
(ArC), 123.35 (ArCH), 122.39 (ArCH), 106.74 (ArCH), 55.39 (OCH3); HRMS (ESI+): Found 
M+ + H 289.0805, C19H12O3 (M+ + H) requires 289.0879, m/z 289.0805 (M+ + H, 100%). 
 
7.4.5.3. Preparation of 3,8-dimethoxytetraphene-7,12-dione 343 
 
Yellow solid (53 mg, 84%); Rf = 0.61 (20% EtOAc /Hexane); mp. 202–
204 (lit 206–207)147; IR (CHCl3): νmax(cm–1): 3089, 2925 and 2849 (C–
H), 1654 and 1618 (C=O), 1587 and 1471 (C=C), 1268 (C–O); 1H NMR 
(500 MHz, CDCl3): δH = 9.52 (1H, d, J = 9.5 Hz, ArH), 8.32 (1H, d, J = 
8.6 Hz, ArH), 8.06 (1H, d, J = 8.6 Hz, ArH), 7.93 (1H, d, J = 7.6 Hz, 
ArH), 7.72 (1H, t, J = 8.1 Hz, ArH), 7.38 (1H, dd, J = 9.5, 2.6 Hz, ArH), 7.31 (1H, d, J = 8.4 Hz, 
ArH), 7.19 (1H, d, J = 2.5 Hz, ArH), 4.06 (3H, s, OCH3), 3.97 (3H, s, OCH3); 13C NMR (126 
MHz): δC = 186.50 (C=O), 183.20 (C=O), 159.64 (ArCO), 159.42 (ArCO), 138.22 (ArC), 137.46 
(ArC), 134.90 (ArCH), 133.80 (ArCH), 130.11 (ArCH), 128.48 (ArC), 125.14 (ArC), 123.58 
(ArCH), 122.21 (ArCH), 120.63 (ArC), 119.78 (ArCH), 117.15 (ArCH), 111.52 (ArC), 106.73 
(ArCH), 56.57 (OCH3), 55.39 (OCH3); HRMS (ESI+): Found M+ + H 319.0957, C20H14O4 (M+ 
+ H) requires 319.0979, m/z 319.0957 (M+ + H, 100%). 
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7.4.6. Preparation of 1,5-diacetoxynaphthalene 328 
 
In a 250 cm3 RB flask was placed 1,5-dihydroxynaphthalene 327 (10.77 g, 67.24 mmol) 
followed by pyridine (53.19 g, 55.0 cm3, 0.672 mol, 10 equiv.) and acetic anhydride (61.78 g, 
60.0 cm3, 0.605 mol, 9.0 equiv.). The reaction was stirred at room temperature for 18 h. H2O 
(100 cm3) was added to quench the reaction causing the product to precipitate. The precipitate 
was filtered and washed with H2O (5 × 100 cm3) to afford the product 328 as a brown-red solid 
(12.18 g, 81%).137 
 
Rf = 0.20 (20% EtOAc /Hexane); 1H NMR (500 MHz, CDCl3): δH = 7.78 (2H, 
d, J = 8.1 Hz, ArH),7.51 (2H, t, J = 7. 6 Hz, ArH), 7.29 (2H, d, J = 7.1 Hz, 
ArH), 2.47 (6H, s, 2 X CH3); 13C NMR (126 MHz): δC = 169.26 (C=O), 
146.76 (ArCO), 128.17 (ArC), 126.05 (ArCH), 119.30 (ArCH), 118.81 
(ArCH), 21.02 (CH3). 
 
7.4.7. Preparation of 5-acetoxy-2-bromo-1,4-naphthalenedione 251 
 
In a 1000 cm3 RB flask fitted with a dropping funnel, N-bromosuccinamide (NBS) (14.64 g, 
82.01 mmol) was dissolved in acetic acid (400 cm3) and H2O (200 cm3) and the reaction heated 
to 65 °C. The dropping funnel was charged with 1,5-dihydroxynaphthalene 328 (5.01 g, 
20.50 mmol) in warm acetic acid (200 cm3) and this solution was added dropwise to the NBS 
solution. After complete addition, the reaction was maintained at 65 °C for a further 45 min. The 
cooled reaction was then extracted with chloroform (4 × 100cm3) and the organic extracts 
combined. The organic phase was washed with H2O (4 × 200cm3) and brine (200cm3) and dried 
over MgSO4 before being concentrated in vacuo. Recrystallization from ethanol afforded the 
product 251 as yellow granules (5.75 g, 95%).137 
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Rf = 0.07 (20% EtOAc /Hexane); 1H NMR (300 MHz, CDCl3): δH = 8.09 
(1H, dd, J = 7.6, 1.6 Hz, H4), 7.96 (1H, s, H1), 7.67 – 7.53 (2H, m, H2 and 
H3 overlapping), 2.52 (3H, s, H5); 13C NMR (75 MHz): δC = 174.88 (C=O), 
167.94 (C=O), 148.73 (ArCO), 134.03 (C–Br), 131.01(C-1), 129.96 
(ArCH), 126.75 (ArC), 124.88 (ArCH), 119.97 (ArCH), 21.64 (C-5). 
 
7.4.8. Preparation of 2-bromo-5-hydroxy-1,4-naphthalenedione 329 
 
3 N HCl (60 cm3) was added to a suspension of 5-acetoxy-2-bromo-1,4-naphthalenedione 251 
(5.16 g, 17.48 mmol) in ethanol (200 cm3). The suspension was heated gently under reflux for 
90mins. The reaction mixture was concentrated in vacuo and the resulting residue extracted with 
chloroform (3 × 100cm3). The organic extracts were combined and washed with H2O (4 × 
200cm3) and brine (200 cm3) before being dried over MgSO4, filtered and the solvent removed in 
vacuo. Column chromatography (5% EtOAc/ Hexane) furnished the product as a yellow solid 
329 (3.03 g, 69%).137 
 
 
Rf = 0.47 (20% EtOAc /Hexane); 1H NMR (300 MHz, CDCl3): δH = 11.81 
(1H, s, OH), 7.77–7.71 (1H, m, ArH), 7.65 (1H, t, J = 7.9 Hz, ArH), 7.50 (1H, 
s, H1), 7.32 (1H, dd, J = 8.4, 1.0 Hz, ArH); 13C NMR (75 MHz): δC = 187.90 
(C=O), 177.29 (C=O), 161.67 (C=O), 147.13 (ArCO), 136.50 (C-1), 135.86 
(ArCH), 131.12 (ArC), 125.30 (ArCH), 120.70 (ArCH), 114.61 (ArC). 
 
7.4.9. Preparation of 2-bromo-5-methoxy-1,4-naphthalenedione 326 
 
In a 100 cm3 RB flask, 2-bromo-5-hydroxy-1,4-naphthalenedione 329 (3.03 g, 11.98 mmol) was 
dissolved in dry CH2Cl2 (40 cm3) followed by addition of silver oxide (10.01 g, 0.13 mol, 
11 equiv.). To this suspension was added methyliodide (3.74 g, 1.7 cm3, 26.35 mmol, 2.2 equiv.) 
and the reaction mixture was stirred for 24 h under argon at room temperature. The suspension 
was filtered through celite and the solvent removed in vacuo. The resulting residue was purified 
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by column chromatography (20% EtOAc/ Hexane) to give the product as a yellow solid 326 
(1.35 g, 43%).137 
 
Rf = 0.07 (20% EtOAc /Hexane); IR (CHCl3): νmax(cm–1):3043 and 2921 (C–
H), 1674 and 1648 (C=O), 1342 (C-O), 666 (C–Br); 1H NMR (500 MHz, 
CDCl3): δH = 7.84 (1H, dd, J = 7.7, 1.0 Hz, ArH), 7.72–7.67 (1H, m, ArH), 
7.35 (1H, d, J = 8.5 Hz, ArH), 4.02 (3H, s, OCH3); 13C NMR (126 MHz): δC 
= 181.50 (C=O), 178.30 (C=O), 160.02 (ArCO), 142.35 (C-1), 136.90 (ArC), 135.09 (C-3), 
133.12 (ArC), 120.67 (C-4), 119.36 (C-2), 118.49 (ArCBr), 56.60 (OCH3).  
 
7.4.10. Preparation of 3-allyl-2-bromo-5-methoxy-1,4-naphthoquinone 329 
 
To a mixture of 2-bromo-5-methoxy-1,4-naphthoquinone 326 (3.55g, 13.29 mmol) and silver 
nitrate (1.16 g, 6.64 mmol, 0.5 equiv.) in dry MeCN (220 cm3) was added vinyl acetic acid (1.72 
g, 2.0 cm3, 19.93 mmol, 1.5 equiv.). The reaction mixture was heated to 65 °C and ammonium 
persulphate (6.04 g, 26.58 mmol, 2.0 equiv.) in distilled water (180 cm3) was added dropwise to 
the reaction mixture over 30 min. After stirring for 16 hours at 65 °C under argon, the cooled 
reaction mixture was extracted into EtOAc (4 × 100 cm3) washed sequentially with NaHCO3 (2 
× 100 cm3) followed by brine (100 cm3) and dried over MgSO4. After filtering through celite 
and the solvent was removed in vacuo, the crude product was purified by silica gel 
chromatography (20–30% EtOAc/Hexane) to yield the product as a yellow solid 329 (0.95 g, 
79%).138 
 
Rf = 0.31 (30% EtOAc /Hexane); IR (CHCl3): νmax(cm–1): 2928 and 
2841 (C–H), 1604 and 1468 (Ar-C=C), 1255 (C–O), 1007 and 909 
(Allyl-C=C); 1H NMR (500 MHz, CDCl3): δH = 7.82 (1H, dd, J = 7.7, 
1.0 Hz, H1), 7.67 (1H, dd, J = 10.2, 6.0 Hz, H2), 7.32 (1H, d, J = 8.4, 0.6 
Hz, H3), 5.86 (1H, ddt, J = 16.7, 10.0, 6.6 Hz, H5), 5.27 (1H, dq, J = 17.1, 1.5 Hz, H6), 5.13 (1H, 
ddd, J = 10.0, 2.6, 1.3 Hz, H6), 4.02 (3H, s, OCH3), 3.60 (2H, dt, J = 6.6, 1.4 Hz, H4); 13C NMR 
(126 MHz): δC = 180.29 (C=O), 178.14 (C=O), 160.08 (ArCO), 150.67 (ArC), 136.61 (ArCBr), 
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134.94 (C-5), 133.34 (ArC), 131.74 (C-2), 120.31 (C-3), 119.21 (ArC), 118.23 (C-1), 118.18 (C-
6), 56.56 (OCH3), 35.76 (C-4).  
 
7.4.11. Preparation of 3-allyl-2-bromo-1,4,5-trimethoxynaphthalene 330 
 
To a clear solution of 3-allyl-2-bromo-5-methoxy-1,4-naphthoquinone 329 (0.47 g, 1.53 mmol) 
in dry THF (25 cm3)  was added sodium dithionite (1.62 g, 9.19 mmol, 6 equiv.) in H2O (10 cm3) 
and TBAI (0.05 g, 0.14 mmol, 0.09 equiv.). The reaction was stirred at room temperature under 
argon for 30 minutes following addition of potassium hydroxide (2.02 g, 35.23 mmol, 23 equiv.) 
in H2O (100 cm3) was added.  The reaction was stirred for 1 hour and dimethyl sulfate (4.06 g, 
3.1 cm3, 32.17 mmol, 21 equiv.) was added. The reaction mixture was stirred for 18 hours before 
being quenched with  25% ammonia (50 cm3) and the organic material extracted into EtOAc (3 × 
100 cm3). The organic layer was sequentially washed with distilled water (100 cm3), 10% HCl 
(100 cm3), brine (100 cm3) and distilled water (100 cm3). The organic extract was dried over 
MgSO4, filtered through celite and concentrated in vacuo. The crude product was purified by 
silica gel chromatography (5% EtOAc/Hexane) to afford the product as a yellow solid 330 
(1.2836g, 75%).138 
 
Rf = 0.67 (50% EtOAc /Hexane); IR (CHCl3): νmax(cm–1): 2930 and 
2835 (C–H), 1611 and 1494 (C=C), 1243 (C–O), 602 (C–Br); 1H NMR 
(500 MHz, CDCl3): δH = 7.70 (1H, dd, J = 8.4, 0.6 Hz, H1), 7.38 (1H, 
dd, J = 8.3, 7.9 Hz,, H2), 6.87 (1H, dd, J = 7.7, 0.5 Hz, H3), 6.06 (1H, 
ddt, J = 16.2, 10.3, 5.9 Hz, H5), 5.05 (1H, ddq, J = 17.0, 15.4, 1.7 Hz, H6) 3.97 (3H, s, OCH3), 
3.92 (2H, dt, J = 6.6, 1.4 Hz, H4), 3.80–3.78 (5H, m, OCH3 and H4 overlapping); 13C NMR (126 
MHz): δC = 156.05 (ArCO), 151.19 (ArCO), 149.69 (ArCO), 136.14 (C-5), 130.41 (ArC), 
129.69 (ArC), 126.67 (ArCH), 120.02 (ArC), 117.46 (C-Br), 115.69 (C-6), 114.98 (ArCH), 
106.62 (ArCH), 62.86 (OCH3), 61.08 (OCH3), 56.16 (OCH3), 34.36 (C-4). 
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5
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7.4.12. Preparation of 1-(bromomethyl)-3-methoxy-5-methylbenzene 338 
 
NBS (5.98 g, 33.59 mmol, 0.95 equiv.) was added to a solution of 3,5-dimethylanisole 337 (4.82 
g, 5.0 cm3, 35.36 mmol) and benzoyl peroxide (0.88 g, 3.54 mmol, 0.11 equiv.) in carbon 
tetrachloride (350cm3). The reaction was heated gently under reflux for 4h. The reaction was 
then concentrated in vacuo and the resulting residue extracted into chloroform (3 × 100 cm3), 
washed with H2O (100 cm3) and dried with MgSO4. The organic phase was filtered and the 
solvent removed in vacuo to afford a yellow oil (5.74g, 75%). The crude product 338 was used 
without purification for the next step.141 
 
Rf = 0.46 (50% EtOAc /Hexane); IR (CHCl3): νmax(cm–1): 2914 and 2840 (C–H 
stretch), 1598 and 1455 (C=C), 1114 (C–O), 644 (C–Br); 1H NMR (500 MHz, 
CDCl3): δH = 6.78 (1H, s, H), 6.72 (1H, s, H), 6.64 (1H, s, H), 4.40 (2H, s, –
CH2–), 3.76 (1H, s, OCH3), 2.29 (3H, s, CH3); 13C NMR (75MHz) δC = 159.76 
(ArCO), 139.90 (ArC), 138.85 (ArC), 122.17 (ArCH), 115.02 (ArCH), 111.46 (ArCH), 55.18 
(OCH3), 33.66 (CH2), 21.38 (CH3). 
 
7.4.13. Preparation of 3-methoxy-5-methylbenzaldehyde 339 
 
1-(bromomethyl)-3-methoxy-5-methylbenzene 338 (5.74 g, 26.67 mmol) in ethanol (5 cm3) and 
2-nitropropane (3.92 g, 4.0cm3, 44.0 mmol) were added to a solution of sodium ethoxide 
[prepared from ethanol (50 cm3) and sodium (1.12 g, 48.8 mmol)] and the reaction mixture 
heated at 90 °C for 4 h under argon during which time it became a creamy paste. The solvent was 
then removed in vacuo and the residue was extracted into chloroform (3 × 50 cm3). The 
combined extracts were combined and dried over MgSO4 , filtered through celite and evaporated 
under reduced pressure. The crude material was purified by column chromatography (5% 
EtOAc/Hexane) to yield the aldehyde 339 as a pale yellow oil (1.20 g, 30%).141  
 
Rf = 0.49 (20% EtOAc /Hexane); IR (CHCl3): νmax(cm–1): 2484 (C–H), 1697 
(C=O), 1594 and 1465 (C=C), 1149 (C–O); 1H NMR (500 MHz, CDCl3): δH = 
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9.92 ( 1H, s, CHO), 7.26 (1H, s, H2), 7.19 (1H, s, H3), 6.98 (1H, s, H1), 3.84 (3H, s, OCH3), 2.39 
(3H, s, CH3); 13C NMR (126 MHz): δC = 192.30 (C=O), 160.18 (ArCO), 140.35 (ArC), 137.78 
(ArC), 124.33 (ArH), 122.12 (ArH), 109.54 (ArH), 55.43 (OCH3), 21.20 (CH3). 
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Appendix 
X-ray chrystallography data for 7H-benzo[3,4]cyclohepta[1,2-b]naphthalene-8,13-dione 
 
         
 
Table A1.  Crystal data and structure refinement. 
 
Identification code  MJ-535 
Empirical formula  C19 H12 O2 
Formula weight  272.29 
Temperature  173(2) K 
Wavelength  0.71069 Å 
Crystal system  Monoclinic 
Space group  P2(1)/n 
Unit cell dimensions a = 7.5170(4) Å a= 90°. 
 b = 8.0460(4) Å b= 90.091(2)°. 
 c = 21.9940(10) Å g = 90°. 
Volume 1330.23(11) Å3 
Z 4 
Density (calculated) 1.360 Mg/m3 
Absorption coefficient 0.087 mm-1 
F(000) 568 
Crystal size 0.41 x 0.40 x 0.04 mm3 
Theta range for data collection 3.71 to 27.99°. 
Index ranges -9<=h<=9, -10<=k<=10, -28<=l<=26 
Reflections collected 18565 
Independent reflections 3207 [R(int) = 0.0290] 
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Completeness to theta = 27.99° 99.6 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.9969 and 0.9653 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3207 / 0 / 190 
Goodness-of-fit on F2 1.050 
Final R indices [I>2sigma(I)] R1 = 0.0408, wR2 = 0.1020 
R indices (all data) R1 = 0.0522, wR2 = 0.1096 
Largest diff. peak and hole 0.369 and -0.161 e.Å-3 
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Table A2. .Atomic coordinates ( x 104) and equivalent isotropic displacement parameters (Å2x 
103). U(eq) is defined as one third of the trace of the orthogonalized Uij tensor. 
 
 x y z U(eq) 
 
C(1) 5444(1) 3687(1) 5912(1) 19(1) 
C(2) 6872(1) 2657(1) 5623(1) 20(1) 
C(3) 6560(2) 2004(1) 4998(1) 21(1) 
C(4) 7956(2) 1214(2) 4695(1) 26(1) 
C(5) 7657(2) 517(2) 4127(1) 32(1) 
C(6) 5983(2) 613(2) 3859(1) 33(1) 
C(7) 4595(2) 1409(2) 4155(1) 28(1) 
C(8) 4887(2) 2115(1) 4728(1) 22(1) 
C(9) 3415(1) 2978(1) 5052(1) 22(1) 
C(10) 3808(1) 3769(1) 5651(1) 20(1) 
C(11) 2299(2) 4649(2) 5966(1) 25(1) 
C(12) 1853(2) 3706(2) 6539(1) 27(1) 
C(13) 2983(2) 3639(2) 7004(1) 28(1) 
C(14) 4739(2) 4441(2) 7011(1) 25(1) 
C(15) 5329(2) 5164(2) 7555(1) 34(1) 
C(16) 6945(2) 5967(2) 7600(1) 39(1) 
C(17) 8053(2) 6039(2) 7094(1) 33(1) 
C(18) 7536(2) 5300(2) 6556(1) 25(1) 
C(19) 5882(2) 4496(1) 6500(1) 20(1) 
O(1) 8225(1) 2287(1) 5899(1) 29(1) 
O(2) 1933(1) 3087(1) 4826(1) 34(1) 
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Table A3.  Bond lengths [Å] and angles [°]. 
 
C(1)-C(10)  1.3582(15) 
C(1)-C(19)  1.4833(15) 
C(1)-C(2)  1.4984(15) 
C(2)-O(1)  1.2205(13) 
C(2)-C(3)  1.4892(15) 
C(3)-C(8)  1.3933(15) 
C(3)-C(4)  1.3969(16) 
C(4)-C(5)  1.3873(17) 
C(4)-H(4)  0.9500 
C(5)-C(6)  1.391(2) 
C(5)-H(5)  0.9500 
C(6)-C(7)  1.3873(18) 
C(6)-H(6)  0.9500 
C(7)-C(8)  1.3996(16) 
C(7)-H(7)  0.9500 
C(8)-C(9)  1.4889(16) 
C(9)-O(2)  1.2221(14) 
C(9)-C(10)  1.4923(16) 
C(10)-C(11)  1.5061(15) 
C(11)-C(12)  1.5095(16) 
C(11)-H(11A)  0.9900 
C(11)-H(11B)  0.9900 
C(12)-C(13)  1.3299(18) 
C(12)-H(12)  0.9500 
C(13)-C(14)  1.4691(17) 
C(13)-H(13)  0.9500 
C(14)-C(15)  1.4027(17) 
C(14)-C(19)  1.4171(16) 
C(15)-C(16)  1.379(2) 
C(15)-H(15)  0.9500 
C(16)-C(17)  1.392(2) 
C(16)-H(16)  0.9500 
C(17)-C(18)  1.3799(17) 
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C(17)-H(17)  0.9500 
C(18)-C(19)  1.4066(16) 
C(18)-H(18)  0.9500 
 
C(10)-C(1)-C(19) 123.14(10) 
C(10)-C(1)-C(2) 119.76(10) 
C(19)-C(1)-C(2) 117.00(9) 
O(1)-C(2)-C(3) 120.19(10) 
O(1)-C(2)-C(1) 121.38(10) 
C(3)-C(2)-C(1) 118.34(10) 
C(8)-C(3)-C(4) 120.24(10) 
C(8)-C(3)-C(2) 120.80(10) 
C(4)-C(3)-C(2) 118.91(10) 
C(5)-C(4)-C(3) 119.52(11) 
C(5)-C(4)-H(4) 120.2 
C(3)-C(4)-H(4) 120.2 
C(4)-C(5)-C(6) 120.34(12) 
C(4)-C(5)-H(5) 119.8 
C(6)-C(5)-H(5) 119.8 
C(7)-C(6)-C(5) 120.45(11) 
C(7)-C(6)-H(6) 119.8 
C(5)-C(6)-H(6) 119.8 
C(6)-C(7)-C(8) 119.55(12) 
C(6)-C(7)-H(7) 120.2 
C(8)-C(7)-H(7) 120.2 
C(3)-C(8)-C(7) 119.89(11) 
C(3)-C(8)-C(9) 119.78(10) 
C(7)-C(8)-C(9) 120.33(11) 
O(2)-C(9)-C(8) 121.07(11) 
O(2)-C(9)-C(10) 120.52(10) 
C(8)-C(9)-C(10) 118.36(10) 
C(1)-C(10)-C(9) 122.05(10) 
C(1)-C(10)-C(11) 120.70(10) 
C(9)-C(10)-C(11) 117.24(9) 
C(10)-C(11)-C(12) 108.42(9) 
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C(10)-C(11)-H(11A) 110.0 
C(12)-C(11)-H(11A) 110.0 
C(10)-C(11)-H(11B) 110.0 
C(12)-C(11)-H(11B) 110.0 
H(11A)-C(11)-H(11B) 108.4 
C(13)-C(12)-C(11) 121.32(11) 
C(13)-C(12)-H(12) 119.3 
C(11)-C(12)-H(12) 119.3 
C(12)-C(13)-C(14) 124.29(11) 
C(12)-C(13)-H(13) 117.9 
C(14)-C(13)-H(13) 117.9 
C(15)-C(14)-C(19) 118.23(11) 
C(15)-C(14)-C(13) 118.32(11) 
C(19)-C(14)-C(13) 123.44(10) 
C(16)-C(15)-C(14) 122.16(12) 
C(16)-C(15)-H(15) 118.9 
C(14)-C(15)-H(15) 118.9 
C(15)-C(16)-C(17) 119.38(12) 
C(15)-C(16)-H(16) 120.3 
C(17)-C(16)-H(16) 120.3 
C(18)-C(17)-C(16) 119.98(12) 
C(18)-C(17)-H(17) 120.0 
C(16)-C(17)-H(17) 120.0 
C(17)-C(18)-C(19) 121.40(11) 
C(17)-C(18)-H(18) 119.3 
C(19)-C(18)-H(18) 119.3 
C(18)-C(19)-C(14) 118.81(10) 
C(18)-C(19)-C(1) 118.24(10) 
C(14)-C(19)-C(1) 122.91(10) 
 
Symmetry transformations used to generate equivalent atoms. 
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Table A4.  Anisotropic displacement parameters (Å2x 103).  The anisotropic displacement factor 
exponent takes the form: -2p2[ h2a*2U11 + ... + 2 h k a* b* U12 ] 
 
 U11 U22 U33 U23 U13 U12 
 
C(1) 21(1)  18(1) 18(1)  2(1) 2(1)  0(1) 
C(2) 21(1)  19(1) 20(1)  2(1) 1(1)  -1(1) 
C(3) 26(1)  17(1) 19(1)  2(1) 2(1)  -1(1) 
C(4) 30(1)  22(1) 25(1)  1(1) 4(1)  2(1) 
C(5) 44(1)  25(1) 26(1)  -2(1) 9(1)  4(1) 
C(6) 53(1)  25(1) 20(1)  -4(1) 2(1)  -2(1) 
C(7) 38(1)  23(1) 22(1)  1(1) -4(1)  -5(1) 
C(8) 28(1)  18(1) 19(1)  2(1) 1(1)  -3(1) 
C(9) 23(1)  23(1) 21(1)  5(1) -1(1)  -4(1) 
C(10) 21(1)  18(1) 21(1)  3(1) 2(1)  -1(1) 
C(11) 21(1)  27(1) 27(1)  1(1) 1(1)  5(1) 
C(12) 22(1)  26(1) 32(1)  0(1) 7(1)  1(1) 
C(13) 30(1)  28(1) 25(1)  1(1) 9(1)  2(1) 
C(14) 29(1)  23(1) 23(1)  -1(1) 2(1)  5(1) 
C(15) 41(1)  38(1) 23(1)  -7(1) 3(1)  7(1) 
C(16) 45(1)  40(1) 31(1)  -16(1) -8(1)  5(1) 
C(17) 31(1)  30(1) 38(1)  -10(1) -8(1)  0(1) 
C(18) 25(1)  23(1) 27(1)  -1(1) -2(1)  2(1) 
C(19) 23(1)  18(1) 20(1)  -1(1) -2(1)  4(1) 
O(1) 23(1)  36(1) 27(1)  -5(1) -4(1)  8(1) 
O(2) 24(1)  49(1) 28(1)  1(1) -5(1)  -2(1) 
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Table A5.   Hydrogen coordinates ( x 104) and isotropic displacement parameters (Å2x 103). 
 
x  y  z  U(eq) 
 
H(4) 9102 1155 4877 31 
H(5) 8600 -27 3921 38 
H(6) 5789 129 3470 39 
H(7) 3455 1474 3970 33 
H(11A) 1247 4694 5695 30 
H(11B) 2652 5801 6067 30 
H(12) 742 3149 6568 32 
H(13) 2633 3032 7354 33 
H(15) 4592 5098 7905 40 
H(16) 7299 6466 7972 46 
H(17) 9165 6596 7119 40 
H(18) 8314 5335 6216 30 
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Table A6.  Torsion angles [°]. 
 
C(10)-C(1)-C(2)-O(1) -165.32(11) 
C(19)-C(1)-C(2)-O(1) 11.17(16) 
C(10)-C(1)-C(2)-C(3) 11.07(15) 
C(19)-C(1)-C(2)-C(3) -172.44(9) 
O(1)-C(2)-C(3)-C(8) 166.27(11) 
C(1)-C(2)-C(3)-C(8) -10.16(15) 
O(1)-C(2)-C(3)-C(4) -11.14(16) 
C(1)-C(2)-C(3)-C(4) 172.43(10) 
C(8)-C(3)-C(4)-C(5) -1.03(17) 
C(2)-C(3)-C(4)-C(5) 176.40(11) 
C(3)-C(4)-C(5)-C(6) 0.42(18) 
C(4)-C(5)-C(6)-C(7) 0.18(19) 
C(5)-C(6)-C(7)-C(8) -0.18(19) 
C(4)-C(3)-C(8)-C(7) 1.03(17) 
C(2)-C(3)-C(8)-C(7) -176.35(10) 
C(4)-C(3)-C(8)-C(9) -179.25(10) 
C(2)-C(3)-C(8)-C(9) 3.37(16) 
C(6)-C(7)-C(8)-C(3) -0.43(17) 
C(6)-C(7)-C(8)-C(9) 179.86(11) 
C(3)-C(8)-C(9)-O(2) -179.76(11) 
C(7)-C(8)-C(9)-O(2) -0.04(17) 
C(3)-C(8)-C(9)-C(10) 2.66(16) 
C(7)-C(8)-C(9)-C(10) -177.63(10) 
C(19)-C(1)-C(10)-C(9) 178.48(10) 
C(2)-C(1)-C(10)-C(9) -5.25(16) 
C(19)-C(1)-C(10)-C(11) -2.60(16) 
C(2)-C(1)-C(10)-C(11) 173.67(10) 
O(2)-C(9)-C(10)-C(1) -179.27(11) 
C(8)-C(9)-C(10)-C(1) -1.68(16) 
O(2)-C(9)-C(10)-C(11) 1.77(16) 
C(8)-C(9)-C(10)-C(11) 179.37(10) 
C(1)-C(10)-C(11)-C(12) -65.64(14) 
C(9)-C(10)-C(11)-C(12) 113.33(11) 
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C(10)-C(11)-C(12)-C(13) 67.46(14) 
C(11)-C(12)-C(13)-C(14) -0.29(19) 
C(12)-C(13)-C(14)-C(15) 142.06(13) 
C(12)-C(13)-C(14)-C(19) -39.21(18) 
C(19)-C(14)-C(15)-C(16) 2.32(19) 
C(13)-C(14)-C(15)-C(16) -178.89(12) 
C(14)-C(15)-C(16)-C(17) -1.4(2) 
C(15)-C(16)-C(17)-C(18) -0.5(2) 
C(16)-C(17)-C(18)-C(19) 1.4(2) 
C(17)-C(18)-C(19)-C(14) -0.44(17) 
C(17)-C(18)-C(19)-C(1) -178.17(11) 
C(15)-C(14)-C(19)-C(18) -1.36(17) 
C(13)-C(14)-C(19)-C(18) 179.91(11) 
C(15)-C(14)-C(19)-C(1) 176.26(11) 
C(13)-C(14)-C(19)-C(1) -2.47(18) 
C(10)-C(1)-C(19)-C(18) -138.88(11) 
C(2)-C(1)-C(19)-C(18) 44.76(14) 
C(10)-C(1)-C(19)-C(14) 43.49(16) 
C(2)-C(1)-C(19)-C(14) -132.87(11) 
 
Symmetry transformations used to generate equivalent atoms.  
 
 
 
 
 
